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ABSTRACT 
  
Pharmaceutical R&D is currently undergoing a productivity crisis. Also, the loss 
of activity of established medicines continues to reduce the pool of agents capable of 
treating infectious diseases. Small molecule synthesis and synthetic methodology 
development continue to be essential scientific endeavors due to the ability of synthetic 
chemistry to create new starting points for the development of medicines. Therefore, in 
order to increase the ability to discover new medicines, more efficient synthetic 
strategies and transformations capable of generating structurally complex drug-like 
molecules are required. 
 This work explored the transannular bis-Michael reaction (TMR) as a potential 
method to access polycyclic natural products in an efficient manner. We sought to 
develop an expedient route to an all-carbon Z,E macrocyclic precursor to the TMR and 
we then evaluated whether the Z,E isomer would follow our proposed model for the 
TMR. Our strategy relied on a 1,3-dipolar cycloaddition to access the TMR precursor. 
However, this 1,3-dipolar synthetic route had a low synthetic efficiency.   
Consistent with our other studies, this Z,E-macrocyclic bis-enone was found to 
be inactive in the transannular bis-Michael reaction cascade for the conditions evaluated. 
En route, we also discovered that our 1,3-dipolar cycloaddition gave a rare 3,4-
disubstituted isoxazole under kinetic reaction conditions. We also demonstrated that the 
dipolar cycloaddition is reversible and the thermodynamic 3,5-disubstituted isoxazole 
can be obtained through isomerization of its 3,4-disubstituted isomer under elevated 
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temperature. Our initial mechanistic studies support the role of hydrogen-bonding in 
accelerating the isomerization process. 
 Our work in developing new palladium-catalyzed reactions resulted in a novel 
palladium-catalyzed enamine Heck reaction. This reaction is capable of generating α,β-
unsaturated ketones directly from aldehydes and vinyl iodides. However, the limitations 
of scope in both vinyl iodide and aldehyde severely limit the synthetic utility of the 
reaction described herein.  
 Also, our work clearly demonstrated a novel enantioconvergent approach to 3-
allyl-3-alykl-indolenines through the use of a chiral palladium/trialkylborane dual 
catalyst system. We suggest a greater role of trialkyl borane beyond allylic alcohol 
activation in previous allylation examples employing R3B/allyl alcohol as the allyl 
source. 
 Finally, we extended or understanding of the role of Et3B to the Tamaru 
allylation. The Lewis acid, Et3B, facilitates enolization and behaves as a co-catalyst to 
effect the allylation of aldehydes. We have also begun developing an enantioselective 
version of this reaction that suffers from low enantioselectivity. This reaction was shown 
to be selective for aldehydes as ketones did not react under the described conditions. 
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NOMENCLATURE 
 
4 Å MS 4 Angstrom Molecular Sieves 
9-BBN 9-Borabicyclo[3.3.1]nonane 
AIBN Azobisisobutyronitrile 
Ar- Aryl 
B Base 
Bn Benzyl 
BOMO Benzyloxymethyl-O-  
dba Dibenzylideneacetone 
 
Cat. Catalytic 
CBS Corey-Bakshi-Shibata 
Cp Cyclopentadienyl 
1,2-DCE 1,2-Dichloroethane 
DCM Dichloromethane 
dia Diastereomer 
DIBAL Diisobutylaluminum Hydride 
DIOP 2,3-O-Isopropylidene-2,3-dihydroxy-1,4- 
 bis(diphenylphosphino)butane 
DIPA Diisopropylamine 
DMA Dimethylacetamide 
DMAP 4-Dimethylaminopyridine 
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DME Dimethoxyethane 
DMF Dimethylformamide 
DMSO Dimethyl sulfoxide 
dppb 1,2-bis(Diphenylphosphino)Butane 
dppe 1,2-bis(Diphenylphosphino)Ethane 
dppf 1,2-bis(Diphenylphosphino)ferrocene 
dppp 1,2-bis(Diphenylphosphino)propane 
dr Diastereomeric Ratio 
DYKAT Dynamic Kinetic Asymmetric Transformation 
ee Enantiomeric Excess 
ent Enantiomer 
FMO Frontier Molecular Orbital 
h, hr, hrs Hour/Hours 
HOMO Highest Occupied Molecular Orbital 
hν Photon Irradiation 
HMPA Hexamethylphosphoramide 
IBX 2-Iodoxy-Benzoic Acid 
i-Pr Isopropyl 
Ln Any Number of Ligands 
LDA Lithium Diisopropylamide 
LiHMDS Lithium bis(Trimethylsilyl)Amide 
LUMO Lowest Unoccupied Molecular Orbital 
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M Metal Atom 
Me Methyl 
n-Bu Butyl 
NCS N-Chloro-Succinimide 
NF-κB Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells  
NHK Nozaki-Hiyama-Kishi 
NIS N-Iodo-Succinimide 
NMO N-Methylmorpholine N-Oxide 
NMR Nuclear Magnetic Resonance 
Nu Nucleophile 
OAc Acetate 
OTf Trifluoromethanesulfonate 
Ph Phenyl 
PHOX 2-[2-(Diphenylphosphino)Phenyl]-2-Oxazoline  
PMB para-Methoxybenzyl 
R Any Alkyl, Aryl, Vinyl, or Alkynyl Group 
r.t. Room Temperature 
 (S)-BINAP (S)-(−)-2,2′-bis(Diphenylphosphino)-1,1′-Binaphthyl 
T Temperature 
TBAC Tetrabutylammonium Chloride 
TBDPS tert-Butyldiphenylsilyl 
TBS tert-Butyldimethylsilyl 
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t-Bu tert-Butyl 
TBAF Tetra-n-Butylammonium Fluoride 
TEMPO (2,2,6,6-Tetramethyl-Piperidin-1-yl)Oxyl 
TES Triethylsilyl 
TFA Trifluoroacetic Acid 
THF Tetrahydrofuran 
TIPS Triisopropylsilyl 
TMR Transannular bis-Michael Reaction 
TMS Trimethylsilyl 
Tol-BINAP 2,2′-Bis(di-p-tolylphosphino)-1,1′-binaphthyl 
TPAP Tetrapropylammonium Perruthenate 
Ts Tosyl 
X- Any Halide 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
 Our world is faced with many challenges, not the least of which are the 
productivity crisis in drug discovery1 and the emergence of drug-resistant pathogens.2 
Faced with the diminishing returns of pharmaceutical R&D and the loss of activity of 
established medicines, small molecule synthesis continues to be an essential scientific 
endeavor. However, new tools for the expedient exploration of diverse chemical space 
are in dire need. Most small molecule libraries used in drug discovery contain molecules 
comprised of extended sp2 systems with little to no stereochemical complexity.3,4 
Therefore, in order to increase the ability to discover new medicines, more efficient 
synthetic strategies and transformations capable of generating structurally complex drug-
like molecules are required. It is through this light that the following research should be 
viewed. The progress described within not only focused on the development of a new 
synthetic strategy to access biologically relevant, stereochemically complex natural 
products; the research also dealt with new palladium-catalyzed bond-forming strategies 
with the aim of eventual application in synthesis.  
 
The Transannular bis-Michael Reaction and Synthetic Studies of Celastrol 
Chemical Structure and Biology of Celastrol 
 The extracts of the Trypterygium wilfordii (Lei Gong Teng), have been used in 
traditional Chinese medicine to treat rheumatoid arthritis, an autoimmune disease, for 
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hundreds of years. Recent interest in the extracts' therapeutic effects has led to eleven 
clinical trials in various stages of completion.5 One of the active components in the 
extracts of T. wilfordii is celastrol 1-1 (Figure 1-1).6,7 Of special interest is the molecular 
biology of celastrol. In animal models of lupus, arthritis, amyotrophic lateral sclerosis 
and Alzheimer's disease, celastrol was found to inhibit the inflammatory response.8 
Celastrol was also shown to induce multiple biological effects at the molecular level, 
such as NF-κB pathway perturbation, proteasome inhibition, topoisomerase II inhibition 
and heat shock response activation.8 While it is known that celastrol can alter these 
pathways, the exact molecular target(s) remains unknown.  
 With the opportunity to explore novel biology as well as develop new chemistry, 
we turned our attention to the structure of 1-1. Celastrol is representative of a small 
group of quinone methide triterpenoids isolated from the families Celastraceae and 
Hippocrateaceae.9 These molecules feature an o-hydroxy substituted p-quinone methide 
ring system embedded within a D:A-freido-nor-oleanane skeleton which contains a 
perhydrophenanthrene ring system (highlighted red in Figure 1-1). As of yet there is no 
total synthesis of celastrol in the literature. 
 
 
Figure 1-1. Celastrol 
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Methods of Perhydrophenanthrene Construction in Total Synthesis 
 The construction of the perhydrophenanthrene ring system of 1-1 is the key 
synthetic challenge in the total synthesis of celastrol. This is due to the large array of all-
carbon quaternary stereocenters without obvious functional group handles for their 
construction. Therefore, a brief examination of previous efforts to synthesize similar 
systems serves to give a setting to our strategy for the perhydrophenanthrene ring system 
of 1-1. The focus is on cascade or intramolecular reactions and these reactions have been 
divided into four categories: cationic cyclization cascades, radical cyclization cascades, 
pericyclic reactions, and Michael reactions. 
Cationic Cyclization Cascade Reactions 
 Fused carbocyclic systems abound in natural products and have captured the 
imagination of synthetic organic chemists for decades. One of the earliest proving 
grounds for synthetic methodology was the collection of natural products known as 
steroids which contain a complex carbocyclic core. One of the first major breakthroughs 
in the synthesis of these steroid molecules was the biomimetic total synthesis of 
progesterone by Johnson and coworkers (Scheme 1-1).10 The development of Stork-
Eschenmoser hypothesis,11 describing the stereochemical relationship between linear 
polyunsaturated systems and the cyclization product resulting from the cationic 
cyclization cascade, allowed for the controlled formation of 1-4 from 1-3  using TFA to 
generate the cationic intermediate from 1-3. This two part sequence of cationic 
cyclization cascade/trapping followed by hydrolysis of the resulting ethylene carbonium 
cation generated 1-4 in 72% yield. It is important to note that the cationic cascade 
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generated three carbocycles and set 6 stereocenters of which two are all-carbon 
quaternary centers. 
 
 
Scheme 1-1. The Johnson synthesis of progesterone 
 Major advances in this strategy include the development of mild and/or 
enantioselective Lewis acid catalysts to effect this transformation. Current examples 
abound in the literature with Corey's synthesis of lupeol in 2009 being noteworthy for 
the rapid enantioselective construction of the polycyclic core.12 
 Despite the history of synthetic achievement for cationic cyclizations, there are 
limitations to this strategy. Chief among these is the requisite formation of a reactive 
carbocationic species in situ. These high energy species are subject to rearrangement and 
hydride shifting and therefore substrates where these side reactions can occur are not 
suitable for the cationic cyclization cascade. 
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Radical Cyclization Cascade Reactions 
  Over the past few decades, many new methods have been developed to generate 
stereochemically complex polycycles. One of the most versatile has proven to be radical 
cyclization cascades. These cascade reactions take advantage of the generation of a 
carbon radical in close proximity to an array of unsaturated groups so that a series of 
free-radical bond-forming and bond-breaking processes give rise to a desired carbocyclic 
system in a highly controlled manner. One of the earliest natural product total synthesis 
strategies to take advantage of this process was the total synthesis of hirsutene by Curran 
and coworkers.13  
 It was not until 1996 that a strategy of generating a complex polycyclic system 
from an entirely linear precursor was developed. Pattenden and coworkers developed a 
means of accessing polycyclic systems in good yields by using polyunsaturated phenyl 
selenoates as precursors.14 In a representative example from this methodology, 
compound 1-5 was exposed to Bu3SnH and AIBN which generated 1-6 in 78% yield by 
means of a radical cyclization cascade (Scheme 1-2). This reaction set six stereocenters, 
of which three were quaternary, and formed four C-C bonds all with a high degree of 
diastereoselectivity for the carbocyclic core.  
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Scheme 1-2. Radical cyclization cascade to synthesize 1-6 
 One of the major advantages of radical cyclization cascades is the low propensity 
of the radical intermediates to undergo rearrangements compared to carbocations. 
However, radical intermediates are still high energy species and premature termination 
as well as polymerization are major side reactions that can be problematic when 
conducting radical reaction cascades. 
Pericyclic Cyclization Reactions 
 Pericyclic reactions have been one of the most versatile sets of transformations 
available to organic chemistry. These reactions include one of the most widely used 
reactions in total synthesis: the Diels-Alder reaction.15 Other members of the pericyclic 
family merit mention as useful strategies to construct polycyclic carbocycles especially 
the [2+2+2]-carbocylization and the intramolecular ene reaction. Many of these reaction 
types have allowed for the rapid construction of all-carbon ring systems in a highly 
efficient manner. 
 One of the classic examples of a Diels-Alder strategy in the synthesis of 
perhydrophenanthrenes is the synthesis of quassin in 1980 by Grieco (Scheme 1-3).16 In 
this synthesis, a key intermolecular Diels-Alder between 1-8 and 1-9 was conducted 
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using a catalytic amount of AlCl3. The highly substituted perhydrophenanthrene 
derivative 1-10 was generated in 48% yield. The stereoselectivity for the Diels-Alder 
reaction arises because of the endo transition state being favored. 
 
 
Scheme 1-3. The Grieco synthesis of quassin 
 Diels-Alder reactions represent a classic method for the construction of 
polycyclic ring systems through either an intramolecular or intermolecular strategy. 
These reactions also benefit from mild reaction conditions and a well studied 
stereoselectivity. 
 Another type of pericyclic reaction capable of polycycle construction is the 
transition metal-mediated [2+2+2] carbocyclization. In 2004, the Malacria group 
reported the cobalt(I)-facilitated [2+2+2] intramolecular cyclization cascade of 
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allenediyne 1-11 to generate 1-12 in 54% yield with only one diastereomer generated 
(Scheme 1-4).17  
 
 
Scheme 1-4. The Co-mediated [2+2+2] 
  As these examples show, pericyclic reactions provide many routes to a diverse 
family of carbon polycycles. Pericyclic reactions also have the major advantage of 
milder conditions than cationic and radical cyclization cascades. Also, no reactive 
intermediates are formed and, thus, the possibility for rearrangements and side reactions 
is reduced. 
Michael Cyclization Cascade Reactions 
 Conjugate additions have long been a major tool for synthetic chemists to 
construct carbocyclic ring systems.18 Especially with the advent of tandem 
intramolecular processes, Michael cyclization cascade reactions have been demonstrated 
to be highly diastereoselective in addition to being able to form complex polycycles. An 
illustrative example developed by Fukumoto and coworkers involves treatment of 1-13 
with LiHMDS to generate 1-14 in 58% yield and as a single isomer (Scheme 1-5).19 This 
intramolecular process generated a high degree of structural complexity in a single step. 
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Scheme 1-5. The Fukumoto Michael cyclization cascade 
 In 2007, a new type of Michael cascade reaction was reported by Evans and 
coworkers in the course of their total synthesis of salvinorin A: the transannular bis-
Michael reaction.20 This reaction is astonishing both in the mild conditions required for 
the reaction (TBAF in THF at -78 oC) and in the 99% yield reported of 1-17 from 1-15 
(Scheme 1-6). Furthermore, only one diastereomer was isolated. The high 
diastereoselectivity of the transannular bis-Michael reaction (TMR) arises from a highly 
ordered transition state, 1-16, with a proposed chair-like conformation adopted in 
transition state.  
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Scheme 1-6. The transannular bis-Michael reaction 
The initial alkene geometries of 1-15 are translated into the relative stereochemistry of 
the angular methyls in 1-17. However, the Evans example is only one isomer of the four 
possible double bond isomers that could react under the TMR conditions. Furthermore, 
the TMR had only been demonstrated in a macrolide setting. We were curious if an all-
carbon macrocycle could undergo the TMR and give a perhydrophenanthrene ring 
system. In addition, a knowledge gap existed regarding the complete relationship 
between the stereochemical structure of the four precursors and that of their cyclized 
products. We therefore proposed a stereochemical model to address this knowledge gap 
and we sought to test the scope of the TMR and evaluate if the TMR could be used in the 
construction of a perhydrophenanthrene ring system.  
The Transannular bis-Michael Reaction 
Advantages of Transannular Reactions 
 Transannular is a term applied to chemical reactions that involve two or more 
groups reacting "across the ring". Transannular reactions are intramolecular reactions by 
definition and, as such, have several key advantages over intermolecular reactions 
(Figure 1-2). The first of which is transannular reactions can take advantage of the 
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conformational preference of ring systems in order to direct the stereochemistry of the 
reaction.18 Medium and large ring systems (8-14 atom rings) have well defined 
conformations and the ability of conformations to direct the stereochemical outcome of 
reactions has long been known in organic chemistry as macrocyclic stereocontrol. 
Secondly, transannular reactions have the advantage of rate acceleration due to the 
proximal nature of the reacting groups. The third key advantage is the ability of 
transannular reactions to form multiple smaller rings in one step from reacting functional 
 
 
Figure 1-2. Types of reactions 
groups that are kept in close proximity. The efficiency of the constructing many rings 
with stereocontrol in one step is of high value to modern organic synthesis.21  
The Stereochemical Model of the Transannular bis-Michael Reaction 
 We set about to compose a model that would allow chemists to predict the 
product of the TMR given the double bond geometry of hypothetical starting material of 
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either macrolide or all-carbon character. We proposed a model analogous to the Stork-
Eschenmoser hypothesis of cationic polyene cyclization whereby the transannular bis-
Michael reaction cascade would proceed through a tight, chair-like transition state 
whenever possible and the initial alkene geometries would translate into the relative 
stereochemistry of the products (Scheme 1-7). 
 
 
Scheme 1-7. A proposed stereochemical model for the TMR 
 We expect that a 9,10-anti perhydrophenanthrene will be generated when the 
macrocyclic bisenone contains a C9-C10 E double bond. Also, our model predicts a 
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9,10-syn perhydrophenanthrene ring system when the C9-C10 double bond is Z. We 
hypothesize that the transition state conformations of the macrocyclic substrates are 
largely determined by the configurations of the C5-C6, C7-C8, and C9-C10 double 
bonds. Also, we expect that the C5-C6 double bond will be Z across all substrates due to 
the favorable hydrogen bond formed between the enol and the adjacent carbonyl oxygen. 
With this model in place, our investigations of the TMR began in the context of eventual 
application in the total synthesis of norzoanthamine (not pictured) and 1-1. We designed 
two classes of TMR precursors: the norzoanthamine class (X=O in Scheme 1-7) and the 
celastrol class (X=CH2 in Scheme 1-7) that would serve the purpose of testing the 
stereochemical model with the appropriate functionality to continue with the respective 
synthesis. 
The Evaluation of the Stereochemical Model of the Transannular bis-Michael Reaction 
  Initially, our model was applied to substrates 1-18 and 1-21 of the 
norzoanthamine class (Scheme 1-8).22 Gratifyingly, these substrates underwent the TMR 
reaction according to our predictions and gave the desired products 1-19 and 1-22 
respectively as characterized by NMR and X-Ray analysis. We hypothesize that the 
three-dimensional structures 1-20 and 1-23 are the reactive conformations of substrates 
1-18 and 1-21. Because of the constraint of the macrocycle in structure 1-18, the C11-
C12 double bond must adopt a pseudo-axial orientation to the incipient ring formed by 
the bond between C21 and C11. In addition, the C21-C22 double bond assumes a 
pseudo-equatorial orientation in the transition state. As a result of these orientations, the 
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cyclization of 1-18 proceeds to give structure 1-19. These same structural analyses can 
be made for 1-21 and yield the same result: our hypothesis holds.  
 
 
Scheme 1-8. Preliminary results of the stereochemical model of the TMR 
The Transannular bis-Michael Reaction in the Total Synthesis of Celastrol 
 Encouraged by our initial results in the evaluation of our model, we turned our 
attention to completing the model with an eye on using the resulting 
perhydrophenanthrenes in the total synthesis of 1-1. As a result of this planning, we 
devised a retrosynthesis as follows (Scheme 1-9). We envisioned that with ester 
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hydrolysis of 1-24 we could synthesize 1-1. The methyl ester 1-24, itself a natural 
product named pristimerin, is expected to come from 1-25 after BCl3 mediated cleavage 
of the methyl ethers followed by oxidative cyclization to form the requisite p-quinone 
methide functionality. Diene 1-25 is expected to be synthesized from 1-26 and A  
through a Pd-mediated cross-coupling followed by functional group manipulations. 
Selective enolization and subsequent transformation of the selectively generated enolates 
is expected to give 1-26 from 1-28. The key transformation in this retrosynthetic plan is  
 
 
Scheme 1-9. Retrosynthetic analysis of 1-1 
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the use of the TMR to generate 1-27 from 1-28 followed by methylation. We therefore 
set out to synthesize 1-28 in order to confirm our stereochemical model and provide a 
synthetic route to celastrol. The course of our experimentation in this endeavor is 
outlined in chapters II and III of this dissertation. 
 
The Development of Novel Palladium-Catalyzed Reactions 
 Organic chemists spend a great deal of time forming C-C bonds and new 
transformations that allow the ready formation of these bond types often revolutionize 
the field of organic synthesis. One of the most extraordinary developments of 20th 
century chemistry was the discovery that palladium reagents could catalyze the 
formation of a myriad of C-C and C-X bond types in an efficient and predictable 
manner.23 In fact, the developments of palladium chemistry had such a broad impact 
beyond the organic chemistry community, the early pioneers of palladium chemistry 
Heck, Negishi and Suzuki were awarded the 2010 Nobel Prize for their work.  
Introduction to Pd-Catalyzed Cross-coupling Reactions 
 In 1968 and 1969 Heck reported the coupling of alkenes with Ar-Hg-X 
derivatives to give arylated alkenes mediated by a stoichiometric Pd(II) salts.24 These 
communications are some of the earliest examples of what would later be known as 
cross-coupling reactions. Any cross-coupling reaction is defined by the combination of 
one molecule with another coupling partner to form a new bond. Some common types of 
palladium catalyzed cross-coupling reactions employed in organic synthesis are outlined 
in Figure 1-3.25 
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Figure 1-3. Some common Pd-catalyzed cross-coupling reactions 
 The reaction types given in Figure 1-3 all give access to new C-C bonds and all 
have limitations on the R groups attached to the coupling partners. New advancements in 
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the field of Pd-catalyzed C-C bond formation focus on two main areas: new C-C bond 
forming reaction types and the expansion of substrate scope for the current classes of 
cross-coupling reactions. This research focuses on the expansion of substrate scope for 
two coupling reaction types: the Heck reaction and the Tsuji-Trost allylation. 
The Heck Reaction 
Introduction to the Catalytic Heck Reaction 
 As was previously stated, in 1968 and 1969 Heck reported the coupling of 
alkenes with Ar-Hg-X derivatives to give arylated alkenes mediated by a stoichiometric 
amount of a Pd(II) salt.24 However, research into the modern catalytic Heck reaction as 
represented in Figure 1-3 was not possible until the work of Mizoroki and co-workers in 
1971.26 This work was the first to report a catalytic, ligand-free palladium system that 
used iodobenzene to arylate alkenes. However, these reaction conditions required a high 
temperature (125 oC) autoclave. Also, the reported scope of the reaction was limited to 
iodobenzene and simple alkenes as coupling partners. Despite these limitations, the 
development of a catalytic version using iodobenzene was a significant improvement.   
 The next key improvement for the Heck reaction was the discovery that 
phosphine ligands could improve the catalytic activity of the proposed Pd0 species. This 
realization came about with the work of Dieck and Heck in 1974.27 The catalytic system 
involved Pd(OAc)2 as the Pd source with the addition of PPh3 as a ligand. The addition 
of PPh3 substantially increased the rate of reaction for aryl iodides, and aryl bromides 
were also found to react, albeit at higher temperatures (100-135 oC). These two 
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developments (catalytic palladium and phosphine ligands) gave rise to the modern Heck 
reaction. 
Mechanism of the Heck Reaction 
 Heck and Nolley proposed the first mechanism for the Pd-catalyzed Heck 
reaction in 1972.28 However, a mechanism including phosphine ligands was not 
described until 1974 by Dieck and Heck.27 The proposed catalytic cycle is comprised of 
four steps: oxidative addition, migratory insertion, β-hydride elimination, and reductive 
elimination of HX. These four steps are outlined in Figure 1-4.  
 
 
Figure 1-4. General mechanism for the Heck reaction 
 The mechanism begins with a Pd0-ligand complex (Pd0Ln) with Pd
0 being formed 
in situ or preformed. Step 1 in Figure 1-4 is the oxidative addition of Pd0Ln to the Ar-X 
bond with aryl iodides and aryl bromides reacting much faster than aryl chlorides. Step 2 
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involves loss of one ligand molecule (L) and the coordination of an alkene. This is 
followed by syn addition of the Ar-PdII(Ln)-X across the C-C double bond as a migratory 
insertion step. Step 3 consists of rotation about the C-C bond, syn β-hydride elimination, 
disassociation of the product, and binding of a ligand molecule L. Finally, step 4 
invovles the reductive elemination of HX from H-PdIILn-X to regenerate Pd
0Ln. The 
reaction is driven by base (B) quenching the HX produced as a byproduct.  
Modern Developments of the Heck Reaction 
 The modern phosphine-Pd catalytic system has seen wide application in both 
academic and industrial synthesis.29 One of the prime uses for the Heck reaction is in the 
construction of carbocycles. An especially interesting use of the Heck reaction was in a 
rare 7-endo-trig cyclization employed by Overman and co-workers in the total synthesis 
of (+)-guanacastepene (Scheme 1-10).30 The tricycle 1-30 was formed in 75% yield 
when 1-29 was exposed to Heck conditions.  
 
 
Scheme 1-10. The 7-endo-trig cyclization of 1-29 
 One of the most important developments of the Heck reaction has been the 
introduction of an asymmetric version capable of synthesizing quaternary stereocenters. 
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This area of research has been largely driven by the groups of Shibasaki and 
Overman.31,32 An excellent use of the asymmetric Heck reaction was in the total 
synthesis of (-)-physostigmine by Overman and co-workers (Scheme 1-11).33 This 
transformation proceeded in greater than 84% yield and afforded 1-32 in 95% ee. Many 
examples of asymmetric Heck reactions in total synthesis have been demonstrated.29 
 
 
Scheme 1-11. Asymmetric Heck reaction 
 In addition to the asymmetric Heck reaction, many other modifications and 
advancements exist. Microwave-assisted Heck reactions have been developed34 as well 
as Heck conditions where water35 is the solvent.  Other major developments include the 
use of an oxidative Heck reaction, the Fujiwara-Moritani reaction.36 This palladium-
catalyzed process is capable of coupling aryl and alkenyl systems without the aryl 
component containing any halide functional group as an activator (i.e. X=H in Figure 1-
3). Finally, the development of large cone angle ligands by Fu and others (i.e. P(t-Bu)3) 
has allowed for the use of previously unreactive aryl chlorides as coupling partners in 
the Heck reaction.37 All of these improvements described allow for an improvement in 
the scope of the Heck reaction and serve to make the Heck reaction a robust synthetic 
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tool. However, many types of coupling partners have yet to be shown capable of 
participating in the Heck reaction. These types, specifically where R1, R2 or R3 in Figure 
1-3 is -NR2, provide a means of directly accessing conjugated enamines (and presumably 
enones after hydrolysis) efficiently should simple enamines be demonstrated as viable 
coupling partners. Chapter IV deals with an exploration of this idea and the development 
of a new type of Heck reaction: the enamine-Heck reaction (Figure 1-5). 
 
 
Figure 1-5. Research into substrate scope expansion for the Heck reaction 
The Tsuji-Trost Reaction 
Introduction to the Tsuji-Trost Reaction 
 The first report of a π-allylpalladium electrophile reacting with soft nucleophiles 
like N,N-dimethylcyclohexenamine or the enolates derived from diethyl malonate and 
ethyl acetoacetate was by Tsuji and co-workers in 1965.38 The allylation described 
involved the stoichiometric use of preformed π-allylpalladium chloride; however, this 
limitation was overcome by the work of Atkins and co-workers when they developed a 
catalytic version.39 One of the seminal contributions in the early Tsuji-Trost reaction was 
by Trost and Fullerton whereby they demonstrated that alkyl substituted π-
allylpalladium intermediates could react with soft nucleophiles to give products with 
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high regioselectivity.40 Also, Trost and Fullerton demonstrated that hard nucleophiles 
like Grignard reagents and organolithium reagents did not attack the alkyl substituted π-
allylpalladium intermediates. Taken together, these works established the Tsuji-Trost 
reaction outlined in Figure 1-3. 
 One of the unique features of the Tsuji-Trost reaction is the wide substrate scope 
for allyl-X as seen in Figure 1-3. A survey of some of the more common allylating 
reagents is given in Figure 1-6. All of the examples given in Figure 1-6 are capable of 
forming π-allylpalladium complexes under mild reaction conditions. 
 
 
Figure 1-6. Some common allylating reagents for the Tsuji-Trost reaction 
 The Tsuji-Trost reaction can be divided into two main reaction types: the 
intermolecular allylation and the intramolecular allylation.18 Both reaction types have 
seen the development of enantioselective versions and both have been broadly applied in 
organic synthesis. 
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Mechanism for the Tsuji-Trost Reaction 
The first mechanistic description of π-allylpalladium intermediates in the Tsuji-Trost 
reaction was by Kurosawa in 1987.41 The current most general mechanism is the result 
of intensive effort and is outlined in Figure 1-7. 
 
 
Figure 1-7. Mechanism for the Tsuji-Trost reaction 
 Following ligand complexation to the Pd0 atom, there are four main steps to the 
catalytic cycle. Step 1 in Figure 1-7 is coordination of allyl-X to the palladium center 
with displacement of one molecule of ligand L followed by oxidative addition of Pd0 to 
the C-X bond to give an allyl-PdIILn-1 complex. Step 2 involves displacement of X
- with 
L to give a cationic (allyl-PdIILn)
+
 complex which is attacked by Nu
- in step 3. This 
 25 
 
generates the allyl-NuPd0Ln complex which dissociates in step 4 to regenerate the 
catalyst and gives product. 
The Intermolecular Allylation 
 One of the applications of the intermolecular allylation was in the synthesis of 
cristatic acid by Fürstner and Gastner.42 The Tsuji-Trost reaction was used to couple bis-
(phenylsulfonyl)methane with 1-33 through the use of palladium catalysis (Scheme 1-
12).  
 
 
Scheme 1-12. The use of the Tsuji-Trost reaction in the synthesis of cristatic acid 
 In this example, 1-34 was formed in 98% yield from 1-33 through the action of 
Pd-dppe formed in situ. Also, the reaction conditions were mild compared to conditions 
normally required to open an oxirane through conjugate addition.29 However, the 
broadest utility of the intermolecular Tsuji-Trost reaction is found in the enantioselective 
version first described by Trost and Strege  in 1977.43 The initial reaction described 
involved the use of a C2-symmetric DIOP ligand and afforded low enantioselectivities 
(Scheme 1-13).  Enantioselectivities as high as 99% have been demonstrated in the 
literature with more modern ligands (i.e. PHOX-type).44  
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Scheme 1-13. First example of the enantioselective Tsuji-Trost reaction 
The Intramolecular Allylation 
 In the intramolecular Tsuji-Trost allylation, the nucleophile and the allylating 
reagent are part of the same molecule. One of the classic examples of this strategy was in 
the total synthesis of (+)-FR182877 by Sorensen and co-workers (Scheme 1-14).45 The 
macrocylization of 1-39 employed an intramolecular Tsuji-Trost allylation using mild 
conditions (10 mol % Pd2dba3 and 40 
oC in THF) to give 1-40 in 80% yield. This 
reaction demonstrates  
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Scheme 1-14. Intramolecular Tsuji-Trost reaction 
the high diastereoselectivity achievable in the Tsuji-Trost reaction as only one 
diastereomer was detected (stereocenter not assigned). Also, a high degree of functional 
group tolerance is demonstrated for the Tsui-Trost reaction in the conversion of 1-39 to 
1-40. 
 Enantioselective conditions have been developed for the intramolecular Tsuji-
Trost reaction. One of the first examples to obtain high ee was the enantioselective 
intramolecular allylation of tosyl carbamates to generate tosyl oxazolidinones developed 
by Trost and Patterson in 1998 (Scheme 1-15).46 The high enantionselectivity was 
imparted by a new class of ligand synthesized by 2-(diphenylphosphino)benzoate and 
cyclohexane-1,2-diamine (1-42 in Scheme 1-15). This class of ligand has seen many  
 
 28 
 
 
Scheme 1-15. The desymmetrization of 1-41 
developments that have led to it becoming a ligand class with broad application in the 
synthetic community.47 However, the main feature of this reaction is that it is one of the 
early examples of a catalytic desymmetrization of a racemic or, in this case, a prochiral 
molecule. The conditions employed by Trost and Patterson were capable of forming 1-
43 in 84 % yield but in greater than 99% ee from 1-41. The work presented in this 
dissertation focuses on the desymmetrization process in the Tsuji-Trost reaction and a 
discussion of desymmetrization is therefore merited. 
Desymmetrization in the Tsuji-Trost Reaction 
There are many examples of desymmetrization in organic chemistry.48 
Desymmetrization reactions can either be conversion of achiral molecules into chiral 
molecules or the transformation of a racemate into a chiral product.49 This is outlined in 
Figure 1-8. 
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Figure 1-8. The two types of desymmetrization reactions 
 Examples of the Tsuji-Trost reaction used to desymmetrize molecules abound49 
and this dissertation presents two new developments in that area: a catalytic 
enantioconvergent decarboxylative allylic alkylation of allyl indolenine-3-carboxylates 
and a catalytic enantioconvergent allylic α-alkylation of aldehydes to give 
enantioenriched quaternary all-carbon centers (Figure 1-9). These two areas are 
discussed in chapters V and VI respectively.  
 
 
Figure 1-9. Research into the desymmetrizing Tsuji-Trost reaction 
 30 
 
CHAPTER II 
THE INTRAMOLECULAR 1,3 DIPOLAR ROUTE  
TO TMR MACROCYCLIC PRECURSOR 
 
 Our synthesis of celastrol (1-1) hinged on an efficient route to an all carbon 
marcyocyclic skeleton (1-28 in Scheme 1-9). A complicating feature of this macrocycle 
is the 1,3-diketone functionality which would have to be concealed for the majority of 
the multi-step synthesis due to the high acidity of 1,3-diketones. We therefore 
envisioned a strategy that would involve not only keeping the 1,3-diketone masked until 
the TMR, but also involve a dual purpose macrocylization and masked 1,3-diketone 
construction step. An intramolecular [3+2] isoxazole synthesis was selected as the means 
to effect this strategy as isoxazoles are known to easily be cleaved to reveal 1,3-
diketones under mild conditions.50 
 
First Generation Intramolecular [3+2] Synthetic Strategy to Access 1-28 
 Accordingly, we envisaged 1-28 coming from isoxazole 2-1 by reducing the 
isoxazole ring and hydrolyzing the resulting vinylogous amide to generate 1-28 (Scheme 
2-1). We expected 2-1 to come from an intramolecular 1,3-dipolar cycloaddition using a 
terminal alkyne and a nitrile oxide as the coupling partners on opposite ends of the 
molecule. This disconnection led us to 2-2 which we anticipated would come from the 
intermolecular coupling of vinyl iodide 2-3 with aldehyde 2-4. Oxidation, protecting 
group removal and condensation with hydroxylamine would yield 2-2.  The olefin 
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geometry of 2-3 would either be Z or E to provide either the Z,Z or Z,E model substrate 
(Scheme 1-7). 
 
 
Scheme 2-1. First generation retrosynthesis strategy  
 Our synthesis of the Z,Z model substrate began with the Myers asymmetric 
alkylation of pseudoephedrine proplyamide with 2-5 (Scheme 2-2).51 Interestingly, this 
reaction gave only 20% conversion even upon exposure to longer reaction times (20 
hours). Despite this, amide 2-6 was reduced to primary alcohol 2-7 which was protected 
with a TBS group in quantitative conversion to give silyl ether 2-8. The TMS alkyne was 
carbometallated according to Snider's procedure to give a Z vinyl silane. This Z vinyl 
silane was then iodinated with retention of olefin geometry to give vinyl iodide 2-3Z in 
56% yield for two steps from 2-8.52 
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Scheme 2-2. Synthesis of 2-3Z 
The synthesis of aldehyde 2-4 commences with silyation of commercially available 2-9 
by first TBS protecting the alcohol followed by installation of a TMS group on the 
alkyne to generate 2-10 in 86% yield for two steps (Scheme 2-3). Again, use of Snider's 
proceedure gave the Z vinyl silane (35% yield 6.25:1 Z:E) which underwent iodinolysis 
with NIS to give vinyl iodide 2-11. Sonogashira cross-coupling of 2-11 with TMS-
acetylene gave enyne 2-12. The TBS group was removed and the resulting primary 
alcohol was oxidized with IBX to generate the requisite aldehyde 2-4 in 24% overall 
yield from 2-10.  
 
 
 33 
 
 
Scheme 2-3. Synthesis of 2-4 
 We then attempted to couple 2-3Z with 2-4 using Nozaki-Hiyama-Kishi 
conditions (Scheme 2-4).53 We initially chose the NHK because of its mild conditions. 
However, all attempts along this line were met with failure as vinyl iodide 2-3Z was 
reduced by Cr(II) to the disubstituted olefin without any coupling product formed. We 
switched to a t-BuLi mediated coupling and found the reaction worked to give 2-13 in 
moderate yield. Our original plan was to oxidize the allylic alcohol to the α,β-
unsaturated ketone. However, when this was done on the Z,E precursor 2-14 (synthesis 
not shown), the desilylation step would only give the oxy-Michael product 2-15. We 
therefore left the allylic alcohol present and globally desilylated 2-13. Treatment of 2-13 
with TBAF in THF gave 2-16 in 66%. A stepwise procedure in which the protecting 
groups were removed through the action of basic methanol followed by acid-catalyzed 
ethanolysis failed to improve the yield. 
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Scheme 2-4. Synthesis of 2-16 
 Both alcohol functionalities of 2-16 were oxidized to give the dicarbonyl species 
2-17 (Scheme 2-5). The aldehyde of 2-17 was selectively converted to the oxime using 
hydroxylamine hydrochloride. To our dismay, this reaction quantitatively produced 
nitrone 2-18. We believe 2-18 was synthesized in a cascade reaction that began by first 
forming the oxime by condensation of hydroxylamine with the aldehyde of 2-17. The 
nitrogen of the resulting oxime then added in a 1,4-addition to the α,β-unsaturated 
ketone. This provides the structure 2-18. We expected the 1,4-addition to be reversible 
so that N-chlorosuccinimide would be able to react with the oxime and form the 
hydroximinoyl chloride. Presumably, the hydroximinoyl chloride would then undergo 
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base-induced elimination to generate the nitrile oxide required for the 1,3-dipolar 
cycloaddition. However, no product was detected when this reaction was run. 
 
 
Scheme 2-5. End stages of first strategy to access 1-28 
 To avoid formation of the electrophilic α, β-unsaturated ketone functionality in 2-
17, we selectively oxidized the primary alcohol. We employed the TEMPO/NCS reagent 
system to oxidize diol 2-16 to aldehyde 2-19 in 86% yield.54 Oxime 2-2 was then formed 
in 94% yield. Initially, it was expected that the terminal alkyne to be significantly more 
reactive than the trisubstituted alkene. Therefore, we presumed that the in situ generated 
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nitrile oxide would react preferentially with the alkyne to form the isoxazole. To our 
surprise, the 1,3 dipolar cyclization gave isoxazoline 2-20 as the exclusive product.  
 We believed that adding a bulky group to the allylic alcohol would block the 
kinetic accessibility of the olefin and thereby drive the nitrile oxide to react with the 
alkyne. Initially, it was thought that a PMB protecting group on the allylic alcohol of 2-
13 would be able to alter the regioselectivity of the nitrile oxide. We attempted the PMB 
protection of 2-13 with 4-methoxybenzyl trichloroacetimidate and were surprised to find 
only allylic alcohol elimination products. After repeated attempts to perform the 
protection using mild conditions, we turned our attention to installing a bulky silyl group 
on the allylic alcohol.  
 
 
Scheme 2-6. Attempts to alter the regioselectivity of the [3+2] cycloaddition 
We explored TIPS protection of the allylic alcohol group in 2-19, however, there was no 
conversion of starting material after 20 hours. We then attempted a TBS protection of 2-
19 and were able to form 2-21 in 47% yield (Scheme 2-6). Oxime 2-22 was then 
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synthesized in 14% yield. With 2-22 in hand, we attempted the 1,3-dipolar cycloaddition 
and were unable to find any detectable cycloaddition product by NMR.   
 At the conclusion of the experiments of Scheme 2-6 it became clear to us that 
this synthetic route had many insurmountable difficulties. Placing the oxime 
functionality four carbons from the α, β-unsaturated ketone resulted in several problems: 
the susceptibility of the primary alcoholic oxygen to cyclization (Scheme 2-4), the 
susceptibility of the oxime to undergo a 1,4-addition to irreversibly generate a nitrone 
(Scheme 2-5), the selectivity of the nitrile oxide for the proximal alkene (Scheme 2-5), 
and the inability to block the reactivity of the proximal alkene by adding bulky 
protecting groups (Scheme 2-6). As a result, we devised an alternate synthetic scheme 
with the hope of resolving these problems. 
 
Second Generation Intramolecular [3+2] Synthetic Strategy to Access 1-28 
 We continued to believe that the best route to access the TMR precursors was the 
late stage intramolecular 1,3-dipolar cycloaddition to both form the macrocycle and 
install the masked 1,3 diketone in one step. Learning from previous experiments we 
switched the position of the alkyne and the oxime. We therefore expected 1-28 to come 
from 2-23 via reduction of the N-O bond and hydrolysis of the vinylogous amide 
(Scheme 2-7). Isoxazole 2-23 would then come from 2-24 through the intramolecular 
1,3-dipolar cycloaddition and 2-24 was expected to be formed through the t-BuLi 
coupling of 2-25 and 2-26 followed by global deprotection, oxidation and selective 
oxime formation. 
 38 
 
 
Scheme 2-7. Second generation retrosynthetic strategy 
 Our synthesis of the Z,E model substrate begins with the conversion of 6-
(trimethylsilyl)hex-5-ynoic acid55 to the corresponding acid chloride using oxalyl 
chloride (Scheme 2-8). The acid chloride was coupled with lithiated (R)-(+)-4-isopropyl-
2-oxazolidinone to give 2-28 in 97% yield for two steps. Substrate 2-28 then underwent 
Evans alkylation (83% yield, 11:1 dr) followed by reduction to give primary alcohol 2-
29. This opening sequence replaced the Meyer's alkylation conditions employed in the 
first generation synthesis.  
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Scheme 2-8. Synthesis of 2-25 
 Alcohol 2-29 was oxidized with TPAP/NMO and the resulting aldehyde was 
converted to gem-dibromo olefin 2-30 in 58% yield for two steps. We completed the 
Corey-Fuchs alkyne synthesis by lithiating 2-30 and trapping the intermediate lithium 
acetylide with TIPSCl. The crude reaction mixture was selectively desilylated by basic 
methanol. Vinyl iodide 2-25 was obtained in 38% yield from 2-30 through the use of 
Negishi's carbometallation conditions.56 
 To synthesize aldehyde 2-26, we coupled the lithium acetylide derived from 2-31 
with ethyl chloroformate to generate alkynyl ester 2-32 quantitatively (Scheme 2-9). 
Cupration to install the Z trisubstituted olefin (17:1 Z:E) followed by reduction and 
TBDPS protection generated 2-33 in three steps in an 83% yield. Protonolysis of the 
TBS ether and IBX oxidation gave the desired aldehyde 2-26 in 80% yield for two steps.  
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Scheme 2-9. Synthesis of 2-26 
 With vinyl iodide 2-25 and aldehyde 2-26 in hand, we attempted the t-BuLi 
coupling (Scheme 2-10). We were pleased to find that the coupling proceeded well in a 
71% yield (3.4:1 dr) to give allylic alcohol 2-34. Alcohol 2-34 was globally desilylated 
with TBAF in 14% yield. This low yield was due to poor conversion and is unoptimized. 
The resulting diol was converted to dicarbonyl 2-35 using IBX as the oxidant in 95% 
yield from 2-34. Finally. Aldehyde 2-35 was converted into oxime 2-24 in 95 % yield 
through the action of hydroxylamine hydrochloride and pyridine.  
 We then tested the intramolecular 1,3-dipolar cycloaddition using NCS and 
triethylamine to generate the intermediate nitrile oxide 2-36. Unexpectedly, this nitrile 
oxide did not cyclize at the terminal alkyne to give 2-23. The cyclization happened at the  
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Scheme 2-10. End stage for second generation intramolecular [3+2] cycloaddition 
previously problematic olefin to give [6.3.0] bicycle 2-37! We had predicted that the 
cyclization would occur to generate the 14-membered ring rather than the 8-membered 
ring due to strain typically associated in an 8-membered transition state. 
 
 
Figure 2-1. Transition state geometry in the reaction of 2-36 
 This result can be analyzed by examining our proposed transition state for the 
1,3-dipolar cycloaddition (Figure 2-1). Much of the strain in a fully saturated 8-
membered ring comes from the diaxial interactions of the axial protons.57 As can be seen 
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in Figure 2-1, the protons labeled with red circles in A are either not present or severely 
distorted in the unsaturated B such that these interactions do not take place. This lowers 
the overall strain in the 8-membered transition state so that it becomes kinetically 
favored. As a result of the 8-membered ring being kinetically favored, we had to 
abandon this synthetic sequence. 
 With the failures of both generations of intramolecular [3+2] strategies to access 
1-28, we sought other means of pursuing our synthetic goals. We still believed that the 
isoxazole was the best way to not only construct the requisite 1,3-diketone moiety, but 
also to conceal it until the TMR. Therefore, we switched to an intermolecular strategy to 
construct the isoxazole en route to the macrocyclic precursor. This work is detailed in 
Chapter III. 
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CHAPTER III 
THE INTERMOLECULAR 1,3 DIPOLAR CYCLOADDITION ROUTE 
TO TMR MACROCYCLIC PRECUSOR *
After the failure of the intramolecular 1,3-dipolar cycloaddition strategy outlined 
in Chapter II, we decided to shift the timing of our synthetic strategy. We retained the 
use of the 1,3-dipolar cycloaddition; however, this reaction would be used to 
intermolecularly couple two fragments instead.  Therefore, we envisioned that 1-1 could 
Scheme 3-1. The new retrosynthetic strategy to celastrol 
* Reprinted with permission from "Regiochemistry discoveries in the use of isoxazole as a handle for the 
rapid construction of an all-carbon macrocyclic precursor in the synthetic studies of celastrol" by Kaiser, 
T.: Huang, J.; Yang, J., 2013. J. Org. Chem., 78, 6297-6302. Copyright 2013 American Chemical Society. 
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be accessed by functional group manipulation and installation of the p-quinone methide 
ring system using 1-28 as the core as explained in Chapter I (Scheme 3-1). We still 
planned to synthesize the perhydrophenanthrene system 3-1 anticipating that the 
stereochemistry of the angular methyls would be dictated by the olefin geometry of 1-28 
through an all-chair transition state during the transannular bis-Michael reaction. Our 
retrosynthesis of 1-28 focused on the use of an isoxazole to rapidly construct the 
requisite 1,3-diketone through the use of a 1,3-dipolar cycloaddition. Therefore, 1-28 
was envisaged to come from 3-2a by desilylation and oxidation of the alcohol to give an 
aldehyde, intramolecular coupling of that aldehyde with the vinyl iodide, and oxidation 
to the ketone. This sequence would be followed by reduction and hydrolysis of the 
isoxazole to generate the desired 1,3-diketone functionality. Isoxazole 3-2a is expected 
to come from the intermolecular 1,3-dipolar cycloaddition of the nitrile oxide derived 
from oxime 3-3 and enyne 3-4. Oxime 3-3 will be synthesized from the known gem-
dibromo olefin 3-558 and enyne 3-4 will be generated from known TBS silyl ether 2-
31.59
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Scheme 3-2. Synthesis of 3-4 
We began our synthesis by constructing the two 1,3-dipolar cycloaddition 
coupling partners 3-3 and 3-4. Our synthesis of 3-4 started with the addition of the 
lithium acetylide derived from 2-31 to ethyl chloroformate to generate an alkynyl ester 
followed by cupration to install the Z-trisubstituted olefin (Scheme 3-2). These steps 
were followed with DIBAL reduction to give 3-6 in 82% yield for 3 steps. The resulting 
allylic alcohol 3-6 was oxidized to an aldehyde using the TPAP/NMO system and then 
converted to 3-4 using LDA and TMSCHN2 in 50% yield over two steps.
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Scheme 3-3. Synthesis of 3-3 
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The synthesis of oxime 3-3 began with the known gem-dibromo olefin 3-5 
(Scheme 3-3) which was lithiated with n-BuLi to form the lithium acetylide. The 
addition of the resulting acetylide to ethyl iodide required the presence of 2 equivalents 
of HMPA. With the desired internal alkyne synthesized, we performed the KAPA-
mediated alkyne zipper reaction using KH and 1,3-diaminopropane. This reaction was 
uncharacteristically slow with 3-7 and produced only degradation products. It is known 
that internal alkynes with a free alcohol are capable of undergoing the KAPA-mediated 
isomerization.20,61 We therefore removed the TBS group and conducted the
isomerization reaction on the crude product. External alkyne 3-8 was obtained in 70% 
over 2 steps from internal alkyne 3-7. Negishi's carbometallation procedure was then 
used to install the vinyl iodide.56 This was followed by IBX oxidation and oxime
formation to form the desired oxime 3-3 in 72% yield from 3-8. 
With 3-3 and 3-4 synthesized, we turned to the 1,3-dipolar cycloaddition for the 
synthesis of 3-2a (Scheme 3-4). In the course of our evaluation of the reaction, it was 
discovered that the outcome of the reaction was highly temperature dependent. 
Conducting the reaction at room temperature led to only the 3,4-disubstituted isomer 3-
2b in 47% yield. However, elevating the reaction temperature to 60 oC resulted in the
production of 3-2a in 45% yield with approximately 20% of 3-2b. Curious if we could 
isomerize 3-2b to 3-2a given limited examples of reversible 1,3-dipolar cylcoadditions,62
we heated 3-2b to 80 oC. Even though the isomerization was accompanied by partial
scrabbling of the C-5 alkene (~3:1 desired to undesired), complete conversion of 3-2b to 
the regio-isomeric 3-2a was observed after 92 hours. 
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Both the temperature-dependent regioselectivity of the 1,3-dipolar cycloaddition 
and the isomerizability of the reaction at elevated temperature are surprising.63 Sharpless
and Fokin, in their study of Cu-catalyzed 1,3-dipolar cylcoadditions, examined the 
activation energies for the formation of regioisomeric 3,4- and 3,5-disubstituted 
isoxazoles by the uncatalyzed cycloaddition of acetonitrile oxide and propyne.64 The
calculations predicted a 2.8 kcal/mole energy difference in the transition states with the 
3,5-regioisomer being strongly favored. Indeed, formation of 3,4-disubstituded 
isoxazoles by the 1,3-dipolar cycloaddition of nitrile oxides and alkynes is rare, if not 
completely unprecedented. However, only the 3,4-disbustituted 3-2b was obtained upon 
reaction of 3-3 and 3-4 at room temperature. We speculate that the reversal of 
regioselectivity is likely due to a substantial increase in the LUMO coefficient at the 
terminal acetylene carbon of 3-4 and a concomitant lowering of the LUMO energy due 
to conjugation of the alkyne.65 Therefore, due to both the largest orbital coefficient of the
nitrile oxide HOMO residing on the oxygen and the largest orbital coefficient of the 
enyne LUMO residing on the terminal carbon, simple FMO analysis predicts the 3,4-
regioisomer to be favored kinetically. 
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Scheme 3-4. Synthesis of 3-2a and 3-2b and isomerization of 3-2b to 3-2a 
 In order to explain the surprising temperature dependence of the regiochemistry 
of the 1,3-dipolar cycloaddition as well as the slow isomerization of 3-2b to 3-2a at 
elevated temperatures, we hypothesize that by-products from the nitrile oxide synthesis 
are responsible for this unusual behavior. The work of Chen et al. discovered that 
hydrogen bond catalysis not only imparted enantiocontrol in the 1,3-dipolar 
cycloaddition of cyclic enones, it also substantially improved the reactivity of the 
substrate.66 We postulate that participation of a hydrogen bond donor (i.e. in situ 
generated succinimide) is leading to activation of the 3,4-regioisomer and providing a 
lower energy pathway for the thermodynamically driven isomerization to take place. In 
order to investigate this hypothesis, we compared the rates of isomerization of 3-2b both 
in the presence of succinimide and without succinimide. Indeed, we found a 1.87 fold 
increase in the rate of isomerization of 3-2b to 3-2a in the presence of succinimide at 70 
oC.67 
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Scheme 3-5. Synthesis of 3-11 
With a robust means of synthesizing 3-2a, we continued in our synthetic studies. 
We were able to synthesize aldehyde 3-9 in 87% yield for two steps from 3-2a (Scheme 
3-5). Using the Nozaki-Hiyama-Kishi reaction,53 allylic alcohol 3-10 was formed in 6-
12% yield from 3-9. The poor yield of this reaction can be attributed to the formation of 
a 14-membered macrocycle with a high degree of strain imparted by the alkene 
functionalities present in the molecule. Also, CrCl2 reductively cleaved the isoxazole in 
3-9 generating a vinylogous amide 3-10. Seeking to keep the isoxazole intact, the 
number of equivalents of CrCl2 was reduced from 10 equivalents to 5 equivalents. Under 
such reaction conditions, allylic alcohol 3-11 was generated in slightly improved yield 
(12-26%). 
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Scheme 3-6. The synthesis of 1-28 
Following the coupling reaction, 3-11 was oxidized to α,β-unsaturated ketone 3-
12 in 94% yield using IBX (Scheme 3-6). We turned our attention to revealing the 1,3-
diketone functional group through reduction and hydrolysis of the isoxazole 
functionality in 3-12. We were pleased to find that the treatment of 3-12 with Mo(CO)6 
in CH3CN generated the desired vinylogous amide 3-13 in 56% yield (2.2:1 mixture of 
E:Z isomers of the C8-C9 double bond, tentatively assigned by NMR).68 Alternatively,
3-13 could be prepared directly from 3-10 through the action of IBX in 55% yield. The 
hydrolysis of 3-13 to give 1-28 proved to be difficult. The use of Cu(OAc)2, 
HOAc/NaOAc, Mn(OAc)3, and CeCl3/Et3N all failed to hydrolyze the vinylogous amide. 
It was only when vinylogous amide 3-13 was dissolved in a 2:2:1 solution of 
AcOH:CH3CN:H2O did the desired molecule 1-28 form in 60% yield (2.7:1 mixture of 
E:Z isomers of the C8-C9 double bond, tentatively assigned by NMR). 
Our investigation of the transannular bis-Michael reaction cascade could now 
proceed with 1-28 accessed. In contrast to the smooth transannular Michael reactions 
when the E,E- or E,Z-macrocyclic bis-enones were employed,22 the starting material was
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fully recovered when 1-28 was treated with TBAF in THF/DMF at -78 oC. Also, we did
not detect any 3-1 when the reaction was carried out at ambient temperature. We 
attempted the transannular Michael reactions on vinylogous amide 3-13 by treatment 
with NaOMe in DMF. Again, no desired transannular reaction product was detected 
even when elevated temperatures were applied. These experimental results were later 
corroborated by our work in 2012 concerning the evaluation of the stereochemical model 
of the transannular bis-Michael reaction in 14-membered macrolide systems.22 
Scheme 3-7. The full scope of the transannular bis-Michael reaction 
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In this work, macrolides 3-14 through 3-17 were prepared and each substrate was 
evaluated for an ability to undergo the transannular bis-Michael reaction (Scheme 3-7). 
It was discovered that the E,Z and E,E macrocycles (3-14 and 3-15 respectively) were 
smoothly transformed into the desired diastereomeric macrocycles in good yield and 
excellent diastereoselectivity (only one diastereomer was detected for each substrate). 
However, the Z,E and Z,Z substrates (3-16 and 3-17 respectively) were found to be inert 
to the reaction conditions. Even if the reactions were conducted at elevated temperatures, 
no product was detected. Given that our all-carbon macrocycle falls under the Z,E-
isomer category, it is not surprising that the transannular bis-Michael reactions of both 1-
28 and 3-13 failed to take place. 
In summary, as part of our synthetic studies toward celastrol, we have developed 
a synthetic route making use of a 1,3-dipolar cycloaddition for the convergent synthesis 
of a 1,3-diketone-containing macrocycle. Consistent with our other studies, this Z,E-
macrocyclic bis-enone was found to be inactive in the transannular bis-Michael reaction 
cascade for the conditions evaluated. We discovered that the 1,3-dipolar cycloaddition of 
3-3 and 3-4 gave the rare 3,4-disubstituted isoxazole under kinetic reaction conditions. 
We also demonstrated that the dipolar cycloaddition is reversible and the thermodynamic 
3,5-disubstituted isoxazole can be obtained through isomerization of its 3,4-disubstituted 
isomer under elevated temperature. Our initial mechanistic studies support the role of 
hydrogen-bonding in accelerating the isomerization process. 
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CHAPTER IV 
THE DIRECT ACYLATION OF VINYL IODIDES TO GENERATE Α,Β-
UNSATURATED KETONES BY MEANS OF PALLADIUM CATALYSIS 
Over the course of our synthetic studies of celastrol we encountered many 
limitations of current reaction methodologies; but, none was more staggering than the 
low-yielding Nozaki-Hiyama-Kishi reaction of Chapter III. Faced with a very low-
yielding reaction in our macrocyclization strategy, we wondered if better ways of 
forming the desired α,β-unsaturated ketone were possible (i.e. a one-step reaction). We 
felt that this exploration of new methodology to access α,β-unsaturated ketones in a one-
step strategy would not only improve the synthetic efficiency of our route to access 
celastrol, this exploration would serve to improve the overall accessibility of the 
versatile α,β-unsaturated ketone69 in the body of synthetic chemistry.
One of the most common methods to access α,β-unsaturated ketones (and 
ketones in general) is a two-step sequence of, first, 1,2-addition of an in situ generated 
vinyl-M species to an aldehyde (M = Mg, Li, Zn, Ti...) followed by a second step where 
the resulting allylic alcohol from the first step is oxidized to the requisite α,β-unsaturated 
ketone (Scheme 4-1). This method of synthesis is limited in the strongly basic and 
reducing conditions employed to effect the 1,2-addition. This limitation significantly 
constrains the functional groups available for use in a synthetic strategy and often 
necessitates the use of protecting groups. 
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Scheme 4-1. Two-step sequence to accessing α,β-unsaturated ketones 
However, new catalytic methods beyond the traditional two-step ketone synthesis 
have been under development for the construction of aliphatic and aryl ketones from 
aldehyde precursors in one step. The two main categories of these methods are a C-H 
activation strategy and a palladium-mediated cross-coupling strategy. However, the C-H 
activation method is limited to only intramolecular reactions.70  Of special interest is the
intermolecular acylation strategy first described by Uriac and co-workers.71 In this work,
prepared enol esters are cross-coupled with aryl bromides to give aryl ketones (Scheme 
4-2). This report was the first demonstration of a direct route to aryl ketones prepared 
from a cross-coupling reaction using activated aldehydes. 
Scheme 4-2. Acylation of aryl bromides developed by Uriac and co-workers 
However, the reaction developed by Uriac is still two steps with the activation of 
aldehydes requiring the formation of enol esters before the acylation reaction can be 
55 
performed. We believed that it would be possible to cross-couple aldehydes with a 
coupling partner directly in one pot without the need to activate the aldehyde for cross-
coupling in a separate step. This concept was clearly demonstrated by Xiao and co-
workers when they discovered a method for the direct acylation of aryl bromides through 
the use of a palladium/pyrrolidine system (Scheme 4-3).72
Scheme 4-3. Direct acylation of aldehydes by Xiao and co-workers 
This reaction centered around the reaction of pyrrolidine with the aldehyde 
coupling partner to form an enamine. The resulting enamine reacted with the aryl 
bromide in the presence of a palladium catalyst analogous to the traditional Heck 
reaction to give an aryl enamine which hydrolyzed upon workup to give the desired acyl 
aromatic group in one step. With this precedent, we set out to extend the substrate scope 
to include vinyl halides in addition to aryl bromides. 
We set out to first attempt the coupling between 4-1a and octanal (Table 4-1). 
We began with the conditions disclosed by Xiao and co-workers72 (entry 1, Table 4-1)
and found that no desired molecule 4-2a was formed. When the molecular sieves were 
replaced with 5 equivalents of K2CO3 and the loading of pyrrolidine was reduced to 0.5 
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equivalents, 4-2a was generated in 20% yield. Conducting the reaction at 50 oC and
using 8 mol% of P(t-Bu)3 generated 4-2a in 71% yield (entry 8, Table 4-1). 
Table 4-1. Initial screening of conditions to generate 4-2a 
Entry L Additive Solvent T (oC) %Yield 
1 dppp 
4 Å MS / 
2 eq. pyrrolidine 
DMF 60 0 
2 Tol-BINAP 
4 Å MS / 
2 eq. pyrrolidine 
DMF 60 0 
3 dppf 
4 Å MS / 
2 eq. pyrrolidine 
DMF 60 0 
4 dppe 
4 Å MS / 
2 eq. pyrrolidine 
DMF 60 0 
5 dppp 
5 eq. K2CO3 / 
2 eq. pyrrolidine 
DMF 60 trace 
6 dppp 
5 eq. K2CO3 / 
0.5 eq. pyrrolidine 
DMF 23 20 
7 dppp (6 mol%) 
5 eq. K2CO3 / 
0.5 eq. pyrrolidine 
DMF 50 55 
8 P(t-Bu)3 (8 mol%) 
5 eq. K2CO3 / 
0.5 eq. pyrrolidine 
DMF 50 71 
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Table 4-2. Optimization for 4-3a 
Entry L Additive Solvent T (oC) %Yield 
1 P(t-Bu)3 (8 mol%) 
5 eq. K2CO3 / 
0.5 eq. pyrrolidine 
DMF 50 30 
2 P(t-Bu)3 (8 mol%) 
5 eq. K2CO3 / 
0.5 eq. pyrrolidine 
DMF 80 42 
3 P(t-Bu)3 (8 mol%) 
5 eq. K2CO3 / 
0.5 eq. pyrrolidine 
DMF 100 34 
4 P(t-Bu)3 (8 mol%) 
5 eq. K2CO3 / 
0.2 eq. pyrrolidine 
DMF 80 15 
5 P(t-Bu)3 (8 mol%) 
5 eq. K2CO3 / 
0.5 eq. pyrrolidine 
NMP 80 17 
6 P(t-Bu)3 (8 mol%) 
5 eq. K2CO3 / 
0.5 eq. pyrrolidine 
Toluene 80 13 
7 P(t-Bu)3 (8 mol%) 
5 eq. K2CO3 / 
0.5 eq. pyrrolidine 
THF 80 11 
8 P(t-Bu)3 (8 mol%) 
5 eq. K2CO3 / 
0.5 eq. pyrrolidine 
DMA 80 65 
9 P(t-Bu)3 (8 mol%) 
5 eq. K2CO3 / 
0.5 eq. morpholine 
DMA 80 trace 
10 DavePhos (8 mol%) 
5 eq. K2CO3 / 
0.5 eq. pyrrolidine 
DMA 80 16 
11 TangPhos (8 mol%) 
5 eq. K2CO3 / 
0.5 eq. pyrrolidine 
DMA 80 0 
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We then sought to test the scope of our conditions by coupling 4-1a with 
hydrocinnamaldehyde (entry 1, Table 4-2). However, we were surprised to find that 
these conditions resulted in only 30% yield for 4-3a. The yield of the reaction improved 
when the temperature was raised to 80 oC (entry 2, Table 4-2). Substantial olefin 
isomerization was detected along with a reduced yield if the reaction was run at 100 oC
(entry 3, Table 4-2). After screening solvents, we found that a 65% yield of 4-3a could 
be obtained when DMA was used as the solvent (entry 8, Table 4-2). We explored 
morpholine as a possible replacement for pyrrolidine and found that only trace yield 
could be obtained (entry 9, Table 4-2). Given the success of P(t-Bu)3 in this reaction, we 
were curious if the yield could be improved with other sterically demanding ligands.73
Therefore, we tested DavePhos and TangPhos (entries 10 and 11, Table 4-2) and found 
that the yield dropped substantially in both cases. 
We then turned our attention to exploring the substrate scope of the enamine 
Heck reaction. Our exploration began by evaluating the tolerance of the reaction to 
various changes with the vinyl iodide coupling partner. We found that aliphatic and 
electron-neutral conjugated vinyl iodides were well tolerated in the reaction (Figure 4-1). 
Vinyl iodides 4-1a and 4-1b gave the resulting cross-coupling products in 65% and 64% 
yield. However, the reaction did not tolerate electron-poor vinyl iodides, 4-1c (0% 
yield), or vinyl-iodides of the type of 4-1d (~10% yield). Also, disubstituted vinyl 
iodides did not undergo cross-coupling (4-1e) and vinyl bromides did not prove react as 
smoothly as vinyl iodides (4-1f). 
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Curious if the aldehyde coupling partner would be less constraining, we 
evaluated the scope of the reaction for the aldehyde component (Figure 4-2). We found 
that the ability of the aldehyde to participate in the cross-coupling was highly dependent 
on the solvent used. Hydrocinnamaldehyde worked well in DMA 4-3a) but octanal 
Figure 4-1. Vinyl iodide substrate scope for the enamine-Heck reaction 
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required the use of DMF (4-2a). Also, decanal and hexanal (4-2b and 4-2c) did not react 
smoothly in DMA whereas, in DMF, decanal reacted to give the desired product in 
<50% yield. 
Figure 4-2. Aldehyde substrate scope for the enamine-Heck reaction 
Taken together, the limitations of scope in both vinyl iodide and aldehyde 
severely limit the synthetic utility of the reaction described herein. However, the 
possibility exists that significant improvements in yield could be achieved by evaluating 
other transition metal systems as catalysts. Also, new synthetic technologies like 
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microwave reactors could enable the current catalytic system to be more broad in 
substrate scope.74
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CHAPTER V 
CATALYTIC ENANTIOCONVERGENT DECARBOXYLATIVE ALLYLIC 
ALKYLATION OF ALLYL 3-ALYKL-INDOLENIN-3-CARBOXYLATES 
One of the strengths of the Tsuji-Trost reaction is the ability to use prochiral sp2
intermediates to generate chiral products through the use of chiral ligands. This feature 
of chiral induction on a prochiral substrate based on rates of equilibration between two 
possible diastereomeric intermediates was first described by Trost and co-workers as 
dynamic kinetic asymmetric transformation, or DYKAT (Scheme 5-1).75 In the DYKAT,
an initial prochiral 5-1 is reacted with the chiral metal-ligand complex, M(0)*, to 
Scheme 5-1. The DYKAT process with prochiral 5-1 
* Reprinted with permission from "Catalytic enantioconvergent decarboxylative allylic alkylation of allyl 
indolenin-3-carboxylates" by Kaiser, T.; Yang, J., 2013. Eur. J. Org. Chem., 2013, 3983-3987. Copyright 
2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
*
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generate a mixture of 5-2 and dia 5-2. The relative concentrations of 5-2 and dia 5-2 are 
dictated by the energetics of the two diastereomeric complexes, and the equilibrium 
proceeds through σ-complex 5-3. Therefore, if M(0)* consists of a metal complex with 
L, the concentration of 5-2 is higher and the reaction proceeds to give 5-4. However, if 
M(0)* consists of a metal complex with ent-L, the concentration of dia 5-2 is higher and 
the reaction proceeds to give dia 5-4. 
The DYKAT is also theoretically capable of using a racemic starting material 
and relying on an intermediate equilibration to set the stereocenter (Scheme 5-2). In this 
case, racemic 5-5 reacts with the chiral metal-ligand complex, M(0)*, to give a similar 
equilibrium in Scheme 5-1. 
Scheme 5-2. The DYKAT process with racemic 5-5 
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Both of the processes outlined in Schemes 5-1 and 5-2 offer ready access to 
enantiomerically enriched intermediates starting from prochiral or racemic 
intermediates. However, we wished to focus on the enantioconvergent DYKAT process 
outlined in Scheme 5-2. This enantioconvergent DYKAT process requires ready access 
to racemic starting materials in order for the DYKAT to be synthetically useful. Also, 
we were specifically interested if homoallylic chiral centers could be constructed in this 
manner rather than the allylic chiral centers presented in the original DYKAT work in 
Schemes 5-1 and 5-2. We therefore selected allyl 3-alkyl-indolenin-3-carboxylates as the 
ideal starting material due to the direct synthesis of these racemic starting materials 
having been recently described by our group (Figure 5-1).76
Figure 5-1. DYKAT of selected allyl 3-alkyl-indolenin-3-carboxylates 
Introduction to the C-3 Allylation of Indoles 
Enantiomerically enriched 3-allyl-3-alkylindolenines are valuable intermediates 
in the synthesis of biologically relevant small molecules.77 As such, robust means of
65 
accessing these useful structures are in demand. However, a strategy of direct allylation 
of the indole core often is beset with significant challenges such as N-allylation, C2 
allylation, inadequate nucleophilicity of the indolyl nucleophile to generate the C3-
quaternary center, unfavorable energetics due to loss of aromaticity and so on.78 In spite
of potential shortcomings, many examples of allylation and benzylation of indole or 
oxindole cores are known. 
The first example of a dearomatizing enantioselective allylation of 3-substituted 
indoles was reported in 2006 by Trost and co-worker.79 In this work, allyl alcohols were
activated with hexyl-9-BBN and cross-coupled with 3-substituted indoles to give 3-allyl-
3-alkylindolenines in 84-95% yield and up to 90% ee (Scheme 5-3). The catalytic 
system was generated from Pd2(dba)3 and 5-L1. 
Scheme 5-3. Enantioselective allylation of 3-substituted indoles by Trost 
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Several other examples of intermolecular dearomatizing reactions have been 
reported recently;80 however, we sought to extend the utility of these 3-allyl-3-
alkylindolenines by developing an intramolecular decarboxylative allylation strategy to 
access these substrates. 
The Decarboxylative Allylic Alkylation of Allyl 3-Alykl-Indolenin-3-Carboxylates 
Our foray into developing such a process started by testing its feasibility by using 
common Pd catalyzed allylic alkylation systems with 5-6a as a model substrate (Table 5-
1).81 Following the precedent of Rawal and co-workers for the intermolecular
decarboxylative allylic alkylation of indoles,80a we treated 5-6a with Pd2(dba)3/(2-
furyl)3P in CH2Cl2. Although decarboxylation product 5-8a was isolated as the major 
product (56% yield), we were pleased to find that desired 3-allyl-3-alkyl indolenine 5-7a 
was also formed (34% yield; Table 5-1, entry 1). The effect of additives was then 
explored. For example, whereas only decarboxylation product 5-8a was formed when 
HOAc was used as an additive (Table 5-1, entry 2), the reaction proceeded essentially 
quantitatively to convert 5-6a into 5-7a and 5-8a in 30 and 70% yield, respectively, in 
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Unless noted otherwise, the following conditions were used for the reactions: Pd2(dba)3 (2.5 mol-%), 
ligand (7.5 mol-%), and R3B (0.5 eq.) when applicable. n.a.: not applicable, n.d.: not determined. 
*Pd2(dba)3 (2.3 mol-%), 5-L1 (11.25 mol-%), and hexyl-9-BBN (1.05 equiv.). 
 
Table 5-1. Optimization of the decarboxylative allylation 
Entry Substrate L Additive Solvent 
T 
(oC) 
%Yield 5-7 / 
5-8 
%ee 
1 5-6a (2-furyl)3P None CH2Cl2 23 34:56 n.a. 
2 5-6a (2-furyl)3P AcOH CH2Cl2 23 0:85 n.a. 
3 5-6a (2-furyl)3P MeOH CH2Cl2 23 30:70 n.a. 
4 5-6a (2-furyl)3P CuI CH2Cl2 23 92:0 n.a. 
5 5-6b (2-furyl)3P CuI CH2Cl2 23 0:0 n.a. 
6 5-6b 5-L1 none CH2Cl2 23 0:37 n.a. 
7 5-6b 5-L1 Et3B CH2Cl2 23 62:16 49 
8 5-6b 5-L1 C12H27BO2 CH2Cl2 23 0:21 n.a. 
9 5-6b 5-L1 Hexyl-9-BBN CH2Cl2 0 44:20 55 
10 5-6b 5-L1 Hexyl-9-BBN Toluene 0 48:14 56 
11 5-6b 5-L1 Hexyl-9-BBN (CH2Cl)2 0 44:23 64 
12 5-6b 5-L1 Hexyl-9-BBN Dioxane 0 48:19 48 
13 5-6b 5-L1 Hexyl-9-BBN THF 0 43:20 65 
14 5-6b 5-L1 Hexyl-9-BBN THF -20 35:12 n.d. 
15 5-6b 5-L2 Hexyl-9-BBN THF 0 44:21 57 
16 5-6b 5-L3 Hexyl-9-BBN THF 0 0:13 n.d. 
17 5-6b 5-L1 Ph3B THF 0 33:14 n.d. 
18 5-6b 5-L1 (F5C6)3B THF 0 0:0 n.d. 
19* 5-6b 5-L1 Hexyl-9-BBN THF 0 80:0 77 
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the presence of MeOH (Table 5-1, entry 3). The highest reaction efficiency was achieved 
when CuI was used as the additive; 5-7a was formed in 92% yield while only a trace 
amount of 5-7b was generated under these same conditions (Table 1, entries 4 and 5). 
The effect of CuI appears to be specific to 5-6a, as no reaction was observed when 
unsubstituted allyl indolenin-3-carboxylate (5-6b) was treated under the same reaction 
conditions. These results were corroborated by computational work by Wheeler and Lu 
whereby the presence of a 7-methyl group leads to a 5 kcal/mol stronger binding of Cu 
at nitrogen (Figure 5-2).82 
 
 
Figure 5-2. Calculated structures of Cu(II) binding to 5-6a(left) and 5-6b(right) 
 Having established the feasibility of the racemic reaction, we turned to chiral 
catalytic systems to develop an enantioconvergent variant of the transformation. Initial 
experiments with the use of Pd2(dba)3 and Trost ligand (R,R)-5-L1 and 5-6b as the 
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substrate proved to be ineffective, as only decarboxylation product 5-8b was formed, in 
37% yield (Table 5-1, entry 6). Being aware of the positive influence of trialkylboranes 
in Pd-catalyzed intermolecular allylation and benzylation reactions of indoles,83,79 we
tested triethylborane (0.5 equiv.) as the reaction additive. Indeed, this led to the 
formation of 5-7b in 62% yield with 49% ee (Table 5-1, entry 7). Encouraged by this 
result, we also tested n-hexylcatecholborane and n-hexyl-9-BBN. Whereas only 
decarboxylation product 5-8b was formed when n-hexylcatecholborane was used (Table 
5-8b, entry 8), the addition of hexyl-9-BBN led to the formation of 2b in 44% yield with 
55% ee (Table 5-1, entry 9). Subsequent testing with Ph3B and (F5C6)3B as the reaction 
additive showed that they were not as effective (Table 5-1, entries 17 and 18). 
Further screening of the reaction conditions revealed THF to be the solvent of 
choice at 0 °C (Table 5-1, entries 13, 15, and 16). We found that lower temperatures 
such as –20 °C resulted in poor conversion (Table 5-1, entry 14). Trost ligand 5-L2 also 
catalyzed this Pd-catalyzed enantioconvergent transformation albeit with slightly 
reduced enantioselectivity (Table 5-1, entry 15). However, other common catalytic 
systems, such as Pd2(dba)3–5-L3 (Table 5-1, entry 16) were found to be ineffective. 
Finally, we were pleased to find that formation of decarboxylation product 5-8b could be 
suppressed if a stoichiometric amount of hexyl-9 BBN (1.05 equivalents) was used, and 
the enantioselectivity could be improved to 77% ee if 11 mol-% of 5-L1 was employed 
(Table 5-1, entry 19).84 The absolute stereochemical configuration of 2b was assigned as
shown by comparing its optical rotation with that of the literature value.79
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Exploration of Substrate Scope
 
 With an enantioconvergent process developed for 5-6a, we sought to test the 
substrate scope of the reaction. We discovered that substitution at the C5 position of the 
aromatic ring was well tolerated in the reaction. For example, 5-methoxy- and 5-methyl-
substituted substrates underwent the decarboxylative allylic alkylation to give the 
corresponding products (i.e., 5-7c and 5-7d) in high yields (82 and 94%) with ee values 
(80 and 76%) similar to that of 5-7b (Scheme 5-4). An electron-withdrawing chloride at 
the C5 position was also compatible even though the yield (61%) and ee (64%) of the 
product (i.e., 5-7e) were somewhat reduced. However, methyl substitution at positions 
C6 and C7 of the aromatic ring was found to be incompatible with the reaction, as only 
the decarboxylation products (i.e., 5-8a and 5-8f) were formed. 
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Scheme 5-4. Initial substrate scope of the enantioconvergent decarboxylative allylation 
 We were also capable of introducing different allyl groups for the 
decarboxylative allylation. We were pleased to observe that 5-7g was formed in 62% 
yield with 74% ee from the corresponding crotyl indolenin-3-carboxylate (Scheme 5-5). 
A reaction temperature of 40 °C was necessary for the reaction of the less-reactive 
methallyl ester to give 2h in 76% yield with a low ee of 29%. When we attempted an 
enantioconvergent decarboxylative prenylation, only racemic indolenine 2i was formed 
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in 52% yield after the corresponding prenyl ester was subjected to the reaction 
conditions at 40 oC. 
 
Scheme 5-5. Effects of substitution on the allyl group 
 Our initial substrate pool was limited by the method of synthesis available for the 
precursor. We were relying on previous work by our laboratory to access the allyl 3-
alykl-indolenin-3-carboxylates which constrained the 3-alkyl substituent to a butan-3-
onyl group (Figure 5-3).76 We therefore sought additional methods of synthesis so that 
we could explore the effects of varying the alkyl substituent on the reaction. 
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Figure 5-3. Initial method of substrate construction 
We explored many strategies to diversify our substrate pool. These methods 
included the oxidative coupling of allyl indole-3-carboxylate with electrophiles, 
intramolecular oxidative dimerization of (Z)-but-2-ene-1,4-diyl bis(1H-indole-3-
carboxylate) and the C3 alkylation of allyl indole-3-carboxylate with electrophiles. 
Fortunately, we found that the C3 alkylation of allyl indole-3-carboxylate with benzyl 
and allyl halides could be effected when allyl indole-3-carboxylate, 5-9, was 
deprotonated with nBuLi and the resulting lithium amide was transmetallated to a zinc 
amide (Scheme 5-6). We later adapted a process by Lin, Hashim and Yang in our group's 
publication of the dearomatizing C3 alkylation of C3 alkyl indoles with alkyl halides to 
give C3 quaternary indolenines.85 This was the first instance of direct C3 alkylation on
indole-3-carboxylates to generate C3 quaternary indolenines. 
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Scheme 5-6. Conditions to alkylate the C3 position of 5-9 
 With a method capable of accessing substrates with a diverse C3 alkyl 
substituent, we continued our substrate scope analysis. Allyl indolenine-3-carboxylates 
with C3 allyl or C3 aryl substitution gave uniformly high yields (>88%) upon 
decarboxylative allylic alkylation even though lower ee values were observed as 
compared to the butan-3-onyl containing substrates (Scheme 5-7). For example, prenyl-
substituted indolenine 5-7k was formed in 60% ee upon decarboxylative allylic 
alkylation, and  
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Scheme 5-7. Enantioconvergent decarboxylative allylation of C3 allyl and aryl substrates 
crotyl-substituted indolenine 5-7f was formed with slightly lower enantioselectivity of 
54% ee. Similar enantioselectivities (59–73% ee) were seen with various benzyl-
substituted C3-quaternary indolenines (i.e., 5-7L to 5-7o) upon reaction of the 
corresponding allyl indolenin-3-carboxylates. 
 
Mechanistic Discussion 
 In order to better understand the mechanism of the enantioconvergent 
decarboxylative allylation, a crossover experiment was carried out in which a 1:1 
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mixture of 5-6g/5-6L was subjected to the reaction conditions (Scheme 5-8). Only 5-7g 
and 5-7L were detected by crude NMR thus indicating that the reactive species that were 
formed from each of the substrates remained closely associated as a tight ion pair during 
the process and recombined to give the products.  
 
 
Scheme 5-8. Crossover experiment of 5-6g and 5-6L 
 Our aggregate experimental findings suggest that the trialkylborane participates 
in the reaction both as a Lewis acid to facilitate decarboxylative elimination of the C3 
esters and as part of a strongly π-nucleophilic N-indolyltrialkylborate species for 
dearomatizing C3-allylic alkylation to form the quaternary carbon center. A proposed 
reaction mechanism that accounts for these effects is depicted in Scheme 5-9.86 First,  
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Scheme 5-9. Proposed mechanism of the enantioconvergent decarboxylative allylation 
N–B coordination of indolenine (5-6) and trialkylborane forms electron-deficient 3H-
indolium intermediate A. This leads to activation of the allyl ester towards oxidative 
addition of Pd(0) and facilitates decarboxylation of the resulting C3 carboxylate to give 
tightly associated ion pair B.87 Subsequent C3 allylation of the solvent-caged N-
indolyltrialkylborate and the chiral cationic Pd–π–allyl complex gives C, which 
dissociates to form enantiomerically enriched C3- quaternary indolenine 5-7. Formation 
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of the electron-rich N-indolyltrialkylborate species is required to increase the π-
nucleophilicity for the dearomatizing C3 allylation reactions. Consistent with this 
hypothesis, only the decarboxylation product (i.e., 5-8a) was formed when 5-6a was 
subjected to the reaction conditions, likely due to impeded N–B coordination as a result 
of 7-Me substitution, which prevented formation of the nucleophilic N-
indolyltrialkylborate species.88 
 
Conclusions 
 This work clearly demonstrated a novel enantioconvergent approach to 3-allyl-3-
alykl-indolenines through the use of a chiral palladium/trialkylborane dual catalyst 
system. Also, we suggest a greater role of trialkyl borane beyond allylic alcohol 
activation in previous allylation examples employing R3B/allyl alcohol as the allyl 
source. It was suggested that formation of strongly π-nucleophilic N-indolylborate 
species for the dearomatizing allylic alkylation was integral to the success of the 
reaction. 
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CHAPTER VI 
ASYMMETRIC ALLYLATION OF ALDEHYDES EMPLOYING BORANE 
ACTIVATION 
  
The key observation of substrate activation by a trialkyl borane came out of our 
efforts to develop an asymmetric decarboxylative allylation of allyl 3-alkyl-indolenin-3-
carboxylates described in Chapter V. With this strategy to effect an asymmetric allylic 
alkylation on an in situ generated nucleophile, we were curious if we could apply this 
strategy to give an asymmetric allylic alkylation of in situ activated aldehydes and 
ketones using a trialkyl borane as the activating reagent. 
 
Introduction to the Tsuji-Trost Reaction on Carbonyl Compounds 
 The enolate was one of the earliest nucleophiles explored in the development of 
the Tsuji-Trost reaction when enolates formed from diethyl malonate and ethyl 
acetoacetate were allylated by Tsuji and co-workers in 1965.38 However, it was not until 
the work of Hayashi in 1988 that a reaction capable of asymmetric allylation of 1,3-
diketones was developed.89 It was found that chiral ferrocene ligand 6-1 and palladium 
were capable of enantioselectively allylating 2-acetyl-cyclohexanone with allyl acetate 
in 88% yield and with 81% ee (Scheme 6-1). The reaction proceeded through an 
intermediate stabilized prochiral enolate generated by initial treatment of the 1,3-
diketone with NaH. 
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Scheme 6-1. Enantioselective allylation of 1,3 diketones by Hayashi and co-workers 
 Many other examples of enantioselective allylation using 1,3-dicarbonyl species 
have been reported with several substrates and catalytic systems giving greater than 95% 
ee.90 
 One of the major limitations of this method is that the allylation reaction involves 
an intermediate enolate which must be generated using strongly basic conditions. 
Therefore, the substrates capable of undergoing this reaction must have other acidic 
functional groups protected. Also, the substrate must either have only one enolizable 
center or have a large difference in acidity between the sites of deprotonation. Therefore, 
a new method of selective allylation was developed simultaneously to address these 
limitations.  
 The first instance of unstabilized enolates undergoing an allylation reaction was 
reported by Tsuji and co-workers in 1980 (Scheme 6-2).91 This reaction is also one of 
the first instances of a decarboxylative allylation strategy and it involved allyl β-
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ketoesters reacting with a palladium catalyst to generate homoallylic ketones as the 
reaction product.  
 
 
Scheme 6-2. The allylation of unstabilized ketones by Tsuji and co-workers 
 Different examples abound for the allylation of unstabilized enolates92 but it was 
not until 2004 when Stoltz and co-worker disclosed an enantioselective Tsuji-Trost 
allylation using allyl enol carbonate substrates (Scheme 6-3).93 This work involved the 
generation of an allyl enol carbonate that underwent enantioselective decarboxylative 
allylation in the presence of palladium and (S)-tert-butyl phosphinooxazoline as the 
ligand. This catalytic system was capable of forming quaternary carbon centers in 55-
96% yield and 79-92% ee. Also of note is the first highly enantioselective synthesis of 2-
allyl-2-methylcyclohexanone in 89% ee. 
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Scheme 6-3. Enantioselective allylation of unstabilized ketones by Stoltz and co-woker 
 Other methods developed to enantioselectively allylate carbonyl compounds 
include the allylation of silyl enol ethers93 and the enantionselective decarboxylation of 
allyl β-ketoesters94 with both methods capable of good yields and excellent 
enantioselectivities. However, the current methodologies for the allylation of 
unstabilized enolates all require the preactivation of the substrate by formation of allyl 
enol carbonates, silyl enol ethers and allyl β-ketoesters. This adds a potentially low-
yielding step to the synthetic sequence that reduces the synthetic efficiency of the 
synthesis. Therefore, methods that can directly and enantioselectively allylate aldehydes 
and ketones are in high demand. 
 
The Enantioselective Allylic Alkylation of Unactivated, Unstabilized Aldehydes 
 The first report of a reaction capable of allylic alkylation of unactivated, 
unstabilized aldehydes was by Tamaru and co-workers in 2001.95 Their methodology 
involved the use of an allylic alcohol as an allylating reagent with Et3B as the activating 
reagent capable coordinating to the allylic alcohol and thereby facilitating the allylic 
alkylation of aldehydes (Scheme 6-4). This reaction proceeded in 63-92% yield. 
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Scheme 6-4. Allylic alkylation of unactivated, unstabilized aldehydes by Tamaru 
 We believed we could use the experience gained in our work outlined in Chapter 
V to create an enantioselective version of this reaction. Initial efforts were directed at 
screening conditions for the allylation of 2-phenyl-propanal (6-2 in Table 6-1). We 
began by first exploring the role of Et3B in the allylation reaction reported by Tamaru. It 
is known that trialkyl boranes can activate allylic alcohols for oxidative addition by 
Pd(0) (Chapter V) and we were curious if Et3B had another role in the reaction. 
 
 
Table 6-1. Conditions screen for racemic allylic alkylation of aldehydes 
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 Therefore, we switched to allylating reagents that do not require boranes for 
activation. The first two allylating reagents we explored were allyl acetate (entry 1, 
Table 6-1) and allyl methyl carbonate (entry 2, table 6-1). To our delight, allyl acetate 
gave a 81% yield with only a 40 minute reaction time while the conditions of entry 2 
gave only 62% yield after 16 hours. Also, when the reaction was conducted without 
Et3B, there was no product detected after 24 hours (entry 3, Table 6-1). 
 With a robust racemic allylation demonstrated, we turned our attention to 
developing an enantioselective version. Our conditions screen began by evaluating 
various ligands (entries 1-5, Table 6-2). We found that phosphoramidite ligand 6-L3 
performed the best of the ligand classes evaluated and gave 6-3 in 91% yield and in 26% 
ee at rt (entry 3, Table 6-2). Our next efforts were focused on the Lewis acid. Previous 
work of ours (Chapter V) had demonstrated that, for the enantioselective 
decarboxylative allylation of allyl 3-alkyl-indolenine-3-carboxylates, the size of the 
trialkyl borane influenced the enantioselectivity of the reaction. Therefore, we screened 
the larger hexyl-9-BBN and we also explored the CBS reagent (S)-Bu-CBS. While 
hexyl-9-BBN gave a similar enantioselectivity (25% entry 6, Table 6-2), the yield of the 
reaction was substantially decreased to <70%. Also, (S)-Bu-CBS failed to give any 
product after 20 hours (entry 8, Table 6-2). We also explored the ability of Zn Lewis 
acids to catalyze this reaction and found that Zn(OTf)2 failed to facilitate the allylation 
(entry 9, Table 6-2).  
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a) reaction was conducted without LiCl; b) allyl methylcarbonante was used as the allyl source 
 
Table 6-2. Conditions screen for the enantioselective allylation of aldehydes 
Entry L Lewis Acid Solvent %Yield  %ee Time 
1 6-L1 2.2 eq. Et3B THF 97 12 24 hrs 
2 6-L2 2.2 eq. Et3B THF 97 9 1 hr 
3 6-L3 2.2 eq. Et3B THF 91 26 1 hr 
4 6-L4 2.2 eq. Et3B THF 67 -8 18 hrs 
5 6-L5 2.2 eq. Et3B THF 60 -1 18 hrs 
6 6-L3 1.09 eq. 9-hexyl-BBN THF <70 25 24 hrs 
7 6-L3 1.09 eq. Et3B THF 95 24 20 hrs 
8 6-L3 2.2 eq. (S)-Bu-CBS THF 0 n/a 20 hrs 
9 6-L3 2.2 eq. Zn(OTf)2 THF 0 n/a 20 hrs 
10 6-L3 2.2 eq. Et3B DCM >95 19 1.5 hrs 
11 6-L3 2.2 eq. Et3B Dioxane 82 23 20 min 
12 6-L3 2.2 eq. Et3B Toluene 93 18 30 min 
13a 6-L3 2.2 eq. Et3B THF >95 21 1 hr 
14b 6-L3 2.2 eq. Et3B THF 83 25 24 hrs 
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 We next looked at solvents (entries 10, 11 and 12) and found that none 
performed better than THF. Also, the role of LiCl was explored and it was found that the 
ee dropped to 21% without LiCl added to the reaction (entry 13). Finally, we were 
curious if the allyl source would affect the enantioselectivity of the reaction and we used 
allyl methyl carbonate instead of allyl acetate and found that there was no change in 
selectivity (entry 14). 
 With our screening complete, we found that current ligand classes were unable to 
impart substantial selectivity of the allylation of 6-2. Curious the substrate class could 
influence the enantioselectivity, we prepared two substrates to explore how changes to 
the electronics and sterics of the intermediate enolate would affect the reaction. 
 In order to study how the electronics of the enolate governed the 
enantioselectivity of the allylation, the electron rich substrate 6-4 was subjected to the 
reaction conditions (Scheme 6-5). It was found that the allylated product 6-5 was formed 
in >95% yield and in 34% ee. This results suggests that the enantioselectivity of the  
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Scheme 6-5. The role of structure and electronics in the enantioselective allylation 
reaction depends on the electronic nature of the intermediate enolate more so than the 
steric bulk of the two substituents. Also, ridged substrate 6-6 was shown to undergo 
allylation to give 6-7 in >95% yield and in 25% ee. Reaction of 6-6 gave similar results 
to that of 6-2 which suggests that increasing the rigidity of the starting material does not 
influence the enantioselectivity of the reaction. 
 Finally, we sought to apply these methods to ketone substrates in order to 
develop a method that was capable of directly allylating ketones to give enantiopure, 
quaternary centers α to the ketone. We began our screen with 2-methyl-cyclohexanone 
and our conditions from the racemic allylation of aldehydes (entry 1, Table 6-3). After  
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Table 6-3. Screen to optimize the direct allylation of ketones 
24 hours, no product was detected. We examined if the reaction would happen without 
the addition of borane (entry 2, Table 6-3) and again found no reactivity. Realizing that 
the pKa of protons α to ketones is higher than protons α to aldehydes, we attempted the  
reaction with stronger bases and still found no product detectible by NMR (entries 3 - 6). 
Also, solvent (entries 7 and 8), the presence/absence of LiCl (entry 9) and a more 
powerful Lewis acid (entry 10) all failed to generate product. The strategy of trialkyl 
borane activation of ketones for direct allylation had been demonstrated not to work.  
 However, the fact that ketones do not undergo the reaction can be useful. The 
direct allylation of aldehydes using Et3B is selective for aldehydes over ketones. This 
Entry Additive Borane Base Solvent  % yield 
1 0.91 eq. LiCl 2.2 eq. Et3B 1.1 eq. Et3N THF 0 
2 0.91 eq. LiCl none 1.1 eq. Et3N THF 0 
3 0.91 eq. LiCl 2.2 eq. Et3B 1.1 eq. Cs2CO3 THF 0 
4 0.91 eq. LiCl 2.2 eq. Et3B 1.1 eq. NaOH THF 0 
5 0.91 eq. LiCl 2.2 eq. Et3B 1.1 eq. KOt-Bu THF 0 
6 0.91 eq. LiCl 2.2 eq. Et3B 1.1 eq. K3PO4 THF 0 
7 0.91 eq. LiCl 2.2 eq. Et3B 1.1 eq. K3PO4 DMF 0 
8 0.91 eq. LiCl 2.2 eq. Et3B 1.1 eq. KOt-Bu Dioxane 0 
9 none 2.2 eq. Et3B 1.1 eq. K3PO4 THF 0 
10 0.91 eq. LiCl 0.3 eq. (F5-Ph)3B 1.1 eq. Et3N THF 0 
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results in a synthetic method that is capable of functionalizing the α position of 
aldehydes while theoretically not having to protect ketone functional groups in the 
molecule due to lack of ketone reactivity under these reaction conditions. 
 
Conclusions 
 In closing, we have developed an understanding of the role of Et3B in the Tamaru 
allylation that goes beyond activation of allyl alcohol. The Lewis acid Et3B facilitates 
enolization and behaves as a co-catalyst to effect the allylation of aldehydes. We have 
also begun developing an enantioselective version of this reaction that suffers from low 
enantioselectivity. Finally, this reaction is selective for aldehydes as ketones have been 
demonstrated to not react under the described conditions. 
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CHAPTER VII 
CONCLUSIONS 
 
 Our work presented on the transannular bis-Michael reaction was two-fold in 
nature. We sought to develop an expedient route to an all-carbon Z,E macrocyclic 
precursor to the TMR and we then evaluated whether the Z,E isomer would follow our 
proposed model for the TMR. At the conclusion of the experiments of Chapter II, it 
became clear to us our initial intramolecular 1,3-dipolar synthetic route had many 
insurmountable difficulties. No matter the placement of the requisite oxime and alkyne 
functionalities, no desired isoxazole product was formed. As a result, we devised an 
alternate synthetic scheme with the hope of resolving these problems. 
 We still believed that the isoxazole was the best way to construct the requisite 
1,3-diketone moiety. Therefore, we switched to an intermolecular strategy to construct 
the isoxazole in our synthesis of the macrocyclic precursor. This work is detailed in 
Chapter III. While the synthetic efficiency was demonstrated to be low, we developed a 
synthetic route making use of a 1,3-dipolar cycloaddition for the convergent synthesis of 
a 1,3-diketone-containing macrocycle. Consistent with our other studies, this Z,E-
macrocyclic bis-enone was found to be inactive in the transannular bis-Michael reaction 
cascade for the conditions evaluated. The combined efforts of our lab to explore the 
utility and stereoselectivity of the TMR led to the discovery that two of the four possible 
olefin isomers (Z,E and Z,Z) were not acceptable substrates for the TMR due to their 
lack of reactivity. As a result of this work, the synthetic utility of the TMR has been 
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increased due to the knowledge gained of not only the stereochemical outcome of the 
E,Z and E,E isomers, but also of the limitations of substrate scope: the Z,E and Z,Z 
substrates cannot participate in the reaction. Therefore, retrosynthetic strategies making 
use of this disconnection can appropriately plan for the limitations described herein. 
We also discovered that our 1,3-dipolar cycloaddition gave a rare 3,4-
disubstituted isoxazole under kinetic reaction conditions. We demonstrated that the 
dipolar cycloaddition is reversible and the thermodynamic 3,5-disubstituted isoxazole 
can be obtained through isomerization of its 3,4-disubstituted isomer under elevated 
temperature. Our initial mechanistic studies support the role of hydrogen-bonding in 
accelerating the isomerization process. This discovery sets the stage for a possible direct 
route to access 3,4-disubstituted isoxazoles. 
 Our work in developing new palladium-catalyzed reactions resulted in a novel 
palladium-catalyzed enamine Heck reaction. This reaction is capable of generating α,β-
unsaturated ketones directly from aldehydes and vinyl iodides. However, the limitations 
of scope in both vinyl iodide and aldehyde severely limit the synthetic utility of the 
reaction described herein. The possibility exists that significant improvements in yield 
could be achieved by evaluating other transition metal systems as catalysts or through 
the use of new synthetic techniques such as microwave acceleration.  
 In addition, our work clearly demonstrated a novel enantioconvergent approach 
to 3-allyl-3-alykl-indolenines through the use of a chiral palladium/trialkylborane dual 
catalyst system. We suggest a greater role of trialkyl borane beyond allylic alcohol 
activation in previous allylation examples employing R3B/allyl alcohol as the allyl 
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source. It was suggested that formation of strongly π-nucleophilic N-indolylborate 
species for the dearomatizing allylic alkylation was necessary for the success of the 
reaction. While this reaction had good to excellent yields across the substrate pool, the 
enantioselectivity was at most good. However, the maximum ee we observed is 
consistent with other literature reports of reactions to access this type of substrate. 
 Finally, we extended or understanding of the role of Et3B to the Tamaru 
allylation. The Lewis acid Et3B facilitates enolization and behaves as a co-catalyst to 
effect the allylation of aldehydes. We have also begun developing an enantioselective 
version of this reaction that suffers from low enantioselectivity. This reaction was shown 
to be selective for aldehydes as ketones did not react under the described conditions. 
 Taken together, this research has explored a diverse area of chemical 
transformations and has provided insight into their respective limitations. It is hoped that 
future work in the area of complex molecule synthesis can avail itself of some of the 
methods and models that are described in the previous chapters. 
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APENDIX A 
EXPERIMENTAL PROCEDURES 
General Information 
All solvents were degassed for by bubbling N2 through the solvent for several hours. The 
solvents were then dried by passing through an alumina column before use. Thin-layer 
chromatography was done on TLC Silica gel 60 F254 commercial plates (EMD 
chemicals). 1H NMR spectra were recorded on Varian Inova 500 (500 MHz) and 
Mercury 300 (300 MHz) spectrometers. All spectra are referenced to the residual solvent 
peak (7.26 ppm for CHCl3). The chemical shift (δ) of each signal is reported in parts per 
million (ppm) and all coupling constants (J) are reported in Hertz (Hz). 13C NMR spectra
were recorded on Varian Inova 500 (125 MHz) and Mercury 300 (75 MHz) 
spectrometers. All spectra are referenced to the residual solvent peak (7.26 ppm for 
CHCl3). The chemical shift (δ) of each signal is reported in parts per million (ppm). 
Chiral HPLC analyses were preformed either on a Shimadzu Prominence SiL-20A 
UFLC or an Agilent Technologies 1200 Series HPLC using Daicel Chemical Industries 
CHIRALPAK® columns (IA, IB, IC, ASH, and AD) eluting with hexane / iso-propanol
mixtures as indicated. The Laboratory for Biological Mass Spectrometry at Texas A&M 
University recorded low and high resolution mass spectra. 
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Proceedures 
CHAPTER II 
 
 
 
(R)-N,2-dimethyl-N-((2R,3R)-3-phenylbutan-2-yl)-6-(trimethylsilyl)hex-5-ynamide 
(2-6). 
n-BuLi (32.3 mL, 51.6 mmol, 1.6 M in hexanes) was added dropwise to a solution of 
HN(i-Pr)2 (7.8 mL, 55.7 mmol) and LiCl (6.95 g, 164 mmol) in THF (37 mL) at -78 
oC 
under N2. The resulting suspension was held at -78 
oC for 5 minutes, transferred to an ice 
bath (~ 4 oC) for 5 minutes and then cooled to -78 oC.  N-methyl-N-((2R,3R)-3-
phenylbutan-2-yl)propionamide1 (6.0 g, 27.1 mmol) in THF (81 mL) was added via 
cannula and the mixture was stirred for 1 hour at -78 oC, warmed to 0 oC for 15 minutes, 
and then stirred at RT for 3 minutes. The flask was then cooled to 0 oC and (4-iodobut-1-
yn-1-yl)trimethylsilane2 (3.26 g, 12.9 mmol) was added. The reaction was stirred for 2 
hours and quenched with saturated NH4Cl (130 mL). The mixture was extracted 4x with 
EtOAc (4x 130 mL). The combined organics were dried over MgSO4 and concentrated. 
The crude material was purified by column chromatography (Hexanes:EtOAc 60:40) to 
give 2-6 (0.86 g, 20%).  1H NMR (CDCl3, 300 MHz) δ 7.39-7.27 (m, 5H), 4.65-4.56 (m, 
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1H), 2.89 (s, 3H), 2.29-2.08 (m, 2H), 1.86-1.74 (m, 1H), 1.64 -1.44 (m, 3H), 1.14 (d, J = 
6.9 Hz, 3H), 1.11 (d, J = 6.9 Hz, 3H), 0.12 (s, 9H). LRMS (EI+) m/z calculated for 
C20H32NO2Si [M+H]
+: 346.22, found: 346.14. 
 
 
(R)-2-methyl-6-(trimethylsilyl)hex-5-yn-1-ol (2-7). 
n-BuLi (5.0 mL, 8.0 mmol, 1.6 M in hexanes) was added dropwise to a solution of HN(i-
Pr)2 (1.2 mL, 8.7 mmol) in THF (8.7 mL) at -78 
oC under N2. The resulting solution was 
stirred at -78 oC for 10 minutes and warmed to 0 oC and stirred for 10 minutes. BH3NH3 
(0.28 g, 8.2 mmol) was added and the suspension was stirred for 15 minutes at 0 oC, 
warmed to RT and stirred for 15 minutes and cooled to 0 oC. 2-6 (0.71 g, 2.1 mmol) in 
THF (5.2 mL) was added dropwise and the reaction was warmed to RT. The reaction 
was followed by TLC and was complete after 3 hours.  The reaction cooled to 0 oC and 
was quenched with the addition of 3M HCl (21 mL) and stirred for 30 minutes at 0 oC. 
The mixture was extracted 3x with diethyl ether (3x 20 mL). The combined organic 
phases were washed 2x with 3M HCl (2x 8.5 mL), 1x with saturated NaHCO3 (8.5 mL), 
1x with CuSO4 and 1x with brine (8.5 mL). The extract was dried over MgSO4, filtered 
and concentrated to give 2-7 (0.332 g, 87%).  1H NMR (CDCl3, 300 MHz) δ 3.55-3.45 
(m, 2H), 2.37-2.17 (m, 2H), 1.81-1.60 (m, 2H), 1.49 (brs, 1H), 1.44-1.33 (m, 1H), 0.93 
(d, J = 6.9 Hz, 3H), 0.14 (s, 9H). 13C NMR (CDCl3, 75 MHz) δ 107.6, 84.7, 67.8, 35.1, 
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32.1, 17.6, 16.4, 0.27. LRMS (EI+) m/z calculated for C10H20LiOSi [M+Li]
+: 191.1438, 
found: 191.1394. 
 
 
 
(R)-tert-butyldimethyl((2-methyl-6-(trimethylsilyl)hex-5-yn-1-yl)oxy)silane (2-8). 
2-7 (0.291 g, 1.58 mmol) was dissolved in DCM (2.1 mL) under N2 and Et3N (0.33 mL, 
2.4 mmol) and DMAP (19 mg, 0.16 mmol) were added. TBS-Cl (0.297 g, 1.97 mmol) 
was then added at RT and the reaction was stirred overnight. The reaction was quenched 
with the addition of 5 mL of H2O and the organic layer was separated. The organic phase 
was washed 2x with H2O (2x 5 mL), dried over MgSO4, filtered and concentrated. The 
crude material was purified by column chromatography (Hexanes:EtOAc 90:10) to give 
2-8 (0.526 g, >95%).  1H NMR (CDCl3, 300 MHz) δ 3.48-3.37 (m, 2H), 2.35-2.16 (m, 
2H), 1.77-1.60 (m, 2H), 1.37-1.24 (m, 1H), 0.89 (m, 12H), 0.14 (s, 9H), 0.04 (s, 6H). 13C 
NMR (CDCl3, 75 MHz) δ 107.8, 84.4, 68.1, 35.1, 32.4, 26.1, 18.5, 17.8, 16.5, 0.3, 0.2. 
LRMS (EI+) m/z calculated for C16H35OSi2 [M+H]
+: 299.2221, found: 299.2054. 
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(R,Z)-tert-butyl((2,5-dimethyl-6-(trimethylsilyl)hex-5-en-1-yl)oxy)dimethylsilane (2-
8a). 
Cp2TiCl2 (0.78 g, 3.1 mmol) was placed in a flame-dried flask under N2 and DCM (6.8 
mL) was added. To this suspension was added Me2AlCl (0.29 mL, 3.1 mmol) and the 
reaction was stirred for 30 minutes at RT. 2-8 (0.47 g, 1.6 mmol) in a flask under N2 was 
added via cannula. The flask containing 2-8  was rinsed with 1 mL of DCM which was 
cannulated to the reaction. The reaction was stirred for 4.5 hours. KOH (11.6 g) was 
dissolved in H2O (35 mL) and this solution was placed in an flask with stir bar under 
AMBIENT atmosphere. When TLC indicated that the carbometallation of 2-8 was 
complete after 4.5 hours, the reaction was slowly cannulated to the vigorously stirred 
solution of KOH in H2O. The reaction flask and cannula were rinsed with DCM. The 
resulting biphasic mixture was then filtered over a celite pad and the pad was washed 
with DCM (50 mL). The organic phase was separated and the aqueous phase was 
extracted 3x with DCM (3x 50 mL). The combined organic phases were dried over 
MgSO4, filtered and concentrated. The crude material was purified by column 
chromatography (Hexanes:EtOAc 100:0) to give 2-8a (0.329 g, 67%).  1H NMR (CDCl3, 
300 MHz) δ 5.18-5.17 (m, 1H), 3.47-3.37 (m, 2H), 2.21-2.00 (m, 2H), 1.82 (d, J = 1.2 
Hz, 3H), 1.62-1.50 (m 2H), 1.22-1.10 (m, 1H), 0.90 (m, 12 H), 0.09 (s, 9H), 0.04 (s, 6H). 
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13C NMR (CDCl3, 75 MHz) δ 156.6, 124.5, 68.3, 36.5, 35.5, 32.6, 26.7, 26.1, 28.5, 16.9, 
0.5, -5.2. LRMS (EI+) m/z calculated for C17H38LiOSi2 [M+Li]
+: 321.2621, found: 
321.2702. 
 
 
 
(R,Z)-tert-butyl((6-iodo-2,5-dimethylhex-5-en-1-yl)oxy)dimethylsilane (2-3Z). 
2-8a (0.257 g, 0.82 mmol) was dissolved in CH3CN (4.9 mL) under N2. The reaction 
was wrapped in foil and NIS (0.295 g, 1.31 mmol) was added in one portion. The 
reaction was stirred for 18 hours and quenched the addition of  saturated NaHCO3 (2.5 
mL) and saturated Na2S2O3 (2.5 mL). The reaction was stirred for 10 minutes and 
extracted 3x with Et2O (3x 10 mL). The combined organics were dried over MgSO4, 
filtered and concentrated. The crude material was purified by column chromatography 
(Hexanes:EtOAc 98:2) to give 2-3Z (0.250 g, 83%).  1H NMR (CDCl3, 300 MHz) δ 
5.81-5.80 (m, 1H), 3.46-3.41 (m, 2H), 2.27-2.18 (m, 2H), 1.88 (d, J = 1.5 Hz, 3H), 1.63-
1.52 (m, 2H), 1.25-1.13 (m, 1H), 0.93 (d, J = 9.0 Hz, 3H), 0.90 (s, 9H), 0.05 (s, 6H). 13C 
NMR (CDCl3, 75 MHz) δ 148.1, 73.9, 68.1, 36.5, 35.7, 30.4, 26.1, 23.3, 18.5, 16.8, -5.2. 
LRMS (EI+) m/z calculated for C14H29IOSi2 [M+H]
+: 369.1105, found: 369.0915. 
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tert-Butyl(hex-5-yn-1-yloxy)dimethylsilane (2-31). 
To a solution of hex-5-yn-1-ol (7.73 mL, 71.3 mmol), triethylamine (15 mL, 107 mmol), 
and DMAP (0.44 g, 3.67 mmol) in DCM (95 mL) under N2 was added TBSCl (13.4 g, 
89 mmol). The reaction was stirred at RT overnight. The reaction was quenched with 
water (75 mL) and the organic phase was separated. The organic phase was washed with 
water (25 mL), saturated NH4Cl (25 mL), and 2x with saturated NaHCO3 (75 mL). The 
organic phase was then dried over MgSO4 and concentrated. The crude material was 
purified by column chromatography (Hexanes:EtOAc 90:10) to give 2-31 (13.9 g, 92%). 
The spectra were identical to those reported in the literature.3 1H NMR (CDCl3, 300 
MHz) δ 3.65 (t, J= 6.0 Hz, 2H), 2.24-2.18 (m, 2H), 1.94 (t, J = 2.7 Hz, 1H), 1.67-1.54 
(m, 4H), 0.89 (s, 9H), 0.05 (s, 6H). 
 
 
tert-butyldimethyl((6-(trimethylsilyl)hex-5-yn-1-yl)oxy)silane (2-10). 
To a solution of 2-31 (2.3 g, 10.8 mmol) in Et2O (7.3 mL) was added drop wise n-BuLi 
(6.9 mL, 11.1 mmol, 1.6 M in hexanes) at -78 oC. The reaction was stirred for 30 
minutes at -78 oC. TMS-Cl (1.42 mL, 11.1 mmol) was added dropwise and the reaction 
was allowed to warm to RT and then stirred for 2 hours. The reaction was quenched with 
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H2O (20 mL) and the mixture was extracted 3x with Et2O (3x 20 mL). The extracts were 
dried over MgSO4, filtered and concentrated.  The crude material was purified by 
column chromatography (Hexanes:EtOAc 90:10) to give 2-10 (2.91 g, 94%). The 
spectra were identical to those reported in the literature.4 1H NMR (CDCl3, 300 MHz) δ 
3.63 (t, J = 6.0 Hz, 2H), 2.24 (t, J = 6.9 Hz, 2H), 1.64-1.52 (m, 4H), 0.89 (s, 9H), 0.14 (s, 
9H), 0.05 (s, 6H). 
 
 
(Z)-tert-butyldimethyl((5-methyl-6-(trimethylsilyl)hex-5-en-1-yl)oxy)silane (2-10a). 
Cp2TiCl2 (5.03 g, 20.5 mmol) was placed in a flame-dried flask under N2 and DCM (45 
mL). Me2AlCl (1.9 mL, 20.5 mmol) was added dropwise at RT and the reaction was 
stirred for 30 minutes. 2-10 (2.91 g, 10.23 mmol) was cannulated over and the canula 
was rinsed with DCM (2 mL). The reaction was stirred for 20 hours. KOH (37.5 g) was 
dissolved in H2O (113 mL) and this solution was placed in an flask with stir bar under 
AMBIENT atmosphere. The carbometallation reaction was slowly cannulated to the 
vigorously stirred solution of KOH in H2O. The reaction flask and cannula were rinsed 
with DCM. The resulting biphasic mixture was then filtered over a celite pad and the pad 
was washed with DCM (150 mL). The organic phase was separated and the aqueous 
phase was extracted 3x with DCM (3x 100 mL). The combined organic phases were 
dried over MgSO4, filtered and concentrated. The crude material was purified by column 
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chromatography (Hexanes:EtOAc 100:0 to 99:1 to 98:2) to give 2-10a (1.07 g, 35%, Z:E 
86:14). The spectra were identical to those reported in the literature.5  1H NMR (CDCl3, 
300 MHz) δ 5.19-5.18 (m, 1H), 3.61 (t, J = 6.3 Hz, 2H), 2.14-2.09 (m, 2H), 1.81 (d, J = 
1.2 Hz, 3H), 1.53-1.42 (m, 4H), 0.89 (s, 9H), 0.08 (s, 9H), 0.05 (s, 6H). 
 
 
(Z)-tert-butyl((6-iodo-5-methylhex-5-en-1-yl)oxy)dimethylsilane (2-11). 
2-10a (1.00 g, 3.33 mmol) was dissolved in CH3CN (20 mL) under N2. The reaction was 
wrapped in foil and NIS (1.20 g, 5.32 mmol) was added in one portion. The reaction was 
stirred for 18 hours and quenched the addition of  saturated NaHCO3 (10 mL) and 
saturated Na2S2O3 (10 mL). The reaction was stirred for 10 minutes and extracted 3x 
with Et2O (3x 25 mL). The combined organics were dried over MgSO4, filtered and 
concentrated. The crude material was purified by column chromatography 
(Hexanes:EtOAc 98:2) to give 2-11 (0.985 g, 84%). The spectra were identical to those 
reported in the literature.5 1H NMR (CDCl3, 300 MHz) δ 5.83-5.82 (m, 1H), 3.63 (t, J = 
6.3 Hz, 2H), 2.22 (t, J = 7.8 Hz, 2H), 1.87 (d, J = 1.2 Hz, 3H), 1.57-1.43 (m, 4H), 0.90 
(s, 9H), 0.05 (s, 6H). 
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(Z)-tert-butyldimethyl((5-methyl-8-(trimethylsilyl)oct-5-en-7-yn-1-yl)oxy)silane (2-12). 
Pd(PPh3)4 (0.30 g, 0.26 mmol) and CuI (98 mg, 0.52 mmol) were combined under N2 
and HN(i-Pr)2 (9.2 mL) was added with stirring at 0 
oC. 2-10 (0.91 g, 2.58 mmol) was 
dissolved in HN(i-Pr)2 (18.4 mL) under N2 and added to the reaction. 
Trimethylsilylacetylene (0.55 mL, 3.87 mmol) was added and the reaction was taken out 
of the ice-bath. After 30 minutes of stirring, the reaction was quenched with the addition 
of saturated NH4Cl (10 mL) and extracted 3x with Et2O (3x 50 mL). The organics were 
washed with 230 mL of a mixture of saturated CuSO4 (30 mL) and H2O (200 mL). The 
organic phase was separated and the aqueous phase was extracted 3x with Et2O (3x 100 
mL). The combined organics were dried over MgSO4, filtered and concentrated to 2-12 
(0.805 g, 96%). 1H NMR (CDCl3, 300 MHz) δ 5.30 (s, 1H), 3.63 (t, J = 6.0 Hz, 2H), 
2.33 (t, J = 7.2 Hz, 2H), 1.77 (d, J = 1.2 Hz, 3H), 1.55-1.47 (m , 4H), 0.89 (s, 9H), 0.18 
(s, 9H), 0.05 (s, 6H). 13C NMR (CDCl3, 75 MHz) δ 154.4, 105.8, 103.6, 96.2, 63.1, 34.6, 
32.6, 26.1, 23.8, 22.6, 18.5, 0.3, -5.1. LRMS (EI+) m/z calculated for C18H37OSi2 
[M+H]+: 325.2377, found: Not Observed. 
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(Z)-5-methyl-8-(trimethylsilyl)oct-5-en-7-yn-1-ol (2-12a). 
2-12 (0.745 g, 2.29 mmol) was dissolved in 1% HCl in 95:5 EtOH:H2O (33 mL) and the 
reaction was stirred at RT for 5 minutes. The reaction was quenched with the addition of 
saturated NaHCO3 (55 mL) and the mixture was extracted 3x with Et2O (55 mL). The 
combined organics were dried over MgSO4, filtered and concentrated. The crude 
material was purified by column chromatography (Hexanes:EtOAc 75:25) to give 2-12a 
(0.48 g, 94%).  1H NMR (CDCl3, 300 MHz) δ 5.3 (s, 1H), 3.67 (t, J = 6.0 Hz, 2H), 2.34 
(t, J = 7.2 Hz, 2H), 1.77 (d, J = 1.5 Hz, 3H), 1.60-1.48 (m, 4H), 0.17 (s, 9H). 13C NMR 
(CDCl3, 75 MHz) δ 154.1, 105.9, 103.5, 96.4, 62.8, 34.4, 32.3, 23.7, 22.6, 0.2. LRMS 
(EI+) m/z calculated for C12H22LiOSi [M+Li]
+: 217.16, found: 217.18. 
 
 
(Z)-5-methyl-8-(trimethylsilyl)oct-5-en-7-ynal (2-4). 
2-12a (0.454 g, 2.16 mmol) was dissolved in DMSO (11 mL) and IBX (2.30 g, 8.2 
mmol) was added at RT. The reaction was stirred for 3 hours and quenched with the 
addition of H2O (22 mL). The slurry was stirred for 5 minutes and filtered through celite. 
The celite was rinsed with Et2O (50 mL) and the filtrate was separated. The aqueous 
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phase was extracted 2x with Et2O (2x 50 mL). The combined organics were dried over 
MgSO4, filtered and concentrated. The crude material was purified by column 
chromatography (Hexanes:EtOAc 85:15) to give 2-4 (0.408 g, 91%).  1H NMR (CDCl3, 
300 MHz) δ 9.79 (t, J = 1.5 Hz, 1H), 5.34 (s, 1H), 2.48-2.43 (m, 2H), 2.36 (t, J = 7.5 Hz, 
2H), 1.85-1.75 (m, 4H), 1.78 (d, J = 1.5 Hz, 3H), 0.17 (s, 9H). 13C NMR (CDCl3, 75 
MHz) δ 202.4, 152.8, 106.9, 103.2, 96.8, 43.1, 33.9, 22.5, 19.9, 0.2.  
 
 
(2R,5Z,11Z)-1-((tert-butyldimethylsilyl)oxy)-2,11-dimethyl-14-
(trimethylsilyl)tetradeca-5,11-dien-13-yn-7-ol (2-13). 
2-3Z (0.337 g, 0.91 mmol) and 2-4 (0.153 g, 0.73 mmol) were combined in a flame dried 
flask and azeotroped to dryness with toluene. The flask was placed under N2 and Et2O 
(2.6 mL) was added. The reaction was cooled to -78 oC and t-BuLi (1.2 mL, 2.1 mmol, 
1.7M in hexanes) was added dropwise. After the addition of t-BuLi, the reaction was 
pulled out of the -78 oC bath and let warm to RT. The reaction was stirred for 75 minutes 
and quenched with the addition of saturated NH4Cl (5 mL). The reaction was diluted 
with H2O (10 mL) and extracted 3x with EtOAc (3x 10 mL). The material was dried 
over Na2SO4, filtered and concentrated. The crude material was purified by column 
chromatography (Hexanes:EtOAc 94:6) to give 2-13 (0.140 g, 44%).  1H NMR (CDCl3, 
300 MHz) δ 5.30 (s, 1H), 5.16 (d, J = 8.1 Hz, 1H), 4.39-4.32 (m, 1H), 3.42 (d, J = 5.7 
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Hz, 2H), 2.40-2.27 (m, 2H), 2.12-2.03 (m, 2H), 1.77 (s, 3H), 1.71 (s, 3H), 1.61-1.25 (m, 
7H), 0.89 (s, 9H), 0.18 (s, 9H), 0.04 (s, 6H). 13C NMR (CDCl3, 75 MHz) δ 154.3, 15.1, 
139.7, 128.6, 128.5, 105.9, 103.6, 79.8, 68.3, 68.2, 68.2, 37.6, 36.0, 35.8, 34.8, 34.7, 
32.1, 32.0, 31.1, 30.0, 29.9, 26.1, 25.8, 25.0, 23.6, 23.6, 22.6, 18.5, 16.9, 16.8, 0.3, 0.1, -
5.2. LRMS (EI+) m/z calculated for C26H50LiO2Si2 [M+Li]
+: 457.3504, found: 
457.3662. 
 
 
 
(2R,5Z,11Z)-2,5,11-trimethyl-14-(trimethylsilyl)tetradeca-5,11-dien-13-yne-1,7-diol 
(2-16). 
2-13 (0.111g, 0.248 mmol) was dissolved in THF (2.5 mL) and cooled to 0 oC. TBAF 
was added dropwise (1.0 mL, 1.0 mmol, 1M in THF) and the reaction was allowed to 
warm to RT. After stirring for 22 hours at RT, the reaction was quenched with the 
addition of water (10 mL) and the mixture was extracted 3x with EtOAc (3x 15 mL). 
The combined organics were dried over Na2SO4, filtered and concentrated. The crude 
material was purified by column chromatography (Hexanes:EtOAc 55:45) to give 2-16 
(43 mg, 66%). 1H NMR (CDCl3, 300 MHz) δ 5.26 (s, 1H), 5.18-5.14 (m, 1H), 4.39-4.32 
(m, 1H), 3.53-3.40 (m 2H), 2.97 (d, J = 2.1 Hz, 1H), 2.37-2.32 (m, 2H), 2.27-1.97 (m 
2H), 1.78 (s, 3H), 1.71 (s, 3H), 1.68-1.39 (m 6H), 1.33-1.12 (m, 1H), 0.95-0.91 (m, 3H).  
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(R,5Z,11Z)-2,5,11-trimethyl-7-oxotetradeca-5,11-dien-13-ynal (2-17). 
2-16 (9.6 mg, 0.036 mmol) was dissolved in DMSO (1.9 mL) and IBX (30.5 mg, 0.109 
mmol) was added at RT. The reaction was stirred for 16 hours and the reaction was 
concentrated. The crude material was purified by column chromatography 
(Hexanes:EtOAc 80:20) to give 2-17 (6.5 mg, 70%). 1H NMR (CDCl3, 300 MHz) δ 9.68 
(d, J = 1.8 Hz, 1H), 6.08 (s, 1H), 5.28 (s, 1H), 2.95 (d, J = 2.4 Hz, 1H), 2.61-2.55 (m, 
3H), 2.46-2.31 (m, 6 H), 1.88 (d, J = 1.5 Hz, 3H), 1.79 (d, J = 1.2 Hz, 3H), 1.78-1.70 (m, 
2H), 1.15 (d, J = 7.2 Hz, 3H). 13C NMR (CDCl3, 75 MHz) δ 189.5, 130.9, 128.8, 124.2, 
105.0, 79.3, 68.2, 46.3, 43.5, 38.7, 33.9, 31.3, 30.4, 28.9, 28.8, 25.4, 23.8, 23.0, 22.3, 
21.8, 14.1, 13.4, 11.0. LRMS (EI+) m/z calculated for C17H24LiO2 [M+Li]
+: 267.1931, 
found: 267.1925. 
 
 
(2R,5Z,11Z)-7-hydroxy-2,5,11-trimethyltetradeca-5,11-dien-13-ynal (2-19). 
A solution at pH = 8.6 was prepared by dissolving NaHCO3 (420 mg) and K2CO3 (69 
mg) in 10 mL of H2O. 2-16 (12.4 mg, 0.047 mmol) was dissolved in DCM (0.4 mL) and 
the pH = 8.6 solution was added (0.4 mL). TEMPO (1.7 mg, 0.01 mmol) and TBAC (2.6 
mg, 0.09 mmol) were added. Then NCS (12.6 mg, 0.096 mmol) was added and the 
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reaction was stirred for 1 hour. The reaction was directly loaded on a column and the 
crude material was purified by column chromatography (Hexanes:EtOAc 75:25) to give 
2-19 (10.6 mg, 86%). 1H NMR (CDCl3, 300 MHz) δ 9.61-9.59 (m, 1H), 5.26 (s, 1H), 
5.23-5.19 (m, 1H), 4.36-4.27 (m, 1H), 2.98 (d, J = 2.1 Hz, 1H), 2.37-2.33 (m, 2H), 2.21-
2.01 (m, 2H), 1.78 (d, J = 1.5 Hz, 3H), 1.73-1.72 (m, 3H), 1.64-1.38 (m, 7H), 1.13 (d, J 
= 7.2 Hz, 3H). 13C NMR (CDCl3, 75 MHz) δ 154.3, 138.1, 137.7, 129.9, 129.6, 104.8, 
81.8, 79.4, 68.1, 67.8, 46.4, 45.9, 37.3, 34.5, 29.9, 29.5, 29.0, 23.5, 23.5, 22.5, 13.8, 
13.7. LRMS (EI+) m/z calculated for C17H26LiO2 [M+Li]
+: 269.2087, found: 269.2111. 
 
 
(2R,5Z,11Z)-7-hydroxy-2,5,11-trimethyltetradeca-5,11-dien-13-ynal oxime (2-2). 
2-19 (4.2 mg, 0.016 mmol) was dissolved in pyridine (130 μL) and hydroxylamine 
hydrochloride (1.5 mg, 0.021 mmol) was added at RT. The reaction was stirred for 25 
minutes and the pyridine was removed en vacuo. The crude reaction was directly loaded 
on a column and the crude material was purified by column chromatography 
(Hexanes:EtOAc 60:40) to give 2-2 (4.1 mg, 94% as a mixture of C1 E/Z isomers). 
NMR for the Z isomer 1H NMR (CDCl3, 300 MHz) δ 7.18 (d, J = 8.4 Hz, 1H), 5.26-5.22 
(m, 2H), 4.39-4.31 (m, 1H), 2.99 (d, J = 2.7 Hz, 1H), 2.45-2.28 (m, 4H), 1.92-1.83 (m, 
1H), 1.78 (d, J = 1.2 Hz, 3H), 1.68 (d, J = 1.2 Hz, 3H), 1.53-1.38 (m, 6H), 1.08 (d, J = 
6.9 Hz, 3H). NMR for the E isomer 1H NMR (CDCl3, 300 MHz) δ 7.30 (d, J = 6.9 Hz, 
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1H), 5.27 (s, 1H), 5.18 (d, J = 9 Hz, 1H), 4.40-4.33 (m, 1H), 3.00-2.98 (m, 1H), 2.41-
2.30 (m, 4H), 2.09-2.00 (m, 1H), 1.78 (d, J = 1.5 Hz, 3H), 1.72-1.70 (m, 3H), 1.63-1.42 
(m, 6H), 1.10 (d, J = 6.9 Hz, 3H). LRMS (EI+) m/z calculated for C17H28NO2 [M+H]
+: 
278.2115, found: 278.1981. 
 
(Z)-1-((6R)-3a,6-dimethyl-3a,4,5,6-tetrahydro-3H-cyclopenta[c]isoxazol-3-yl)-5-
methyloct-5-en-7-yn-1-ol (2-20). 
2-2 (4.1 mg, 0.015 mmol) was dissolved in CHCl3 (200 μL) and NCS (2.0 mg, 0.0145 
mmol) and pyridine (0.1 μL) were added at RT. The reaction was stirred for 30 minutes 
and the reaction was diluted with CHCl3 (1.3 mL). Et3N (2.1 μL, 0.015 mmol) was then 
addedabd tge reactuib was sturred fir 20 hours at RT. The crude reaction concentrated 
and directly loaded on a column and the crude material was purified by column 
chromatography (Hexanes:EtOAc 75:25 to 50:50) to give 2-20 (0.9 mg, 22%). 1H NMR 
(CDCl3, 300 MHz) δ 5.27 (s, 1H), 3.94 (d, J = 4.5 Hz, 0.2 H), 3.89 (d, J = 5.7 Hz, 3H), 
3.57-3.50 (m, 1H), 2.97 (d, J = 2.1 Hz, 1H), 1.79 (m, 3H) (NOTE: due to the amount of 
material analyzed, the proton NMR data set is incomplete). LRMS (EI+) m/z calculated 
for C17H26NO2 [M+H]
+: 276.1958, found: 276.1882. 
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(2R,5Z,11Z)-7-((tert-butyldimethylsilyl)oxy)-2,5,11-trimethyltetradeca-5,11-dien-13-
ynal (2-21). 
2-19 (10.6 mg, 0.04 mmol) was azeotroped with toluene and dissolved in DCM (0.5 mL) 
under N2 in a flame-dried flask. TEA (40 μL, 0.28 mmol), DMAP (1 mg), and TBSCl 
(30.4 mg, 0.20 mmol) were added and the reaction was stirred for 19 hours at RT. The 
reaction was directly loaded on a column and the crude material was purified by column 
chromatography (Hexanes:EtOAc 93:7) to give 2-21 (7.2 mg, 47%). 1H NMR (CDCl3, 
300 MHz) δ 9.63 (s, 1H), 5.25 (s, 1H), 5.17-5.11 (m, 1H), 4.35-4.26 (m, 1H), 2.97 (d, J 
= 2.1 Hz, 1H), 2.35-2.31 (m, 2H), 2.03-1.92 (m, 1H), 1.77 (s, 3H), 1.68 (s, 3H), 1.58-
1.29 (m, 8H), 1.13 (m, 3H), 0.86 (s, 9H), -0.01 (s, 6H). LRMS (EI+) m/z calculated for 
C23H41O2Si [M+H]
+: 377.2870, found: 377.3446. 
 
 
(2R,5Z,11Z)-7-((tert-butyldimethylsilyl)oxy)-2,5,11-trimethyltetradeca-5,11-dien-
13-ynal oxime (2-22). 
2-21 (7.1 mg, 0.019 mmol) was dissolved in pyridine (300 μL) and hydroxylamine 
hydrochloride (1.8 mg, 0.025 mmol) was added at RT. The reaction was stirred for 60 
minutes and the pyridine was removed en vacuo. The crude reaction was directly loaded 
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on a column and the crude material was purified by column chromatography 
(Hexanes:EtOAc 80:20) to give 2-22 (1.0 mg, 14%). 1H NMR (CDCl3, 300 MHz) δ 6.77 
(d, J = 9.9 Hz, 1H), 5.26 (s, 1H), 5.13 (d, J = 9.0 Hz, 1H), 4.36-4.28 (m, 1H), 2.99 (s, 
1H), 2.37-2.30 (m, 3H), 2.14-1.91 (m, 2H), 1.91 (s, 3H), 1.7* (d, J = 1.5 Hz, 3H), 1.50-
1.30 (m, 6H), 1.10 (d, J = 6.9 Hz, 3G), 0.87 (s, 9H), 0.01 (s, 6H). LRMS (EI+) m/z 
calculated for C17H26NO [M-HOTBS]
+: 260.2009, found: 260.2027. 
 
 
(R)-4-isopropyl-3-(6-(trimethylsilyl)hex-5-ynoyl)oxazolidin-2-one (2-28). 
Two drops of DMF were added to a solution of 6-(trimethylsilyl)hex-5-ynoic acid6 (5.27 
g, 28.6 mmol) in dry benzene (40 mL) under N2. To this reaction was added dropwise 
oxalyl chloride (4.84 mL, 57.2 mmol) and the reaction was stirred at RT for 2 hours. 
After 2 hours, the reaction was concentrated en vacuo and the crude acid chloride was 
used in the next step without further purification. 
(R)-4-isopropyloxazolidin-2-one (2.46 g, 19.1 mmol) was dissolved in THF (24.6 mL) 
and cooled to 0 oC. n-BuLi (11.2 mL, 1.6 M in hexanes) was added dropwise and the 
reaction was stirred at 0 oC for 5 minutes. 6-(trimethylsilyl)hex-5-ynoyl chloride (28.6 
mmol) was added and the reaction was stirred and followed by TLC. After 14 hours, the 
reaction was quenched with the addition of saturated NH4Cl (10 mL) and diluted with 
H2O (10 mL). The mixture was then extracted 3x with EtOAc (3x 50 mL). The orgs 
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were dried over Na2SO4, filtered and concentrated. The crude material was purified by 
column chromatography (Hexanes:EtOAc 90:10) to give 2-28 (5.45 g, 97%). 1H NMR 
(CDCl3, 300 MHz) δ 4.45-4.40 (m, 1H), 4.30-4.18 (m, 2H), 3.14-2.94 (m, 2H), 2.41-2.29 
(m, 3H), 1.92-1.82 (m, 2H), 0.92-0.86 (m, 6H), 0.14-0.12 (m, 9H). 13C NMR (CDCl3, 75 
MHz) δ 172.8, 154.1, 106.2, 85.6, 63.5, 58.5, 34.4, 28.5, 23.3, 19.3, 18.1, 14.8, 0.2. 
LRMS (EI+) m/z calculated for C15H25LiNO3Si [M+Li]
+: 302.1758, found: 302.1651. 
 
 
(R)-4-isopropyl-3-((R)-2-methyl-6-(trimethylsilyl)hex-5-ynoyl)oxazolidin-2-one (2-28a). 
To a solution of NaHMDS (11.1 mL, 1.0 M in THF) in THF (38 mL) at -78 oC was 
added 2-28 (2.95 g, 10 mmol) in THF (18 mL) under N2. The reaction was stirred at -78 
oC  for 30 minutes and MeI (3.11 mL, 50 mmol) was added dropwise. After addition of 
MeI, the reaction was stirred for 5 minutes at -78 oC, warmed to -40 oC and stirred for 
1.5 hours. Saturated NH4Cl (15 mL) was added to quench the reaction and the resulting 
mixture was diluted with H2O (20 mL). The mixture was extracted 3x with EtOAc (3x 
50 mL). The combined organics were dried over Na2SO4, filtered and concentrated. The 
crude material was purified by column chromatography (Hexanes:EtOAc 80:20) to give 
2-28a (2.50 g, 83%, 11:1 dr). 1H NMR (CDCl3, 500 MHz) δ 4.45-4.42 (m, 1H), 4.26 (t, J 
= 9.0 Hz, 1H), 4.21-4.18 (m, 1H), 3.95-3.84 (m, 1H), 2.36-2.29 (m, 1H), 2.26-2.23 (m, 
2H), 2.00-1.93 (m, 1H), 1.64-1.57 (m, 1H), 1.22 (d, J = 7.0 Hz, 3H), 0.91-0.86 (m, 6H), 
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0.13 (s, 9H). 13C NMR (CDCl3, 75 MHz) δ 176.5, 153.6, 106.3, 85.4, 63.4, 58.5, 37.0, 
31.6, 28.6, 18.1, 18.0, 17.8, 14.8, 0.2. LRMS (EI+) m/z calculated for C15H27LiNO3Si 
[M+Li]+: 316.1915, found: 316.1727. 
 
 
(R)-2-methyl-6-(trimethylsilyl)hex-5-yn-1-ol (2-29). 
2-28a (2.51 g, 8.12 mmol) was dissolved in Et2O (95 mL) under N2 and H2O (0.16 mL) 
was added. The reaction was cooled to 0 oC and LiBH4 (0.198 g, 9.1 mmol) was added. 
The reaction was stirred for 1 hour at 0 oC and quenched with the addition of NaOH (10 
mL, 1M in H2O). The reaction was then extracted 3x with Et2O (3x 10 mL). The 
organics were dried over MgSO4, filtered and concentrated to give 2-29 (0.997 g, 67%, 
yields ranged from 67-89%). The material was used without further purification. 1H 
NMR (CDCl3, 500 MHz) δ 3.53-3.46 (m, 2H), 2.34-2.19 (m, 2H), 1.78-1.72 (m, 1H), 
1.69-1.62 (m, 1H), 1.57 (brs, 1H), 1.42-1.35 (m, 1H), 0.93 (d, J = 7.0 Hz, 3H), 0.13 (s, 
9H). 13C NMR (CDCl3, 125 MHz) δ 107.6, 84.7, 67.8, 35.1, 32.1, 17.6, 16.4, 0.3. LRMS 
(EI+) m/z calculated for C10H21OSi [M+H]
+: 185.1356, found: 185.1337. 
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(R)-(7,7-dibromo-5-methylhept-6-en-1-yn-1-yl)trimethylsilane (2-30). 
To a solution of 2-29 (0.184 g, 1 mmol) in DCM (20 mL) under N2 was added NMO 
(0.176 g, 1.5 mmol) and 4Å molecular sieves (0.267 g). The reaction was cooled to 0 oC 
and stirred for 1 hour. TPAP (10.5 mg, 0.03 mmol) was added and the reaction was 
stirred for 16 hours.  The reaction mixture was filtered through a short pad of silica gel 
and the silica gel was rinsed with 150 mL of DCM. The organics were concentrated to 
~2 mL en vacuo due to the high volatility of the aldehyde and used in the next step 
without further purification.  
PPh3 (1.12 g, 4.28 mmol) was added to a solution of CBr4 (0.71 g, 2.14 mmol) in DCM 
(7.2 mL) at 0 oC under N2. The solution was stirred at 0 
oC for 10 minutes and 2-29a 
(from the previous step in ~1.6 mL of DCM) was added by cannula and the cannula was 
rinsed with DCM (1.6 mL). The reaction was allowed to warm to RT and stirred for 70 
minutes. The reaction was quenched with saturated NaHCO3 (3.6 mL) and the organic 
layer was separated. The aqueous phase was extracted 3x with DCM (3x 18 mL) and the 
combined organics were dried over MgSO4, filtered and concentrated. The crude 
material was purified by column chromatography (100% Hexanes) to give 2-30 (0.1947 
g, 58% over 2 steps). 1H NMR (CDCl3, 500 MHz) δ 6.17 (d, J = 9.5 Hz, 1H), 2.64-2.57 
(m, 1H), 2.23 (t, J = 7.0 Hz, 2H), 1.63-1.52 (m, 2H), 1.03 (d, J = 7.0 Hz, 3H), 0.14 (s, 
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9H). 13C NMR (CDCl3, 125 MHz) δ 143.3, 106.7, 88.4, 85.1, 37.7, 35.0, 19.0, 18.0, 0.3. 
LRMS (EI+) m/z calculated for C11H19Br2Si [M+H]
+: 336.9617, found: Not Observed. 
 
 
(R)-triisopropyl(3-methyl-7-(trimethylsilyl)hepta-1,6-diyn-1-yl)silane (2-30a). 
2-30 (0.189 g, 0.558 mmol) was dissolved in THF (4.1 mL) under N2 and cooled to -78 
oC. n-BuLi (0.77 mL, 1.6 M in hexanes) was added dropwise and the reaction was stirred 
for 1 hour at -78 oC. After 1 hour, the reaction was warmed to RT and stirred for 1 hour. 
The reaction was then cooled to 0 oC and TIPSCl (0.15 mL, 0.725 mmol) was added and 
the reaction was stirred for 16 hours. Saturated NH4Cl (6 mL) was added to quench the 
reaction and the slurry was diluted with water (6 mL). The mixture was then extracted 
3x with EtOAc (3x 20 mL). The combined organic phases were dried over MgSO4, 
filtered and concentrated. The crude material was purified by column chromatography 
(100% Hexanes) to give 2-30a (0.130 g, 70%). 1H NMR (CDCl3, 500 MHz) δ 2.65-2.57 
(m, 1H), 2.45-2.33 (m, 2H), 1.68-1.61 (m, 2H), 1.19 (d, J = 7.0 Hz, 3H), 1.08-0.98 (m, 
21H), 0.14 (s, 9H). 13C NMR (CDCl3, 125 MHz) δ 112.6, 107.1, 84.7, 80.7, 36.0, 26.4, 
21.2, 18.8, 18.1, 11.4, 0.30. LRMS (EI+) m/z calculated for C20H39Si2 [M+H]
+: 
335.2585, found: Not Observed. 
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(R,E)-(7-iodo-3,6-dimethylhept-6-en-1-yn-1-yl)triisopropylsilane (2-25). 
2-30a (0.1222 g, 0.365 mmol) was dissolved in Et2O (0.6 mL) and saturated K2CO3 in 
MeOH (1.2 mL) was added. The reaction was stirred vigorously for 3 hours and 
quenched with the addition of saturated NH4Cl (18 mL) and extracted 3x with hexanes 
(3x 20 mL). The combined organics were dried over MgSO4, filtered and concentrated to 
give 2-30b (0.0995 g, 104 %) which was used in the next step without further 
purification. 1H NMR (CDCl3, 300 MHz) δ 2.70-2.57 (m, 1H), 2.43-2.30 (m, 2H), 1.94 
(t, J = 2.7 Hz, 1H), 1.69-1.59 (m, 2H), 1.20 (d, J = 6.9 Hz, 3H), 1.09-0.97 (m, 21H). 13C 
NMR (CDCl3, 75 MHz) δ 112.5, 84.2, 80.8, 68.5, 36.0, 26.3, 21.2, 18.8, 16.7, 11.4.  
To a suspension of Cp2ZrCl2 (0.111 g, 0.38 mmol) in (CH2Cl)2 (0.5 mL) was added 
Me3Al (0.38 mL, 2.0 M in hexanes) under N2. The reaction was stirred for 15 minutes at 
which point the mixture became homogeneous. To this solution was added 2-30b 
(0.0995 g, 0.38 mmol) in (CH2Cl)2 (0.5 mL) and the reaction was stirred at RT for 7.5 
hours. Then, the reaction was cooled to 0 oC and I2 (0.1155 g, 0.46 mmol) in THF (0.6 
mL) was added via cannula and the reaction was stirred overnight. The reaction was 
quenched with the addition of water (1 mL) and saturated NH4Cl (2 mL) and stirred for 
10 minutes. The resulting slurry was filtered through celite and the pad was washed with 
Et2O. The mixture was then diluted with water (10 mL) and extracted 3x with Et2O (3x 
20 mL). The combined organics were dried over MgSO4, filtered and concentrated. The 
crude material was purified by column chromatography (100% Hexanes) to give 2-25 
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(0.1111 g, 72%). 1H NMR (CDCl3, 500 MHz) δ 5.92 (s, 1H), 2.47-2.33 (m, 3H), 1.84 (s, 
3H), 1.61-1.48 (m, 2H), 1.19 (d, J = 7.0 Hz, 3H), 1.07-1.00 (m, 21H). 13C NMR (CDCl3, 
75 MHz) δ 147.8, 113.0, 80.7, 75.1, 37.5, 35.3, 26.6, 24.0, 21.4, 19.0, 11.4.  
 
 
 
Ethyl 7-((tert-butyldimethylsilyl)oxy)hept-2-ynoate (2-32). 
n-BuLi (3.0 mL of 1.6 M in hexanes, 4.76 mmol) was added dropwise to a solution of 2-
31 (1.0 g, 4.71 mmol) in THF (4.7 mL) under N2 at -78 
oC. The reaction was stirred at -
78 oC for 10 min and cannulated over 15 minutes to a solution of ethyl chloroformate 
(0.9 mL, 9.4 mmol) in THF (18.8 mL) at -78 oC. The reaction was stirred for 1 hr and 
quenched with the addition of saturated NH4Cl (4 mL) and allowed to warm to RT. The 
reaction was diluted with water (15 mL) and extracted with ether 3x (20 mL). The 
organics were dried over MgSO4 and concentrated to give 2-32 (1.32 g, 100%). The 
crude product was used in the next reaction without further purification. 1H NMR 
(CDCl3, 500 MHz) δ 4.22 (q, J = 7.0 Hz, 2H), 3.63 (t, J = 6.0 Hz, 2H), 2.36 (t, J = 7.0 
Hz, 2H), 1.69-1.56 (m, 4H), 1.30 (t, J = 7.5 Hz, 2H), 0.89 (s, 9H), 0.04 (s, 6H). The 
spectra were identical to those reported in the literature.7 
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(Z)-ethyl 7-((tert-butyldimethylsilyl)oxy)-3-methylhept-2-enoate (2-32a). 
MeLi (11.8 mL, 18.8 mmol) was added slowly to a suspension of CuI (1.79 g, 9.42 
mmol) in THF (5 mL) at 0 oC. The mixture was stirred at 0 oC until colorless and 
homogeneous. The reaction was then cooled to -78 oC and 2-32 (1.34 g, 4.71 mmol) was 
added. The reaction was then stirred for 1 hr at - 78 oC and quenched with the dropwise 
addition of a saturated solution of NH4Cl in 4:1 EtOH:H2O (10 mL). The reaction was 
further quenched with 10 mL sat (aq.) NH4Cl and allowed to warm to RT. Air was then 
bubbled into the reaction over 1 hr. The reaction was dituled with water (30 mL) and 
extracted 3x with EtOAc (50 mL). The orgs were dried over MgSO4, filtered and 
concentrated. The organics were then flashed through a pad of silica gel (hexanes:EtOAc 
90:10) to give 2-32a  and used in the next step without further purification. 1H NMR 
(CDCl3, 300 MHz) δ 5.65 (s, 1H), 4.13 (q, J = 7.2 Hz, 2H), 3.64-3.59 (m, 2H), 2.63 (t, J 
= 7.5 Hz, 2H), 1.87 (d, J = 1.2 Hz, 3H), 1.68-1.45 (m, 4H), 1.26 (t, J = 7.2 Hz, 3H), 0.88 
(s, 9H), 0.03 (s, 6H). 
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(Z)-7-((tert-butyldimethylsilyl)oxy)-3-methylhept-2-en-1-ol (3-6). 
2-32a (4.2 mmol crude from the preveous step) was azeotroped to dryness with toluene 
and dissolved in DCM (7.5 mL) under N2. The reaction was cooled to -78 
oC and 
DIBAL-H (1.0 M in THF) was added dropwise (10.4 mL, 10.4 mmol). The reaction was 
stirred for 2 hrs and quenched with the careful addition of water (2.5 mL). The mixture 
was then stirred for 10 minutes and a 15 % solution of NaOH in water (10 mL) was 
added and the reaction was stirred for an additional 10 minutes. Water was again added 
(7.5 mL) and the reaction was stirred for 15 minutes, filtered through a plug of celite and 
dried over MgSO4. The Organic phase was then filtered, concentrated and the material 
was purified by column chromatography (Hexanes:EtOAc 88:12) to give 3-6 (1.00 g, 
82% for 3 steps). 1H NMR (CDCl3, 500 MHz) δ 5.41 (t, J = 8.5 Hz, 1H), 4.11 (d, J = 7 
Hz, 2H), 3.60 (t, J = 6 Hz, 2H), 2.07 (t, J = 7.5 Hz, 2H), 1.72 (s, 3H), 1.51-1.39 (m, 4H), 
0.88 (s, 9H), 0.04 (s, 6H). 13C NMR (CDCl3, 125 MHz) δ 140.3, 124.4, 63.1, 59.1, 32.6, 
31.7, 26.1, 24.6, 23.5, 18.5. LRMS (EI+) m/z calculated for C14H31O2Si [M+H]
+: 
259.2088, found: 259.2049. 
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(Z)-7-((tert-butyldiphenylsilyl)oxy)-5-methylhept-5-en-1-ol (2-33a). 
2-32b (1.00 g, 3.88 mmol) was dissolved in DCM (5.2 mL) under N2 at RT. Et3N (0.82 
mL, 5.82 mmol), DMAP (24 mg, 0.19 mmol), and TBDPSCl (1.26 mL, 4.85 mmol) 
were added. The reaction was stirred overnight. The reaction was quenched with 
saturated NH4Cl (25 mL) and diluted with water (30 mL). The organic phase was 
separated, dried over MgSO4, filtered and concentrated to give 2-33. The crude material 
was used in the next step without further purification. 
2-33 (~3.88 mmol) was dissolved in a 1% HCl solution in 95:5 EtOH:H2O (25 mL). The 
reaction was stirred for 20 minutes and quenched with the careful addition of saturated 
NaHCO3 (25 mL) and diluted with water (30 mL). The mixture was extracted 3x with 
EtOAc (3x 50 mL). The organics were dried over MgSO4, filtered and concentrated. The 
crude material was purified by column chromatography (Hexanes:EtOAc 85:15 to 
80:20) to give 2-33a (1.41 g, 95%). 1H NMR (CDCl3, 500 MHz) δ 7.71-7.69 (m, 4H), 
7.45-7.37 (m, 6H), 5.42 (t, J = 6.5 Hz, 1H), 4.20 (d, J = 7.5 Hz, 2H), 3.55 (t, J = 6.5 Hz, 
2H), 1.89 (t, J = 7.5 Hz, 2H), 1.71-1.70 (m, 3H), 1.46-1.31 (m, , 4H), 1.05 (s, 9H). 13C 
NMR (CDCl3, 125 MHz) δ 137.7, 135.7, 134.1, 129.6, 127.7, 125.0, 62.9, 60.8, 32.5, 
31.8, 27.0, 24.2, 23.4, 19.3. LRMS (EI+) m/z calculated for C24H36O2Si [M+H]
+: 
383.2401, found: Not Observed. 
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(Z)-7-((tert-butyldiphenylsilyl)oxy)-5-methylhept-5-enal (2-26). 
2-33a (200 mg, 0.52 mmol) was dissolved in DMSO (2.6 mL) and IBX (0.366 g, 1.31 
mmol) was added. The reaction was stirred for 14 hours and quenched with the addition 
of water (3.5 mL). The slurry was stirred for 15 minutes and filtered through celite and 
the celite plug was washed with EtOAc. After concentration, the crude material was 
purified by column chromatography (Hexanes:EtOAc 95:5) to give 2-26 (0.158 g, 80%). 
1H NMR (CDCl3, 300 MHz) δ 9.67 (t, J = 1.8 Hz, 1H), 7.74-7.68 (m, 4H), 7.46-7.36 (m, 
6H), 5.45 (t, J = 6.6 Hz, 1H), 4.17 (d, J = 6.6 Hz, 2H), 2.28 (dt, J = 1.5, 7.5 Hz, 2H), 
1.90 (t, J = 7.2 Hz, 2H), 1.70 (s, 3H), 1.66-1.56 (m, 2H), 1.05 (s, 9H). 13C NMR (CDCl3, 
75 MHz) δ 202.4, 136.7, 135.7, 134.0, 129.7, 127.9, 127.8, 125.9, 60.7, 43.4, 31.2, 27.0, 
23.2, 20.3, 19.3. 
 
 
(2Z,8E,12R)-1-((tert-butyldiphenylsilyl)oxy)-3,9,12-trimethyl-14-
(triisopropylsilyl)tetradeca-2,8-dien-13-yn-7-ol (2-34). 
2-25 (0.111g, 0.275 mmol) and 2-26 (0.0954 g, 0.25 mmol) were combined in a flame-
dried flask and azeotroped with benzene and placed under N2. The material was 
dissolved in THF (2.5 mL) and cooled to -78 oC. To this solution was added t-BuLi (0.55 
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mL, 1.1 M in hexanes, 0.6 mmol) and the reaction was stirred for 45 minutes. The 
reaction was quenched with the addition of saturated NH4Cl at -78 
oC and the reaction 
was slowly warmed to RT. The slurry was then diluted with water (10 mL) and the 
mixture was extracted 3x with EtOAc (3x 20 mL). The combined organics were dried 
over Na2SO4, filtered and concentrated. The crude material was purified by column 
chromatography (Hexanes:EtOAc 90:10) to give 2-34 (0.1169 g, 71%, 3.4:1 dr). 1H 
NMR (CDCl3, 300 MHz) δ 7.73-7.67 (m, 4H), 7.45-7.35 (m, 6H), 5.41(t, J = 6.3 Hz, 
1H), 5.17-5.13 (m, 1H), 4.31-4.23 (m, 1H), 4.19 (d, J = 7.8 Hz, 2H), 2.47-2.38 (m, 1H), 
2.26-2.03 (m, 3H), 1.87 (t, J = 7.5 Hz, 2H), 1.69-1.69 (m, 3H), 1.64 (t, J = 1.5 Hz, 3H), 
1.56-1.43 (m, 2H), 1.35-1.23 (m, 3H), 1.22 (d, J = 6.9 Hz, 3H), 1.09-1.02 (m, 30H). 13C 
NMR (CDCl3, 75 MHz) δ 138.6, 138.5, 137.7, 137.7, 135.8, 134.1, 129.6, 128.3, 128.1, 
127.7, 125.1, 113.6, 113.5, 68.6, 60.8, 37.5, 37.4, 35.5, 35.4, 32.2, 32.0, 31.7, 27.0, 26.8, 
26.7, 25.8, 25.6, 23.9, 23.5, 23.4, 21.5, 21.4, 19.3, 18.8, 16.8, 16.6, 11.4.   
 
 
(2Z,8E,12R)-3,9,12-trimethyltetradeca-2,8-dien-13-yne-1,7-diol (2-34a). 
2-34 (0.1169 g, 0.177 mmol) was dissolved in THF (0.1 mL) at RT and TBAF (0.885 
mL, 1.0 M in THF) was added. The reaction was stirred for 90 minutes and quenched 
with 1/3 saturated NaCl (3 mL). The mixture was extracted 3x with EtOAc (3x 20 mL). 
The combined organics were dried over Na2SO4, filtered and concentrated. The crude 
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material was purified by column chromatography (Hexanes:EtOAc 60:40) to give 2-34a 
(7.2 mg, 15%). 1H NMR (CDCl3, 500 MHz) δ 5.44 (t, J = 8.5 Hz, 1H), 5.21-5.18 (m, 
1H), 4.39-4.34 (m, 1H), 4.15-4.08 (m, 2H), 2.44-2.37 (m, 1H), 2.22-2.07 (m, 3H), 2.05 
(d, J = 1.5 Hz, 1H), 1.7.-1.73 (m, 3H), 1.69 (t, J = 1.0 Hz, 3H), 1.58-1.52 (m, 3H), 1.46-
1.37 (m, 4H), 1.20 (d, J = 6.5 Hz, 3H).  
 
 
(R,2Z,8E)-3,9,12-trimethyl-7-oxotetradeca-2,8-dien-13-ynal (2-35). 
2-34a (7.2 mg, 0.0277 mmol) was dissolved in DMSO (1 mL) at RT and IBX (23.2 mg, 
0.0762 mmol) was added. The reaction was stirred for 17 hours and the DMSO was 
pulled off en vacuo. The crude material was purified using a pipette silica gel column 
(Hexanes:EtOAc 90:10) to give 2-35 (6.8 mg, 95%). 1H NMR (CDCl3, 500 MHz) δ 9.93 
(d, J = 8.0 Hz, 1H), 6.06 (s, 1H), 5.90 (d, J = 8.5 Hz, 1H), 2.59 (t, J = 7.5 Hz, 2H), 2.48 
(t, J = 7.0 Hz, 2H), 2.45-2.40 (m, 1H), 2.37-2.31 (m, 1H), 2.25-2.19 (m, 1H), 2.14 (s, 
3H), 2.08 (d, J = 2.0 Hz, 1H), 1.99 (s, 3H), 1.88-1.82 (m, 2H), 1.62-1.57 (m, 2H), 1.21 
(d, J = 7.0 Hz, 3H). 13C NMR (CDCl3, 125 MHz) δ 190.9, 159.1, 158.8, 129.0, 123.3, 
88.2, 69.2, 43.2, 39.0, 34.6, 31.9, 25.6, 25.0, 22.8, 21.1, 19.6, 18.8.  
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(Z)-3,8-dimethyl-3-((R)-3-methylpent-4-yn-1-yl)-3,3a,6,7-
tetrahydrocycloocta[c]isoxazolin-4(5H)-one (2-37). 
2-35 (6.8 mg, 0.026 mmol) was dissolved in pyridine (1 mL) and H2NOH
.HCl (2.8 mg, 
0.031 mmol) was added at RT. the reaction was stirred for 30 minutes and the pyridine 
was removed en vacuo. The residue was then partitioned between EtOAc (5 mL) and 
water (3 mL). The organic phase was removed and the aqueous phase was extracted 1x 
with EtOAc (1x 10 mL). The combined organics were dried over Na2SO4, filtered and 
concentrated to give 2-24 (6.8 mg, 95% yield). 
2-24 (6.8 mg, 0.0247 mmol) was dissolved in CHCl3 (0.1 mL) and NCS (3.4 mg, 0.0247 
mmol) was added. To this solution was added pyridine (40 μL) and the reaction was 
stirred for 20 minutes. The reaction was diluted with CHCl3 (9.7 mL) and Et3N (35 μL) 
was added. The reaction was stirred for 6.5 hours and quenched with the addition of 
saturated NaHCO3 (15 mL). The mixture was diluted with DCM (5 mL) and the organic 
phase was separated. The aqueous phase was extracted 3x with DCM (3x 25 mL) and 
the combined organics were dried over Na2SO4, filtered and concentrated. The crude 
material was purified using a pipette silica gel column (Hexanes:EtOAc 90:10) to give 2-
37 (2.2 mg, 30%). 1H NMR (CDCl3, 300 MHz) δ 6.45 (s, 1H), 3.84-3.82 (m, 1H), 3.08-
2.87 (m, 1H), 2.51-2.28 (m, 4H), 2.15-2.08 (m, 2H), 2.07-2.05 (m, 1H), 1.97 (s, 3H), 
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1.95-1.88 (m, 2H), 1.50-1.39 (m, 2H), 1.23-1.20 (m, 3H), 1.19 (s, 3H). LRMS (EI+) m/z 
calculated for C17H23NO2 [M+H]
+: 274.1802, found: 274.1636. 
 
CHAPTER III 
 
 
(Z)-7-((tert-butyldimethylsilyl)oxy)-3-methylhept-2-enal (3-6a). 
3-6 (0.41 g, 1.58 mmol) was dissolved under N2 in DCM (32 mL) at RT and NMO (0.28 
g, 2.4 mmol) and 4 Å molecular sieves (0.44 g) were added. The reaction was cooled to 
0 oC and the reaction was stirred for 1 hr. TPAP (16.7 mg, 0.048 mmol) was added and 
the reaction was stirred for 15 hrs and flashed over a silica gel plug (Hexanes:EtOAc 
80:20) until all product was off. The product was concentrated to give 3-6a (0.405 g, 100 
%) and was used in the next step without further purification. 1H NMR (CDCl3, 500 
MHz) δ 9.95 (d, J = 8.0 Hz, 1H), 5.88 (d, J = 8.0 Hz, 1H), 3.63 (t, J = 6.0 Hz, 2H), 2.59 
(t, J = 7 Hz, 2H), 1.97 (s, 3H), 1.65-1.52 (m, 4H), 0.88 (s, 9H), 0.04 (s, 6H).13C NMR 
(CDCl3, 125 MHz) δ 190.7, 160.6, 128.5, 62.6, 32.4, 32.3, 25.9, 25.1, 24.9, 18.3, 0.0. 
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(Z)-tert-butyldimethyl((5-methyloct-5-en-7-yn-1-yl)oxy)silane (3-4). 
Diisopropylamine (0.13 mL, 0.94 mmol) was dissolved in THF (6.2 mL) under N2 and 
cooled to   -78 oC. n-BuLi (1.6 M in hexanes, 0.59 mL, 0.94 mmol) was added dropwise 
and the reaction was stirred for 15 minutes. Trimethylsilyldiazomethane (2.0 M in 
hexanes, 0.47 mL, 0.94 mmol) was added dropwise and the mixture was stirred at -78 oC 
for 30 minutes. 3-6a (0.2 g, 0.78 mmol) in THF (1.6 mL) was added dropwise and the 
reaction was left to slowly warm to RT over the course of an hour. After 10 minutes at 
RT the reaction was quenched with water (6 mL) and stirred for 10 minutes. The mixture 
was then extracted 3x with EtOAc (25 mL). The organics were dried over MgSO4, 
filtered and concentrated. The material was purified by column chromatography 
(Hexanes:EtOAc 97:3) to give 3-4 (120 mg, 50% for 2 steps).   1H NMR (CDCl3, 500 
MHz) δ 5.26 (s, 1H), 3.63 (t, J = 6.0 Hz, 2H), 2.96 (s, 1H), 2.34 (t, J = 7.5 Hz, 2H), 1.79 
(d, J = 1 Hz, 3H), 1.57-1.48 (m, 4H), 0.89 (s, 9H), 0.04 (s, 6H). 13C NMR (CDCl3, 125 
MHz) δ 154.7, 104.6, 81.8, 79.3, 63.0, 34.4, 32.5, 26.1, 23.8, 22.5, 18.5, 0.2. LRMS 
(EI+) m/z calculated for C15H29OSi [M+H]
+: 253.1988, found: 253.1925. 
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(±)-tert-butyldimethyl((2-methylhex-3-yn-1-yl)oxy)silane (3-7). 
3-5 (0.25 g, 0.7 mmol) was dissolved in THF (6.5 mL) and cooled to -78 oC under N2. n-
BuLi (0.96 mL, 1.54 mmol, 1.6 M in hexanes) was added dropwise and the reaction was 
stirred at -78 oC for 1 hour. The reaction was then stirred at RT for 1 hour. The reaction 
was cooled to 0 oC and HMPA (0.24 mL, 1.4 mmol) was added. The reaction was cooled 
to -78 oC and ethyl iodide (0.28 mL, 3.5 mmol) was added and the reaction was stirred 
for 6 hours while warming to RT. The reaction was quenched with sat. NH4Cl (1 mL) 
and diluted with water. The mixture was then extracted 3x with EtOAc (30 mL) and the 
organics were dried over MgSO4, filtered and concentrated. The material was purified by 
column chromatography (Hexanes:EtOAc 96:4) to give 3-7 (113 mg, 71%).1H NMR 
(CDCl3, 500 MHz) δ 3.67-3.64 (m, 1H), 3.41-3.38 (m, 1H), 2.55-2.50 (m, 1H), 2.18-2.13 
(m, 2H), 1.13-1.09 (m, 6H), 0.89 (s, 9H), 0.06 (s, 6H). 13C NMR (CDCl3, 125 MHz) δ 
82.6, 81.5, 67.6, 29.1, 25.9, 26.0, 18.6, 17.7, 14.3, 12.4. LRMS (EI+) m/z calculated for 
C13H26LiOSi [M+H]
+: 233.1913, found: 233.2026 
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(±)-hex-3-yn-2-ol (3-7a). 
3-7 (0.46 g, 2.0 mmol) was dissolved in 1% HCl in 95:5 EtOH:H2O (29 mL). The 
reaction was stirred for 20 minutes and quenched with sat. NaHCO3 (20 mL). The 
mixture was diluted with H2O (50 mL) and extracted 3x with ether (70 mL). The organic 
phases were combined, dried over MgSO4, filtered and concentrated to give 0.39 g of 3-
7a. The material was used in the next step without purification. 
 
 
(±)-2-methylhex-5-yn-1-ol (3-8). 
In a glovebox, a flask was charged with KH (0.97 g) that had been washed with hexanes 
to rid the KH of mineral oil. This flask was taken from the glovebox and placed under 
N2 on a Schlenk line. 1,3-Diaminopropane (20.2 mL) was added to the flask and the 
reaction was heated with a heat gun until foaming occurred. The reaction was then 
stirred at RT for 1 hour. 3-7a (~2.0 mmol from previous step) in 1 mL of 1,3 
diaminopropane was added to the reaction at RT and the reaction was stirred for 19 
hours with monitoring by NMR. After NMR indicated the reaction was complete, the 
reaction was cooled to 0 oC and quenched with the careful addition of sat. NH4Cl (20 
mL). The mixture was diluted with H2O (20 mL) and extracted 3x with EtOAc (50 mL). 
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The organics were dried over MgSO4, filtered and concentrated. The material was 
purified by column chromatography (Hexanes:EtOAc 60:40) to give 3-8 (158 mg, 70% 
for 2 steps). 1H NMR (CDCl3, 500 MHz) δ 3.54-3.46 (m, 2H), 2.32-2.18(m, 2H), 1.94 (t, 
J = 3.0 Hz, 1H), 1.82-1.76 (m, 1H), 1.72-1.65 (m, 1H), 1.46 (brs, 1H), 1.41-1.34 (m, 
1H), 0.94 (d, J= 6.5 Hz, 3H). 13C NMR (CDCl3, 125 MHz) δ 84.6, 68.5, 67.8, 34.9, 31.9, 
16.3, 16.2. LRMS (EI+) m/z calculated for C7H13O [MH+]
+: 113.0961, found: 113.1089. 
 
 
(±)-(E)-6-iodo-2,5-dimethylhex-5-en-1-ol (3-8a). 
Cp2ZrCl2 (0.39 g, 1.3 mmol) was dissolved in (CH2Cl)2 (2 mL) under N2 and Me3Al (2.0 
M in toluene, 1.9 mL, 3.8 mmol)  was added at RT. The reaction was stirred for 15 
minutes and 3-8 (0.15 g, 1.3 mmol) in (CH2Cl)2 (0.4 mL) was added dropwise at 0 
oC. 
The reaction was stirred and allowed to warm to RT over 2 hours. After TLC indicated 
carbometallation was complete, the reaction was cooled to 0 oC and I2 (0.42 g, 1.66 
mmol) in THF (2 mL) was added dropwise. The reaction was warmed to RT and stirred 
for 10 minutes. The reaction was quenched with the dripwise addition of NH4Cl (20 
mL). Water (10 mL) was then added and the mixture was extracted 3x with diethyl ether 
(3x 50 mL). The organics were dried over MgSO4, filtered and concentrated. The 
material was then flashed over a short silica gel plug to remove inorganic impurities 
(Hexanes:Et2O 40:60). The material was then concentrated and used in the next step 
without further purification. Yields varied from 76 - 34%. 1H NMR (CDCl3, 500 MHz) δ 
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5.90-5.89 (m, 1H), 3.53-3.44 (m, 2H), 2.31-2.18 (m, 1H), 1.84 (d, J = 1.0 Hz, 3H), 1.63 - 
1.56 (m, 2H), 1.28-1.21 (m, 2H), 0.93  (d, J = 6.5 Hz, 3H). 
 
 
(±)-(E)-6-iodo-2,5-dimethylhex-5-enal (3-8b). 
3-8a (1.20 g, 4.71 mmol) was dissolved in DMSO (87 mL) and IBX (1.98 g, 7.07 mmol) 
was added. The reaction was stirred for 15 hours and quenched with the addition of H2O 
(100 mL) and stirred for 8 minutes. The slurry was filtered over a pad of celite and the 
celite was rinsed wit ether (100 mL). The filtrate was diluted with brine (20 mL) and the 
organic phase was removed. The aqueous phase was extracted with ether (75 mL) and 
the organics were combined, dried over Na2SO4, filtered and concentrated. The material 
was used for the next step without further purification.  
 
 
(±)-(5E)-6-iodo-2,5-dimethylhex-5-enal oxime (3-3). 
3-8a (~1.20 g, 4.71 mmol) was dissolved in pyridine (13 mL) and NH2OH
.HCl (0.43 g, 
6.12 mmol) was added at RT. The reaction was stirred for 30 minutes and poured into 
ether (12 mL). The organic mixture was washed with a saturated solution of CuSO4 and 
137 
 
water. The organic phase was then dried over Na2SO4, filtered and concentrated to give 
3-3 (1.17 g, 95% yield for 2 steps). 1H NMR (CDCl3, 300 MHz) δ 7.28 (d, J = 6.9 Hz, 
0.8H), 6.49 (d, J = 7.8 Hz, 0.2H) 5.92-5.90 (m, 1H), 2.39-2.30 (m, 1H), 1.84-1.83 (m, 
3H), 2.23 (t, J = 7.2 Hz, 2H), 1.67-1.25 (m, 2H), 1.25 (brs, 1H), 1.10-1.08 (d, J = 6.9 Hz, 
3 H). 13C NMR (CDCl3, 75 MHz) δ 156.9, 155.9, 147.4, 75.4, 37.3, 37.0, 34.0, 32.8, 
32.6, 29.8, 29.1, 24.0, 18.1, 17.6. LRMS (EI+) m/z calculated for C8H15INO2 [M+H]
+: 
268.0193, found: 268.0240. 
 
 
(±)-5-((Z)-6-((tert-butyldimethylsilyl)oxy)-2-methylhex-1-en-1-yl)-3-((E)-6-iodo-5-
methylhex-5-en-2-yl)isoxazole (3-2a). 
3-3 (1.17 g, 4.38 mmol) was dissolved in CHCl3 (2.8 mL) and added dropwise to a 
solution of NCS (0.585 g, 4.38 mmol) and pyridine (7 μL, 0.09 mmol) in CHCl3 (2.8 
mL). The reaction was stirred until the solid disappeared (~20 minutes) and 3-4 (1.33 g, 
5.3 mmol) in CHCl3 (2.8 mL) was added in one portion. A solution of Et3N (0.62 mL, 
4.38 mmol) in CHCl3 (11.4 mL) was added slowly and the reaction was heated to 60 
oC 
overnight. The reaction was then cooled to RT and washed with water, NaHCO3 and 
brine. The organic phase was dried over Na2SO4, filtered and concentrated. The material 
was purified by column chromatography (Hexanes:EtOAc 90:10) to give 3-2a (1.01 g, 
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45%).1H NMR (CDCl3, 300 MHz) δ 6.11 (s, 1H), 5.88-5.87 (m, 2H), 3.65-3.61 (m, 2H), 
2.91-2.83 (m, 1H), 2.49-2.42 (m, 2H), 2.24-2.14 (m, 2H), 1.93 (d, J = 1.2 Hz, 3H), 1.82 
(d, J = 1.2 Hz, 3H), 1.80-1.68 (m, 2H), 1.60-1.51 (m, 4H), 1.27 (d, J = 6.9 Hz, 3H), 0.89 
(s, 9H), 0.04 (s, 6H). 13C NMR (CDCl3, 75 MHz) δ 168.7, 167.8, 147.8, 147.5, 112.0, 
99.6, 75.3, 63.0, 37.2, 34.4, 34.3, 33.6, 32.6, 31.3, 26.1, 24.6, 24.2, 24.1, 20.2, 18.5, -5.1. 
LRMS (EI+) m/z calculated for C23H41INO2Si [M+H]
+: 518.1951, found: 518.1999. 
 
 
(±)-4-((Z)-6-((tert-butyldimethylsilyl)oxy)-2-methylhex-1-en-1-yl)-3-((E)-6-iodo-5-
methylhex-5-en-2-yl)isoxazole (3-2b). 
3-3 (134 mg, 0.51 mmol) was dissolved in CHCl3 (0.33 mL) and added dropwise to a 
solution of NCS (68 mg, 0.51 mmol) and pyridine (1 μL, 0.01 mmol) in CHCl3 (0.33 
mL). The reaction was stirred until the solid disappeared (~20 minutes) and 3-4 (0.154 g, 
0.61 mmol) in CHCl3 (0.33 mL) was added in one portion. A solution of Et3N (72 μL, 
0.51 mmol) in CHCl3 (1.3 mL) was added slowly and the reaction was stirred overnight 
at RT. The reaction was then washed with water, NaHCO3 and brine. The organic phase 
was dried over Na2SO4, filtered and concentrated. The material was purified by column 
chromatography (Hexanes:EtOAc 80:20) to give 3-2b (0.125 g, 47%).1H NMR (CDCl3, 
300 MHz) δ 8.02 (brs, 1H), 5.90-5.88 (m, 1H), 5.23 (d, J = 1.5 Hz, 1H), 3.64-3.60 (m, 
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2H), 2.61-2.37 (m, 3H), 2.19 (t, J = 7.5 Hz, 2H), 1.86 (d, J = 1.2 Hz, 3H), 1.82 (d, J = 
0.9 Hz, 3H), 1.81-1.69 (m, 1H), 1.57-1.50 (m, 5H), 1.17 (d, J = 6.9 Hz, 3H), 0.89 (s, 
9H), 0.04 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 157.6, 148.1, 147.5, 104.7, 100.6, 
75.3, 63.1, 38.8, 38.1, 37.2, 35.2, 32.8, 32.7, 32.4, 26.1, 24.1, 23.9, 23.0, 19.0, 18.5. 
LRMS (EI+) m/z calculated for C23H41INO2Si [M+H]
+: 518.1951, found: 518.2119. 
 
 
Thermal Isomerization of 3-2b to 3-2a. 
3-2b (8.3 mg, 0.016 mmol) was dissolved in CDCl3 (0.7 mL) and placed in an NMR 
tube. The tube was wrapped thoroughly with parafilm. The reaction was heated to 80 oC 
and followed by NMR. Analysis by NMR indicated that conversion of 3-2b to 3-2a was 
complete after 92 hours. Also, it was observed that olefin isomerization occurred with a 
distribution of 3:1 desired to undesired. TLC analysis indicated that the olefin isomers 
were inseparable. 
 
 
140 
 
 
(±)-(Z)-6-(3-((E)-6-iodo-5-methylhex-5-en-2-yl)isoxazol-5-yl)-5-methylhex-5-en-1-ol 
(3-2ab). 
3-2a (0.125 g, 0.24 mmol) was dissolved in 3.3 mL of 1% HCl in 95:5 EtOH:H2Oand 
the reaction was stirred for 20 minutes. The reaction was quenched with the addition of 
saturated NaHCO3 (1.5 mL) and diluted with water (7 mL). The aqueous phase was 
extracted 3x with EtOAc (3x 20 mL) and the organics were dried over Na2SO4, filtered, 
and concentrated. The crude material was used in the next step without further 
purification. 1H NMR (CDCl3, 300 MHz) δ 6.10 (s, 1H), 5.89-5.87 (m, 2H), 3.71-3.67 
(m, 2H), 2.90-2.83 (m, 1H), 2.49-2.45 (m, 2H), 2.23-2.13 (m, 2H), 1.94 (d, J = 1.2 Hz, 
3H), 1.81 (d, J = 0.9 Hz, 3H), 1.79-1.68 (m, 3H), 1.66-1.55 (m, 6H), 1.26 (d, J = 7.2 Hz, 
3H). 
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(±)-(Z)-6-(3-((E)-6-iodo-5-methylhex-5-en-2-yl)isoxazol-5-yl)-5-methylhex-5-enal (3-
9). 
3-2ab (0.24 mmol from the previous step) was dissolved in DMSO (0.7 mL) and IBX 
(102 mg, 0.36 mmol) was added. The reaction was stirred for 20 hours and quenched 
with the addition of water (2 mL). The slurry was stirred for 15 minutes and then filtered 
over celite. The celite was washed 3x with EtOAc (3x 10 mL). The filtrate was dried 
over MgSO4 and concentrated. The material was purified by column chromatography 
(first neutralization with 1% Et3N in Hexanes, then the column was run in 
Hexanes:EtOAc 85:15) to give 3-9 (84 mg, 87% for 2 steps).  1H NMR (CDCl3, 300 
MHz) δ 9.80-9.79 (m, 1H), 6.13(s, 1H), 5.98 (s, 1H), 5.87 (s, 1H), 2.91-2.84 (m, 1H), 
2.56-2.45 (m, 4H), 2.26-2.13 (m, 2H), 2.94 (s, 3H), 1.90-1.65 (m, 4H), 1.81 (s, 3H), 1.27 
(d, J = 6.9 Hz, 3H). 13C NMR (CDCl3, 75 MHz) δ 202.2, 168.3, 138.0, 147.5, 146.3, 
112.6, 100.1, 75.3, 43.6, 37.2, 34.2, 33.3, 31.2, 24.9, 24.1, 20.2, 20.1. LRMS (EI+) m/z 
calculated for C17H25INO2 [M+H]
+: 402.0924, found: 402.1143. 
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(±)-(2Z, 7E,13Z)-3-amino-9-hydroxy-4,7,13-trimethylcyclotetradeca-2,7,13-trienone 
(3-10). 
In a glovebox, CrCl2 (0.255 g, 2.09 mmol) and NiCl2 (2.7 mg, 0.021 mmol) were 
combined in a flame-dried flask. The flask was placed under N2 on a Schlenk line. THF 
(0.24 mL) was added to the mixture of CrCl2 and NiCl2. 3-9 (84 mg, 0.21 mmol) was 
dissolved in DMF (21 mL) and the resulting solution was cannulated at RT to the flask 
containing CrCl2, NiCl2, and THF. The reaction was then stirred at RT for 20 hours and 
quenched with the addition of a potassium serinante solution (7 mL).viii The reaction was 
stirred for 1 hour and the DMF was removed in vacuo. The resulting solids were 
partitioned between 50 mL of water and 125 mL EtOAc. The organic phase was 
separated and the aqueous phase was extracted 2x with EtOAc (2x 125). The combined 
organics were dried over Na2SO4, filtered and concentrated. The material was purified 
by column chromatography (Hexanes:EtOAc 50:50 to 40:60) to give 3-10 (7 mg, 12% as 
a 1:1.5 mixture of diastereomers).   1H NMR (CDCl3, 300 MHz) δ 9.95 (brs, 1H), 5.75 
(s, 0.6 H), 5.72 (s, 0.4H), 5.39 (d, J = 8.1 Hz, 0.4 H), 5.24 (d, J = 8.7 Hz, 0.6H), 5.13 (s, 
0.6H), 5.11 (s, 0.4H), 4.99 (brs, 1H) 4.44-4.35 (m, 1H), 22.55-1.96 (m, 4H), 1.93-1.45 
(m, 7H), 1.78-1.77 (m, 3H), 1.72 (s, 1.2H), 1.65 (s, 1.8 H), 1.33 (brs, 1H), 1.18-1.15 (m, 
3H). 13C NMR (CDCl3, 75 MHz) δ 193.23, 193.17, 169.5, 168.1, 144.2, 144.1, 139.8, 
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139.5, 129.8, 129.3, 129.2, 129.1, 97.1, 96.7, 67.9, 67.2, 45.9, 41.2, 40.2, 39.1, 37.0, 
36.8, 36.4, 35.2, 33.6, 31.7, 31.0, 24.4, 24.1, 23.3, 21.7, 15.5, 8.8. LRMS (EI+) m/z 
calculated for C17H28NO2 [M+H]
+: 278.2115, found: 278.2467. 
 
 
(±)-(5E,11Z)-2,5,11-trimethyl-14-oxa-15-azabicyclo[11.2.1]hexadeca-
1(15),5,11,13(16)-tetraen-7-ol (3-11). 
In a glovebox, CrCl2 (46 mg, 0.37 mmol) and NiCl2 (~1 mg, 0.008 mmol) were 
combined in a flame-dried flask. The flask was placed under N2 on a Schlenk line. THF 
(84 μL) was added to the mixture of CrCl2 and NiCl2. 3-9 (30 mg, 0.075 mmol) was 
dissolved in DMF (7.5 mL) and the resulting solution was cannulated at RT to the flask 
containing CrCl2, NiCl2, and THF. The reaction was then stirred at RT for 21 hours and 
quenched with the addition of a potassium serinante solution (2.5 mL).ix The reaction 
was stirred for 1 hour and the DMF was removed in vacuo. The resulting solids were 
partitioned between 18 mL of water and 45 mL EtOAc. The organic phase was separated 
and the aqueous phase was extracted 2x with EtOAc (2x 45). The combined organics 
were dried over Na2SO4, filtered and concentrated. The material was purified by column 
chromatography (Hexanes:EtOAc 70:30 to 50:50) to give 3-11 (4.7 mg, 23% as a 1:2.1 
mixture of diastereomers). 1H NMR (CDCl3, 300 MHz) δ 6.09 (s, 0.3 H), 6.06 (s, 0.7H), 
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6.00 (s, 0.3H), 5.91 (s, 0.7H) 5.13 (d, J = 9.0 Hz 0.3H), 5.03 (d, J = 9.0 Hz, 0.7 H), 4.32-
4.19 (m, 1H), 3.11-3.00 (m, 0.3H), 2.92-2.81 (m, 0.7H), 2.52-2.31 (m, 1H), 2.19-1.64 
(m, 5H), 1.92-1.90 (m, 3H), 1.52 (s, 2.1 H), 1.47 (s, 0.9 H), 1.45-1.15 (m, 4H), 1.30-1.26 
(m, 3H). 13C NMR (CDCl3, 75 MHz) δ 167.9, 167.7, 149.0, 148.5, 140.1, 139.5, 128.3, 
127.5, 112.3, 112.1, 101.4, 101.2, 68.1, 68.0, 39.0, 36.9, 36.6, 35.1, 34.3, 34.1, 33.9, 
32.9, 32.2, 32.1, 26.1, 25.9, 22.6, 22.3, 21.7, 20.1, 17.8, 15.9. LRMS (EI+) m/z 
calculated for C17H24NO [M-H2O]
+: 258.1852, found: 258.2101. 
 
 
(±)-(5E,11Z)-2,5,11-trimethyl-14-oxa-15-azabicyclo[11.2.1]hexadeca-
1(15),5,11,13(16)-tetraen-7-one (3-12). 
3-11 (24 mg, 0.087 mmol) was dissolved in DMSO (1.0 mL) and IBX (36.5 mg, 0.13 
mmol) was added in one portion. The reaction was stirred at RT for 16 hrs. The reaction 
was quenched with the addition of H2O (1.2 mL) and stirred for 15 minutes. The slurry 
was filtered through a plug of celite and the plug was washed with EtOAc. The filtrate 
was dried over Na2SO4 and concentrated. The material was purified by column 
chromatography (Hexanes:EtOAc 90:10 to 80:20) to give 3-12 (22.4 mg, 94%). 1H 
NMR (CDCl3, 300 MHz) δ 6.09 (s, 1H), 5.84 (s, 1H), 5.54 (s, 1H), 2.99-2.87 (m, 1H), 
2.34-2.17 (m, 5H), 2.08 (d, J = 0.9 Hz, 3H), 2.08-1.98 (m, 1H), 1.91 (d, J = 1.5 Hz, 3H), 
1.86-1.67 (m, 4H), 1.27 (d, J= 7.2 Hz, 3H). 13C NMR (CDCl3, 75 MHz) δ 201.1, 168.0, 
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167.3, 158.8, 147.9, 124.2, 112.9, 101.9, 42.0, 38.9, 32.8, 32.4, 31.9, 24.5, 23.1, 21.1, 
19.3. LRMS (EI+) m/z calculated for C17H24NO2 [M+H]
+: 274.1802, found: 274.1937. 
 
 
(±)-(2Z,8E,13Z)-13-amino-3,9,12-trimethylcyclotetradeca-2,8,13-triene-1,7-dione (3-
13). 
3-12 (9.5 mg, 0.035 mmol) was dissolved in CH3CN (0.7 mL) under N2 in a 1.5 mL 
flame dried bomb. To this solution was added H2O (1 μL) followed by Mn(CO)6 (4.7 
mg, 0.018 mmol). The reaction was sealed and heated to 80 oC and stirred for 40 
minutes. The solution was concentrated and the material was purified by column 
chromatography  (Hexanes:EtOAc 60:40 ) to give 3-13 (3.7 mg, 56% 2.2:1 mixture of 
E:Z isomers by NMR). The spectra were consistent with material previously prepared 
using the alternate synthesis of 3-13. See alternate synthesis of 3-13 for spectral analysis. 
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Alternate synthesis of 3-13. 
3-10 (6.1 mg, 0.022 mmol) was dissolved in DMSO (0.35 mL) at RT and IBX (9.2 mg, 
0.033 mmol) was added. The reaction was stirred for 8 hours and quenched with the 
addition of 0.36 mL of water. The reaction was stirred for 15 minutes and then the slurry 
was filtered over celite. The celite was washed with EtOAc and the aqueous phase was 
extracted 3 x with EtOAc (3x 10 mL). The organic phases were dried over Na2SO4, 
filtered and concentrated. The material was purified by column chromatography  
(Hexanes:EtOAc 60:40 ) to give 3-13 (4.7 mg, 55%). 1H NMR (CDCl3, 300 MHz) δ 
9.97 (brs, 1H), 6.15 (s, 1H), 5.85 (s, 1H), 5.13 (s, 1H), 4.91 (brs, 1H), 2.15-2.27 (m, 5H), 
2.26-2.08 (m, 2H), 2.15 (s, 3H), 1.89-1.65 (m, 4H), 1.79 (s, 3H), 1.17 (d, J = 6.9 Hz, 
3H). 13C NMR (CDCl3, 75 MHz) δ 200.9, 192.4, 167.7, 156.9, 145.0, 129.9, 125.1, 97.3, 
43.4, 40.4, 39.8, 32.2, 30.1, 24.3, 23.4, 21.4, 18.1. LRMS (EI+) m/z calculated for 
C17H26NO2 [M+H]
+: 276.1958, found: 276.1739. 
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(±)-(2Z,8E,13Z)-13-hydroxy-3,9,12-trimethylcyclotetradeca-2,8,13-triene-1,7-dione 
(1-28). 
3-13 (3.0 mg, 0.012 mmol) was dissolved in AcOH (0.1 mL). To this solution was added 
H2O (50 μL) followed by CH3CN (0.1 mL). The reaction was stirred at RT for 6 hours 
and diluted with DCM (1mL) and water (1 mL). The aqueous phase was washed with 3x 
with DCM (3x 3 mL) and the organic phases were combined, dried over Na2SO4 and 
concentrated. The material was purified by column chromatography  (Hexanes:EtOAc 
88:12 ) to give 1-28 (1.7 mg, 60% 2.7:1 mixture of E:Z isomers). 1H NMR (CDCl3, 300 
MHz) δ 15.63-15.54 (m, 1H), 5.97 (s, 1H), 5.81 (s, 0.7H), 5.78 (s, 0.3H), 5.50 (s, 1H), 
2.75-2.65 (m, 1H), 2.38-2.20 (m, 5H), 2.16 (d, J = 1.2 Hz, 2H), 2.10-1.94 (m 3H), 1.87 
(d, J = 1.2 Hz, 1H), 1.83 (d, J = 1.2 Hz, 3H), 1.71-1.61 (m, 2H), 1.13-1.08 (m, 3H). 13C 
NMR (CDCl3, 75 MHz) δ 200.2, 199.8, 158.7, 151.0, 125.0, 124.5, 124.2, 123.7, 101.4, 
100.9, 43.6, 43.5, 42.1, 41.6, 40.8, 39.8, 32.5, 31.3, 31.1, 31.0, 30.8, 29.8, 27.9, 26.1, 
24.5, 24.4, 22.7, 22.0, 19.5, 19.1, 18.4. LRMS (EI+) m/z calculated for C17H25O3 
[M+H]+: 277.1798, found: 277.2102. 
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CHAPTER IV 
 
 
(E)-1-iodo-2-methylhex-1-ene (4-1a). 
This molecule was prepared according to the method of Negishi et al.x Isolated material: 
1.35 g, 60% yield. 1H NMR (CDCl3, 500 MHz) δ 5.86-5.85 (m, 1H), 2.20 (t, J = 8.0 Hz, 
2H), 1.82 (d, J = 1 Hz, 3H0, 1.44-1.38 (m, 2H), 1.32-1.25 (m, 2H), 0.90 (t, J = 7.5 Hz, 
3H). 
 
 
(E)-(1-iodoprop-1-en-2-yl)benzene (4-1b). 
This molecule was prepared according to the method of Negishi et al.x Isolated material: 
2.13 g, 87% yield. 1H NMR (CDCl3, 500 MHz) δ 7.36-7.27 (m, 5H), 6.52-6.52 (m, 1H), 
2.28 (d, J = 1.5 Hz, 3H). 
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(E)-1-chloro-4-(1-iodoprop-1-en-2-yl)benzene (4-1c). 
To a suspension of Cp2ZrCl2 (2.92 g, 10 mmol) in 1,2-DCE (25 mL) was added Me3Al 
(1.92 mL, 20 mmol) under N2. The rection was stirred for 10 minutes and 1-chloro-4-
ethynylbenzenexi (1.37 g, 10 mmol) in 1,2 DCE (5 mL) was added. The reaction was 
stirred overnight at r.t. After 17 hours, the reaction was cooled to 0 oC and I2 (3.04 g, 12 
mmol) in THF (15 mL) was added dropwise. The reaction was stirred for 10 min and 
then worked up as in Negishi et al.x A yellow oil was isolated (2.12 g, 76% yield). 1H 
NMR (CDCl3, 500 MHz) δ 7.32-7.26 (m, 4H), 6.56-6.55 (m, 1H), 2.27 (d, J = 1.0 Hz, 
3H). 13C NMR (CDCl3, 125 MHz) δ 146.3, 140.1, 134.0, 128.9, 127.6, 80.1, 24.6. 
 
 
(iodomethylene)cyclohexane (4-1d). 
This substrate was prepared according to the method of Stork and Zhao.xii Isolated 
material: 0.670 g, 44% yield. 1H NMR (CDCl3, 500 MHz) δ 5.78-5.76 (m, 1H), 2.31-
2.23 (m, 4H), 1.57-1.49 (m, 6H).  
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(E)-1-iodohex-1-ene (4-1e). 
This substrate was prepared according to the method of Liu et al.xiii 1H NMR (CDCl3, 
300 MHz) δ 6.56-6.46 (m, 1H), 6.00-5.94 (m, 1H), 2.09-2.02 (m, 2H), 1.43-1.23 (m, 
4H), 0.92-0.86 (m, 3H). 
 
 
(E)-1-bromo-2-methylhex-1-ene (4-1f). 
To a suspension of Cp2ZrCl2 (2.92 g, 10 mmol) in 1,2-DCE (25 mL) was added Me3Al 
(1.92 mL, 20 mmol) under N2. The rection was stirred for 10 minutes and 1-hexyne was 
added (1.15 mL, 10 mmol). The reaction was stirred overnight at r.t. After 17 hours, the 
reaction was cooled to 0 oC and NBS (2.14 g, 12 mmol) in THF (30 mL) was added 
dropwise. The reaction was stirred for 1 hour and then worked up as in Negishi et al.x A 
yellow oil was isolated (0.82 g, 46% yield). 1H NMR (CDCl3, 500 MHz) δ 5.88-5.87 (m, 
1H), 2.12-2.08 (m, 2H), 1.78 (d, J = 1.5 Hz, 3H), 1.44-1.38 (m, 2H), 1.32-1.25 (m, 2H), 
0.90 (t, J = 7.5 Hz, 3H). 13C NMR (CDCl3, 125 MHz) δ 142.1, 101.0, 38.2, 29.8, 22.3, 
19.2, 14.0. 
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Direct Acylation Method A (DMF). The synthesis of (E)-5-methyltetradec-5-en-7-
one (4-2a) is representative. 
 To a flame-dried flask in a glove box were added dry K2CO3 (172 mg, 1.25 
mmol), Pd2dba3 (4.6 mg, 0.005 mmol) and (t-Bu)3P (4.0 mg, 0.02 mmol). The flask was 
capped with a rubber septum and placed on a Schlenk line. DMF (1 mL), (E)-1-iodo-2-
methylhex-1-ene (56 mg, 0.25 mmol), octanal (48 μL, 0.3 mmol), and pyrrolidine (10 
μL, 0.125 mmol) were added and the reaction was heated to 50 oC. The reaction was 
stirred for 6 hours and then diluted with EtOAc. The reaction was filtered and the solid 
was washed with EtOAc (15 mL). The organics were concentrated and a column was run 
(Hexanes:EtOAc 99.5:0.5) to give 4-2a as a yellow oil (40 mg, 71%). 1H NMR (CDCl3, 
500 MHz) δ 6.04-6.04 (m, 1H), 2.41-2.38 (m, 2H), 2.11 (d, J = 1.0 Hz, 3H), 1.60-1.53 
(m, 4H), 1.47-1.41 (m, 2H), 1.33-1.23 (m, 10H), 0.92-0.85 (m, 6H). 13C NMR (CDCl3, 
125 MHz) δ 201.7, 158.7, 123.2, 44.6, 41.0, 31.8, 29.8, 29.4, 29.3, 24.4, 22.7, 22.5, 19.4, 
14.2, 14.0. 
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Direct Acylation Method B (DMA). The synthesis of (E)-5-methyl-1-phenylnon-4-
en-3-one (4-3a) is representative. 
 To a flame-dried flask in a glove box were added dry K2CO3 (172 mg, 1.25 
mmol), Pd2dba3 (4.6 mg, 0.005 mmol), (t-Bu)3P (4.0 mg, 0.02 mmol), DMA (1 mL), 
(E)-1-iodo-2-methylhex-1-ene (56 mg, 0.25 mmol), hydrocinnamaldehyde (40.2 mg, 0.3 
mmol), and pyrrolidine (10 μL, 0.125 mmol) were added. The flask was capped with a 
rubber septum, placed on a Schlenk line and the reaction was heated to 80 oC. The 
reaction was stirred for 3 hours and then diluted with EtOAc. The reaction was filtered 
and the solid was washed with EtOAc (15 mL). The organics were concentrated and a 
column was run (Hexanes:EtOAc 99.5:0.5) to give 4-3a as a light red oil (35.6 mg, 
65%). 1H NMR (CDCl3, 300 MHz) δ 7.31-7.15 (m, 5H), 6.05-6.03 (m, 1H), 2.95-2.90 
(m, 2H), 2.78-2.71 (m, 2H), 2.14 (d, J = 1.2 Hz, 3H), 1.64-1.25 (m, 6H), 0.91 (t, J = 7.2 
Hz, 3H). The proton spectrum was consentient with the literature.xiv  
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(E)-5-methylhexadec-5-en-7-one (4-2b). 
 Following direct acylation method A, the crude material crude product was 
purified by flash chromatography on silica gel (Hexanes/EtOAc, 99.5:0.5) to give 4-2b 
(31.8 mg) as a yellow oil NMR analysis suggests that the yield is far less than 50%. See 
NMR labeled 4-2b.  
 
CHAPTER V 
Preparation of 3,3 Disubstituted 3H-Indole Starting Materials 
 
 
General procedure A for the synthesis of 3-(3-oxobutyl)-3H-indole-3-carboxylates. 
The synthesis of (±)-allyl 7-methyl-3-(3-oxobutyl)-3H-indole-3-carboxylate (5-6a) is 
representative. 
2-Nitrotoluene (0.59 mL, 5 mmol) was dissolved in THF (30 mL) and cooled to -78 oC 
under N2. A solution of freshly prepared (E)-but-2-en-1-ylmagnesium chloride was 
added dropwise (1.5 M in THF, 4.33 mL). The reaction was stirred at -78 oC for 30 
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minutes and quenched with the addition of saturated aqueous NH4Cl (5 mL). The 
mixture was then allowed to warm to rt. The mixture was diluted with water (30 mL) 
and extracted three times with ethyl acetate (3x 40 mL). The organic phases were 
combined and dried over Na2SO4, filtered and concentrated to give crude (E)-N-(but-3-
en-2-ylidene)-2-methylaniline oxide. The residue was used in the next reaction without 
further purification.  
(E)-N-(but-3-en-2-ylidene)-2-methylaniline oxide was dissolved in toluene (23 mL) and 
allyl propiolate (0.78 g, 7.1 mmol) was added. The reaction was heated to 80 oC for 14 
hours. After cooling to rt, the reaction was concentrated and a silica gel column 
(Hexanes/EtOAc, 73:27) was run to give (±)-allyl 7-methyl-3-(3-oxobutyl)-3H-indole-3-
carboxylate, 5-6a (0.185 g, 51 %) as a dark yellow oil. 1H NMR (CDCl3, 500 MHz) δ 
8.11 (s, 1H), 7.32-7.17 (m, 3H), 5.88-5.75 (m, 1H), 5.24-5.17 (m, 2H), 4.62-4.50 (m, 
2H), 2.61-2.37 (m, 2H), 2.59 (s, 3H), 2.19-2.04 (m, 2H), 1.98 (s, 3H). 13C NMR (CDCl3, 
125 MHz) δ 206.8, 170.2, 169.2, 153.7, 135.8, 131.3, 131.2, 130.6, 126.9, 120.8, 118.8, 
66.9, 66.3, 37.7, 30.0, 27.4, 16.8. HRMS (EI+) m/z calculated for C17H20NO3 [M+H]
+: 
286.1438, found: 286.1441. 
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(±)-Allyl 3-(3-oxobutyl)-3H-indole-3-carboxylate (5-6b). 
Following general procedure A for the synthesis of 5-6a with the exception of a 1 day 
stir at rt instead of overnight at 80 oC, the crude product was purified by flash 
chromatography on silica gel (Hexanes/EtOAc, 73:27) to give 5-6b (0.109 g, 13 %) as a 
yellow oil. 1H NMR (CDCl3, 500 MHz) δ 8.14 (s, 1H), 7.63 (d, J = 8.0 Hz, 1H), 7.49 (d, 
J = 8 Hz, 1H), 7.41 (t, J = 6.5 Hz, 1H), 7.30 (t, J = 7.5 Hz, 1H), 5.86-5.78 (m, 1H), 5.22-
5.18 (m, 2H), 4.60-4.52 (m, 2H), 2.60-2.54 (m, 1H), 2.46-2.40 (m, 1H), 2.14-2.01 (m, 
2H), 1.96 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 206.7, 171.4, 169.0, 155.1, 135.9, 
131.1, 129.2, 127.0, 123.5, 121.4, 118.9, 66.7, 66.3, 37.6, 30.0, 27.3. HRMS (EI+) m/z 
calculated for C16H18NO3 [M+H]
+: 272.1281, found: 272.1292. 
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(±)-Allyl 5-methoxy-3-(3-oxobutyl)-3H-indole-3-carboxylate (5-6c). 
Following general procedure A for the synthesis of 5-6a, the crude product was purified 
by flash chromatography on silica gel (Hexanes/EtOAc, 73:27) to give 5-6c allyl 5-
methoxy-3-(3-oxobutyl)-3H-indole-3-carboxylate (0.23 g, 16 %) as a dark yellow oil. 1H 
NMR (CDCl3, 500 MHz) δ 7.99 (s, 1H), 7.52 (d, J = 8.5, Hz, 1H), 7.03 (d, J = 2.5 Hz, 
1H), 6.91 (dd, J = 2.5, 8.5 Hz, 1H) 5.86-5.76 (m, 1H), 5.23-5.17 (m, 2H), 4.61-4.51 (m, 
2H), 3.82 (s, 3H) 2.60-2.52 (m, 1H), 2.41-2.35 (m, 1H), 2.14-1.99 (m, 2H), 1.96 (s, 3H). 
13C NMR (CDCl3, 125 MHz) δ 206.8, 169.3, 169.2, 159.2, 148.9, 137.7, 131.3, 121.9, 
119.0, 114.3, 109.7, 66.9, 66.4, 55.9, 37.6, 30.1, 27.6. HRMS (EI+) m/z calculated for 
C17H19NO4Na [M+Na]
+: 324.1206, found: 324.1208. 
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(±)-Allyl 5-methyl-3-(3-oxobutyl)-3H-indole-3-carboxylate (5-6d). 
Following general procedure A for the synthesis of 5-6a, the crude product was purified 
by flash chromatography on silica gel (Hexanes/EtOAc, 73:27) to give 5-6d (0.330 g, 25 
%) as a dark yellow oil. 1H NMR (CDCl3, 500 MHz) δ 8.03 (s, 1H), 7.46 (d, J = 7.5 Hz, 
1H), 7.26 (s, 1H), 7.15 (d, J = 7.5 Hz, 1H), 5.81-5.74 (m, 1H), 5.18-5.13 (m, 2H), 4.56-
4.48 (m, 2H), 2.55-2.49 (m, 1H), 2.39-2.33 (m, 1H), 2.36 (s, 3H), 2.12-1.97 (m, 2H), 
1.93 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 206.7, 170.4, 169.2, 152.9, 137.0, 136.0, 
131.2, 129.8, 124.1, 120.9, 118.7, 66.5, 66.2, 37.6, 29.9, 27.4, 21.5.  HRMS (EI+) m/z 
calculated for C17H20NO3 [M+H]
+: 286.1438, found: 286.1447. 
 
 
(±)-Allyl 5-chloro-3-(3-oxobutyl)-3H-indole-3-carboxylate (5-6e). 
Following general procedure A for the synthesis of 5-6a, the crude product was purified 
by flash chromatography on silica gel (Hexanes/EtOAc, 73:27) to give 5-6e (0.151 g, 12 
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%) as a dark yellow oil. 1H NMR (CDCl3, 500 MHz) δ 8.14 (s, 1H), 7.56 (d, J = 8.0 Hz, 
1H), 7.49 (d, J = 3.5 Hz, 1H), 7.39 (dd, J = 3.5, 8.0 Hz, 1H), 5.88-5.79 (m, 1H), 5.27-
5.22 (m, 2H), 4.65-4.55 (m, 2H), 2.61-2.55 (m, 1H), 2.43-2.38, (m, 1H), 2.13-2.10 (m, 
2H), 2.01 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 206.3, 171.6, 168.4, 153.7, 137.7, 
132.9, 131.0, 129.5, 124.1, 122.3, 119.3, 67.1, 66.6, 37.6, 30.0, 27.5. HRMS (EI+) m/z 
calculated for C16H17ClNO3 [M+H]
+: 306.0891, found: 306.0893. 
 
 
General procedure B for the synthesis of 3-alkyl-3H-indole-3-carboxylates. The 
synthesis of  (±)-(E)-allyl 3-(but-2-en-1-yl)-3H-indole-3-carboxylate (5-6k). 
Allyl 1H-indole-3-carboxylate (0.30 g, 1.5 mmol) is dissolved in 1,4 dioxane (4.5 mL) 
under N2 at rt. To this solution is added t-BuOK (0.185 mg, 1.65 mmol). The reaction is 
stirred at rt for 15 minutes. A solution of Et3B in THF (0.165 mL, 1.65 mmol) is then 
added dropwise and the reaction is stirred for 30 minutes. trans-crotyl bromide (0.24 
mL, 3 mmol at 85% purity) is added and the reaction is stirred at 50 oC for 16 hours. The 
reaction was quenched with the careful addition of saturated aqueous ammonium 
chloride (2 mL) and the mixture was diluted with water (10 mL). The aqueous phase was 
extracted 3x with EtOAc (15 mL) and the organic phases were combined, dried 
(Na2SO4) and concentrated. Silica gel chromatography  (Hexanes/EtOAc 85:15) was run 
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to yield 5-6k (0.280 g, 35 %) as a light yellow oil. 1H NMR (CDCl3, 300 MHz) δ 8.22 
(s, 1H), 7.63 (d, J = 7.5 Hz, 1H), 7.53 (d, J = 7.5 Hz, 1H), 7.43-7.27 (m, 2H), 5.91-5.78 
(m, 1H), 5.59-5.47 (m, 1H), 5.30-5.18 (m, 3H), 4.65-4.52 (m, 2H), 2.93-2.85 (m, 1H), 
2.63-2.55 (m, 1H), 1.59 (d, J = 6.3 Hz, 3H). 13C NMR (CDCl3, 125 MHz) δ 171.9, 
169.2, 155.1, 136.8, 131.5, 130.8, 129.1, 126.8, 124.0 ,123.6, 121.4, 118.8, 67.8, 66.3, 
38.2, 18.0.  HRMS (EI+) m/z calculated for C16H17NO2 [M+H]
+: 256.1338, found: 
256.1343. 
 
 
(±)-allyl 3-(3-methylbut-2-en-1-yl)-3H-indole-3-carboxylate (5-6j). 
Following general procedure B for the synthesis of 5-6k, the crude product was purified 
by flash chromatography on silica gel (Hexanes/EtOAc, 90:10) to give 5-6j (0.160 g, 39 
%) as a light yellow oil. 1H NMR (CDCl3, 500 MHz) δ 8.21 (s, 1H), 7.62 (d, J = 7.5 Hz, 
1H), 7.55 (d, J = 7 Hz, 1H), 7.39 (dt, J = 1.5, 8.0 Hz, 1H), 7.8 (t, J = 7.0, 1H), 5.87-5.79 
(m, 1H), 5.24-5.19 (m, 2H), 4.98-4.94 (m, 1H), 4.63-4.53 (m, 2H), 2.94 (dd, J = 7.5, 14 
Hz, 1H), 2.60 (dd, J = 7.5, 14 Hz, 1H), 1.63 (s, 3H), 1.54 (s, 3H). 13C NMR (CDCl3, 125 
MHz) δ 172.1, 169.3, 155.1, 136.9, 136.7, 131.5, 129.0, 126.7, 123.5, 121.3, 118.7, 
117.2, 67.8, 66.2, 33.7, 25.9, 18.1.  HRMS (EI+) m/z calculated for C17H19LiNO2 
[M+Li]+: 276.1576, found: 276.1493. 
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(±)-(E)-allyl 3-(but-2-en-1-yl)-3H-indole-3-carboxylate (5-6L). 
Following general procedure B for the synthesis of 5-6k, the crude product was purified 
by flash chromatography on silica gel (Hexanes/EtOAc, 90:10) to give 5-6L (183 mg, 42 
%) as a light yellow oil. 1H NMR (CDCl3, 300 MHz) δ 8.22 (s, 1H), 7.56 (t, J = 8.1 Hz, 
2H), 7.40 (t, J = 7.5 Hz, 1H) 7.33-7.19 (m, 4H), 7.08-7.04 (m, 2H), 5.84-5.71 (m, 1H), 
5.19-5.13 (m, 2H), 4.61-4.49 (m, 2H), 3.57 (d, J = 13.5 Hz, 1H), 3.11 (d, J = 13.5 Hz, 
1H). 13C NMR (CDCl3, 75 MHz) δ 171.5, 169.0, 154.9, 136.5, 134.2, 131.1, 1297, 
129.1, 128.3, 127.3, 126.6, 123.7, 121.4, 118.8, 68.3, 66.2, 41.3.  HRMS (EI+) m/z 
calculated for C19H17NO2 [M+H]
+: 292.1338, found: 292.1348.  
 
 
(±)-allyl 3-(4-methylbenzyl)-3H-indole-3-carboxylate (5-6m). 
Following general procedure B for the synthesis of 5-6k, the crude product was purified 
by flash chromatography on silica gel (Hexanes/EtOAc, 90:10) to give 5-6m (0.170 g, 
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37 %) as a light yellow oil. 1H NMR (CDCl3, 500 MHz) δ 8.21 (s, 1H), 7.58-7.54 (m, 
2H), 7.39 (dt, J = 1.0, 7.5 Hz, 1 H), 7.31 (t, J = 7.5 Hz, 1H), 7.02 (d, J = 8 Hz, 2 H), 6.94 
(d, J = 8 Hz, 2 H), 5.82-5.74 (m, 1H), 5.19-5.14 (m, 2H), 4.59-4.51 (m, 2H), 3.55 (d, J = 
13.5 Hz, 1H), 3.09 (d, J = 13.5 Hz, 1H), 2.29 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 
171.8, 169.2, 155.1, 137.1, 136.7, 132.2, 131.3, 129.6, 129.2, 129.1, 126.7, 123.8, 121.5, 
118.9, 68.5, 66.3, 41.1, 21.2.  HRMS (EI+) m/z calculated for C20H19NO2 [M+H]
+: 
306.1494, found: 306.1508.  
 
 
(±)-allyl 3-(4-(tert-butyl)benzyl)-3H-indole-3-carboxylate (5-6n). 
Following general procedure B for the synthesis of 5-6k, the crude product was purified 
by flash chromatography on silica gel (Hexanes/EtOAc, 90:10) to give 5-6n (0.201 g, 37 
%) as a light yellow oil. 1H NMR (CDCl3, 500 MHz) δ 8.23 (s, 1H), 7.59 (d, J = 7.5 Hz, 
1H), 7.56 (d, J = 7.5 Hz, 1H), 7.40 (dt, J = 1.5, 7.5 Hz, 1H), 7.31 (t, J = 7.5 Hz, 1H), 
7.25 (d, J = 8 Hz, 2H), 7.02 (d, J = 8 Hz, 2H), 5.79-5.71 (m, 3H), 5.16-5.10 (m, 2H), 
4.60-4.49 (m, 2H), 3.56 (d, J = 13.5 Hz, 1H), 3.03 (d, J = 13.5 Hz, 1H), 1.29 (s, 9H). 
13C NMR (CDCl3, 125 MHz) δ 171.9, 169.2, 155.0, 150.3, 136.8, 132.4, 131.3, 129.5, 
129.2, 126.8, 125.4, 123.8, 121.5, 118.8, 68.5, 66.3, 51.2, 34.6, 31.4.  HRMS (EI+) m/z 
calculated for C23H25NO2 [M+H]
+: 348.1964, found: 348.1977. 
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(±)-allyl 3-(naphthalen-2-ylmethyl)-3H-indole-3-carboxylate (5-6o). 
Following general procedure B for the synthesis of 5-6k, the crude product was purified 
by flash chromatography on silica gel (Hexanes/EtOAc, 90:10) to give 5-6o (0.190 g, 37 
%) as a light yellow oil. 1H NMR (CDCl3, 500 MHz) δ 8.28 (s, 1H), 7.80-7.78 (m, 1H), 
7.74-7.0 (m, 2H), 7.59-7.57 (m, 3 H) 7.47-7.43 (m, 2H), 7.41 (t, J = 7.5 Hz, 1H), 7.32 (t, 
J = 8.5 Hz, 1H), 7.18 (dd, J = 1.5, 7 Hz, 1H),  5.78-5.70 (m, 1H), 5.14-5.10 (m, 2H), 
4.59-4.51 (m, 2H), 3.77 (d, J = 13.5 Hz, 1H), 3.27 (d, J = 13.5 Hz, 1H). 13C NMR 
(CDCl3, 125 MHz) δ 171.6, 169.2, 155.1, 136.7, 133.3, 133.0, 132.6, 131.2, 129.3, 
128.8, 128.1, 127.8, 127.8, 127.7, 126.8, 126.3, 126.0, 123.8, 121.6, 119.0, 68.6, 66.4, 
41.7.  HRMS (EI+) m/z calculated for C23H20NO2 [M+H]
+: 342.1494, found: 342.1513. 
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(±)-(E)-But-2-en-1-yl 5-methoxy-3-(3-oxobutyl)-3H-indole-3-carboxylate (5-6g). 
Following general procedure A for the synthesis of 5-6a, the crude product was purified 
by flash chromatography on silica gel (Hexanes/EtOAc, 73:27) to give 5-6g (0.154 g, 20 
%) as a dark yellow oil. 1H NMR (CDCl3, 300 MHz) δ 8.01 (s, 1H), 7.55 (d, J = 8.4 Hz, 
1H), 7.06 (d, J = 2.4 Hz, 1H), 6.92 (dd, J = 2.4, 8.4 Hz, 1H), 5.80-5.68 (m, 1H), 5.55-
5.46 (m, 1H), 4.59-4.43 (m, 2H), 3.85 (s, 3H), 2.66-2.52 (m, 1H), 2.44-2.34 (m, 1H), 
2.17-2.03 (m, 2H), 1.99 (s, 3H), 1.70 (d, J = 8.1 Hz, 3H). 13C NMR (CDCl3, 75 MHz) δ 
206.8, 169.4, 169.2, 159.1, 148.7, 137.6, 132.2, 124.2, 121.8, 114.2, 109.7, 66.8, 66.6, 
55.8, 37.6, 30.0, 27.6, 17.8. HRMS (EI+) m/z calculated for C18H22NO4 [M+H]
+: 
316.1543, found: 316.1489. 
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(±)-2-Methylallyl 5-methoxy-3-(3-oxobutyl)-3H-indole-3-carboxylate (5-6h). 
Following general procedure A for the synthesis of 5-6a with the exception of a 4 day 
stir at rt instead of overnight at 80 oC, the crude product was purified by flash 
chromatography on silica gel (Hexanes/EtOAc, 73:27) to give 5-6h (0.341 g, 26 %) as a 
dark yellow oil. 1H NMR (CDCl3, 500 MHz) δ 8.00 (s, 1H), 7.52 (d, J = 8.5Hz, 1H), 
7.03 (d, J = 2.5 Hz, 1H), 6.91 (dd, J = 2.5, 8.5 Hz, 1H), 4.87 (s, 1H), 4.84 (s, 1H), 4.48 
(s, 2H), 3.82 (s, 3H), 2.60-2.54 (m, 1H), 2.43-2.37 (m, 1H), 2.15-1.99 (m, 2H), 1.97 (s, 
3H), 1.65 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 206.8, 169.3, 169.1, 159.2, 148.9, 
139.1, 137.7, 121.9, 114.4, 113.6, 109.6, 69.0, 55.9, 37.7, 30.1, 27.5, 25.7, 19.4. HRMS 
(EI+) m/z calculated for C18H22NO4 [M+H]
+: 316.1543, found: 316.1725. 
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(±)-3-Methylbut-2-en-1-yl 5-methoxy-3-(3-oxobutyl)-3H-indole-3-carboxylate (5-6i). 
Following general procedure A for the synthesis of 5-6a with the exception of a 3 day 
stir at rt instead of overnight at 80 oC, the crude product was purified by flash 
chromatography on silica gel (Hexanes/EtOAc, 73:27) to give 5-6i (0.185 g, 30 %) as a 
dark yellow oil. 1H NMR (CDCl3, 500 MHz) δ 8.00 (s, 1H), 7.50 (d, J = 8.5 Hz, 1H), 
7.04 (d, J = 2.5 Hz, 1H), 6.91 (dd, J = 2.5, 8.5 Hz, 1H), 5.28-5.24 (m, 1H), 4.63-4.51 (m, 
2H), 3.84 (s, 3H), 2.58-2.52 (m, 1H), 2.41-2.35 (m, 1H), 2.15-2.04 (m, 2H), 1.98 (s, 3H), 
1.72 (s, 3H), 1.65 (s, 3H) . 13C NMR (CDCl3, 125 MHz) δ 206.8, 269.5, 169.4, 159.1, 
148.7, 140.0, 137.7, 121.7, 117.8, 114.2, 109.7, 66.9, 62.8, 55.8, 37.6, 30.0, 27.7, 25.7, 
18.1.  HRMS (EI+) m/z calculated for C19H24NO4 [M+H]
+: 330.1705, found: 330.1536. 
 
 
(±)-Allyl 6-methyl-3-(3-oxobutyl)-3H-indole-3-carboxylate (5-6f). 
Following general procedure A for the synthesis of 5-6a, the crude product was purified 
by flash chromatography on silica gel (Hexanes/EtOAc, 73:27) to give 5-6f (0.185 g, 10 
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%) as a dark yellow oil. 1H NMR (CDCl3, 500 MHz) δ 8.11 (s, 1H), 7.45 (s, 1H), 7.36 
(d, J = 7.5 Hz, 1H), 7.11 (d, J = 7.5 Hz, 1H), 5.82-5.78 (m, 1H), 5.23-5.17 (m, 2H), 
4.60-4.52 (m, 2H), 2.57-2.51 (m, 1H), 2.45-2.39 (m, 1H), 2.42 (s, 3H), 2.15-2.01 (m, 
2H), 1.97 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 206.8, 171.6, 169.2, 155.5, 139.4, 
132.9, 131.2, 127.7, 123.1, 122.1, 118.8, 66.4, 66.3, 37.7, 30.0, 27.3, 21.6. HRMS (EI+) 
m/z calculated for C17H20NO3 [M+H]
+: 286.1438, found: 286.1432. 
 
III. Decarboxylative Allylic Alkylation of Allyl Indolenine-3-Carboxylates 
Scheme S1. General reaction and ligands. 
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Table S1. Extended Reaction Conditions. 
 
entry R ligand additive solvent T (oC) 2 / 3 / 4 
 
%ee  
1 7-Me (5-6a) Ph3P none toluene 60 (44) / (38) / (23) n/a 
2 7-Me (5-6a) (2-furyl)3P none CH2Cl2 23 (34) / (56) / 0 n/a 
3 7-Me (5-6a) (2-furyl)3P AcOH CH2Cl2 23 0 / 85 / 0 n/a 
4 7-Me (5-6a) (2-furyl)3P MeOH CH2Cl2 23 30 / 70 / 0 n/a 
5 7-Me (5-6a) (2-furyl)3P CuI CH2Cl2 23 (92) / 0 / 0 n/a 
6 H (5-6b) (2-furyl)3P CuI CH2Cl2 23 0 / 0 / 0 n/a 
7 H (5-6b) (2-furyl)3P CuI toluene 23 0 / 0 / 0 n/a 
8 H (5-6b) (2-furyl)3P Et3B (1eq.) toluene 23 82 / 17 / 0 n/a 
9 H (5-6b) L1 Et3B (1eq.) toluene 23 (95) / 0 / 0 48 
10 H (5-6b) L1 hexyl-9-BBNa toluene 0 48 / 14 / 0 56 
11 H (5-6b) L1 hexyl-9-BBNa CH2Cl2 0 44 / 20 / 0 55 
12 H (5-6b) L1 hexyl-9-BBNa 1,4-dioxane 0 48 / 19 / 0 48 
13 H (5-6b) L1 hexyl-9-BBNa DCE 0 44 / 23 / 0 64 
14 H (5-6b) L1 hexyl-9-BBNa THF 0 43 / 20 / 0 65 
17 H (5-6b) L2 hexyl-9-BBNa THF 0 44 / 21 / 0 57 
18 H (5-6b) L3 hexyl-9-BBNa THF 0 0 / 13 / 0 N.D. 
15 H (5-6b) L1 hexyl-9-BBNa toluene -20 35 / 12 / 0 N.D. 
16 H (5-6b) L1 hexyl-9-BBNa THF -20 35 / 12 / 0 N.D. 
17 H (5-6b) L1 hexyl-9-BBNb THF 0 48 / 13 / 0 72 
20 5-MeO (5-6c) L1 hexyl-9-BBNb THF 0 (70) / 30 / 0 70 
21 5-MeO (5-6c) L1 hexyl-9-BBNc THF 0 32 / 37 / 0 70 
22 5-MeO (5-6c) L1 hexyl-9-BBNd THF 0 (92) / 12 / 0 74 
23 5-MeO (5-6c) L1 hexyl-9-BBNe THF 0 (82) / 12 / 0 80 
 24 5-MeO (5-6c) L4 Nonef THF:propyl 
amine:dioxane (1:18) 
50 0/trace N/A 
25 5-MeO (5-6c) L4 hexyl-9-BBNg THF:propyl 
amine:dioxane (1:18) 
50 0/0 N/A 
 
a)  0.025 eq. of Pd2dba3, 0.075 eq. L, 0.525 eq. hexyl-9-BBN 
b)  0.0375 eq. of Pd2dba3, 0.1125 eq. L, 0.525 eq. hexyl-9-BBN 
c)  0.0375 eq. of Pd2dba3, 0.1125 eq. L, 0.25 eq. hexyl-9-BBN 
d) 0.0375 eq. of Pd2dba3, 0.1125 eq. L, 1.05 eq. hexyl-9-BBN 
e)  0.023 eq. of Pd2dba3, 0.1125 eq. L, 1.05 eq. hexyl-9-BBN 
f)  0.02 eq. of Ir(cod)Cl2, 0.04 eq. L4, 0 eq. hexyl-9-BBN 
g)  0.02 eq. of Ir(cod)Cl2, 0.04 eq. L4, 1.05 eq. hexyl-9-BBN 
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Synthesis of 4-(3-allyl-7-methyl-3H-indol-3-yl)butan-2-one 5-7a. 
A flame-dried flask was charged under N2 with Pd2dba3 (4.1 mg, 0.0045 mmol), tri(2-
furyl)phosphine (2.1 mg, 0.009 mmol) and dissolved in DCM (0.3 mL). This solution 
was then added to CuI (8.6 mg, 0.045 mmol) under N2. A solution of 0.15 mmol (42.8 
mg)  of Allyl 7-methyl-3-(3-oxobutyl)-3H-indole-3-carboxylate, 5-6a, in DCM (3 mL) 
was then added to the reaction flask and the reaction was then stirred overnight at RT. 
The reaction was then concentrated and a silica gel column (Hexanes/EtOAc, 65:35) was 
run to give 4-(3-allyl-7-methyl-3H-indol-3-yl)butan-2-one (33 mg, 90 %) as a yellow oil.  
1H NMR (CDCl3, 500 MHz) δ 7.95 (s, 1H), 7.20-7.11, (m, 2H), 7.09-7.03, (m, 1H), 
5.52-5.38 (m, 1H), 5.07-4.90 (m, 2H), 2.64-2.44 (m, 2H), 2.59 (s, 3H), 2.35-2.25 (m, 
1H), 2.18-2.09 (m, 1H), 1.96-1.70 (m, 2H), 1.89 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 
207.8, 176.6, 154.1, 140.5, 132.3, 130.9, 129.5, 126.3, 119.5, 118.8, 60.9, 39.9, 37.9, 
30.0, 27.5, 16.8. HRMS (EI+) m/z calculated for C16H20NO [M+H]
+: 242.1545, found: 
242.1534. 
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General procedure C for the synthesis of 3-alkyl-3H-indole-3-carboxylates. The 
synthesis of  (R)-4-(3-allyl-3H-indol-3-yl)butan-2-one (5-7b) is representative. 
Borane generation: A flame-dried 3 mL conical flask was placed under nitrogen and 
charged with a solution of 9-BBN in THF (0.5 M, 0.63 mL, 0.315 mmol). This solution 
was then diluted with THF (0.63 mL) and 1-hexene (93 μL, 0.75 mmol) was added. The 
reaction was stirred at RT for 4 hrs. 
Enantioconvergent decarboxylative allylic alkylation: A flame-dried 10 mL flask was 
charged with Pd2dba3 (4.0 mg, 0.004 mmol) and (R,R)-ANDEN-phenyl Trost ligand L1 
(17.4 mg, 0.0214 mmol). It was placed under nitrogen and THF (4.4 mL) was added. 
The solution was cannulated to a flask containing (±)-allyl indolenin-3-carboxylate (0.19 
mmol) under nitrogen atmosphere at 0 oC. The reaction was stirred for 2 min at 0 oC and 
0.8 mL of the aforementioned borane solution was added. The reaction was sealed with 
parafilm and stirred at 0 oC for 16 hrs. Workup A: The reaction was quenched with the 
addition of saturated NaHCO3 (3 mL) and the mixture was vigorously stirred for 2 hrs. 
The mixture was then diluted with 5 mL water and extracted with EtOAc (15 mLx3). 
The organic layers were combined, dried (Na2SO4), filtered, and concentrated. Workup 
B: The reaction was quenched with the addition of 2 N NaOH (2 mL) and diluted with 
EtOAc (3 mL). The mixture was then vigorously stirred for 2 hrs before it was diluted 
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with 5 mL water and extracted with EtOAc (15 mLx3). The organic layers were 
combined, dried (Na2SO4), filtered, and concentrated. Workup C: Ethanolamine (35 μL, 
0.57 mmol) was added to the reaction and the solution was stirred vigorously for 2 hrs. 
The resulting mixture was filtered and the filtrate was washed with EtOAc (15 mL). The 
combined organic phase was washed with sat. Na2CO3 (5 mL) and brine (5 mL) before it 
was dried over Na2SO4, filtered, and concentrated. Workup A was used for the 
synthesis of 5-7b and the crude product was purified by flash chromatography on silica 
gel (Hexanes/EtOAc, 73:27) to give 5-7b (35 mg, 80 % yield) as a light yellow oil. The 
spectra of 5-7b were consistent with the reported literature values.xv [αD]
20 (c 1.0, 
CH2Cl2) = 20.4
o. The ee was determined to be 77 % by chiral HPLC (Chiralpak IA, 
90:10 hexane:iPrOH, 1.0 mL/min, 8.58 min major, 8.25 min minor).  
 
Chiral Chromatogram for 5-7. 
 
 
 
 
171 
 
Racemic Chromatogram for 5-7b. 
 
 
 
(R)-4-(3-allyl-5-methoxy-3H-indol-3-yl)butan-2-one (5-7c). 
Following general procedure C with Workup A was used for 5-7c. A silica gel column 
was then run (Hexanes/EtOAc 73:27) to give 5-7c (40.0 mg, 82 % yield) as a light 
yellow oil. The spectra of 5-7c were consistent with the reported literature values.xv 
[αD]
20 (c .047, CH2Cl2) = 8.5
o. The ee was determined to be 80 % by chiral HPLC 
(Chiralpak IA, 90:10 hexane:iPrOH, 1.0 mL/min, 11.37 min major, 10.75 min minor). 
 
 
 
 
 
 
172 
 
Chiral Chromatogram for 5-7c. 
 
 
Racemic Chromatogram for 5-7c. 
 
 
 
(R)-4-(3-allyl-5-methyl-3H-indol-3-yl)butan-2-one (5-7d). 
Following general procedure C with Workup A for the synthesis of 5-7b, the crude 
product was purified by flash chromatography on silica gel (Hexanes/EtOAc, 73:27) to 
give 5-7d (41 mg, 94 %) as a light yellow oil. [αD]
20 (c 1.0, CH2Cl2) = 19.8
o. 1H NMR 
(CDCl3, 300 MHz) δ 7.89 (s, 1H), 7.49 (d, J = 8 Hz, 1H), 7.14 (d, J = 8 Hz, 1H), 7.04 (s, 
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1H), 5.48-5.40 (m, 1H), 5.02-4.94 (m, 2H), 2.60-2.46 (m, 2H), 2.39 (s, 3H), 2.32-2.26 
(m, 1H), 2.15-2.08 (m, 1H), 1.93-1.87 (m, 1H), 1.89 (s, 3H), 1.80-1.74 (m, 1H). 13C 
NMR (CDCl3, 125 MHz) δ 207.9, 176.9, 153.4, 140.7, 136.3, 132.3, 128.8, 122.8, 120.7, 
118.8, 60.6, 39.9, 37.8, 30.0, 27.5, 21.5.  HRMS (EI+) m/z calculated for C16H19LiNO 
[M+Li]+: 248.1627, found: 248.1639. The ee was determined to be 76 % by chiral HPLC 
(Chiralpak IC, 95:5 hexane:iPrOH, 1.0 mL/min, 19.09 min major, 21.11 min minor).  
Chiral Chromatogram for 5-7d. 
 
 
Racemic Chromatogram for 5-7d. 
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(R)-4-(3-allyl-5-chloro-3H-indol-3-yl)butan-2-one (5-7e). 
Following general procedure C with Workup A for the synthesis of 5-7b except 
conducting the reaction at RT, the crude product was purified by flash chromatography 
on silica gel (Hexanes/EtOAc, 73:27) to give 5-7e (30.5 mg, 61 %) as a light yellow oil. 
[αD]
20 (c 0.5, CH2Cl2) = 8.3
o. 1H NMR (CDCl3, 300 MHz) δ 7.96 (s, 1H), 7.55 (d, J = 8.5 
Hz, 1), 7.34 (dd, J = 2, 8 Hz, 1H), 7.23 (d, J = 2 Hz, 1H), 5.47-5.39 (m, 1H), 5.04-4.98 
(m, 2H), 2.57-2.48 (m, 2H), 2.36-2.30 (m, 1H), 2.15-2.09 (m, 1H), 1.93 (s, 3H), 1.92 - 
1.79 (m, 2H). 13C NMR (CDCl3, 125 MHz) δ 207.6, 178.5, 154.5, 142.9, 123.7, 131.9, 
128.8, 123.0, 122.5, 119.7, 61.7, 40.0, 38.1, 30.3, 27.5. HRMS (EI+) m/z calculated for 
C15H17ClNO [M+H]
+: 262.0999, found: 262.0996. The ee was determined to be 64 % by 
chiral HPLC (Chiralpak IA, 90:10 hexane:iPrOH, 1.0 mL/min, 8.76 min major, 8.38 min 
minor).  
Chiral Chromatogram for 5-7e. 
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Racemic Chromatogram for 5-7e. 
 
 
 
(S,E)-3-allyl-3-(but-2-en-1-yl)-3H-indole 5-7k. 
Following general procedure C with Workup Bxvi for the synthesis of 5-7b, the crude 
product was purified by flash chromatography on silica gel (Hexanes/EtOAc, 90:10) to 
give 5-7k (38 mg, 94 %) as a colorless oil. [αD]
20 (c 1.0, CH2Cl2) = -8.1
o. 1H NMR 
(CDCl3, 500 MHz) δ 8.03 (s, 1H), 7.62 (d, J = 7.5 Hz, 1H), 7.34 (dt, J = 1.5, 6 Hz, 1 H), 
7.30 - 7.23 (m, 2H), 5.47-5.38 (m, 2H), 5.15-5.09 (m, 1H), 5.01-4.92 (m, 2H), 2.57-2.40 
(m, 4H), 1.56 (d, J = 8 Hz, 3H). 13C NMR (CDCl3, 125 MHz) δ 178.2, 155.6, 141.8, 
132.6, 129.5, 127.9, 126.0, 124.9, 122.4, 121.2, 118.6, 61.2, 38.5, 37.6, 18.0. HRMS 
(EI+) m/z calculated for C15H17N [M+H]
+: 212.1439, found: 212.1447. The ee was 
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determined to be 54 % by chiral HPLC (Chiralpak AD, 99:1 hexane:iPrOH, 0.5 mL/min, 
23.05 min major, 23.96 min minor). 
Chiral Chromatogram for 5-7k. 
 
Peak Retention 
Time (min) 
Area (mAU's) Area % 
1 23.049 1648.22668 77.28  
2 23.960 484.45633 22.72  
Total  2132.68 100.00  
 
Racemic Chromatogram for 5-7k. 
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(S)-3-allyl-3-(3-methylbut-2-en-1-yl)-3H-indole (5-7j). 
Following general procedure C with Workup Bxvi for the synthesis of 5-7b, the crude 
product was purified by flash chromatography on silica gel (Hexanes/EtOAc, 90:10) to 
give 5-7j (46.5 mg, >95 %) as a colorless oil. [αD]
20 (c 1.0, CH2Cl2) = -7.6
o. 1H NMR 
(CDCl3, 500 MHz) δ 8.02 (s, 1H), 7.61 (d, J = 8.0 Hz, 1H), 7.36 - 7.29 (m, 2H), 7.26 - 
7.23 (m, 1H), 5.45 - 5.37 (m, 1H), 5.01 - 4.91(m, 2H), 4.88 - 4.83 (m, 1H), 2.60 - 2.49 
(m, 3H), 2.43 - 2.39 (m, 1H), 1.60 (s, 3H), 1.53 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 
178.2, 155.5, 141.8, 135.1, 132.7, 127.8, 125.9, 1222.2, 121.1, 118.4, 118.1, 62.6, 38.4, 
32.9, 25.8, 18.0. HRMS (EI+) m/z calculated for C16H20N [M+H]
+: 226.1596, found: 
226.1588. The ee was determined to be 60 % by chiral HPLC (Chiralpak AD, 95:5 
hexane:iPrOH, 0.5 mL/min, 11.63 min major, 11.24 min minor). 
Chiral Chromatogram for 5-7j. 
 
178 
 
Peak Retention 
Time (min) 
Area (mAU's) Area % 
1 11.236 4348.13086 19.94 
2 11.630 1.74538e4 80.06 
Total  21798 100.00  
 
Racemic Chromatogram for 5-7j. 
 
 
 
(S)-3-allyl-3-benzyl-3H-indole (5-7L). 
Following general procedure C with workup Bxvi for the synthesis of 5-7b, the crude 
product was purified by flash chromatography on silica gel (Hexanes/EtOAc, 90:10) to 
give 5-7L (43 mg, 92 %) as a colorless oil. [αD]
20 (c 0.5, CH2Cl2) = -86.5
o. 1H NMR 
(CDCl3, 500 MHz) δ 8.08 (s, 1H), 7.53 (d, J = 7.5 Hz, 1H), 7.33-7.30 (m, 1H), 7.28-7.24 
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(m, 2H), 7.17-7.14 (m, 3H), 6.96-6.94 (m, 2H), 5.43-5.34 (m, 1H), 5.01-4.92 (m, 2H), 
3.12 (d, J = 13.5 Hz, 1H), 3.03 (d, J = 13.5 Hz, 1H), 2.65-2.57 (m, 2H). 13C NMR 
(CDCl3, 125 MHz) δ 177.4, 136.1, 132.3, 129.8, 128.0, 127.9, 126.7, 125.8, 122.6, 
121.2, 118.7, 61.8, 41.1, 38.7. HRMS (EI+) m/z calculated for C18H18N [M+H]
+: 
248.1434, found: 248.1431. The ee was determined to be 73 % by chiral HPLC 
(Chiralpak IB, 90:10 hexane:iPrOH, 1.0 mL/min, 6.53 min major, 6.14 min minor). 
Chiral Chromatogram for 5-7L. 
 
 
Racemic Chromatogram for 5-7L. 
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(S)-3-allyl-3-(4-methylbenzyl)-3H-indole (5-7m). 
Following general procedure C with workup Bxvi for the synthesis of 5-7b, the crude 
product was purified by flash chromatography on silica gel (Hexanes/EtOAc, 90:10) to 
give 5-7m (50 mg, >95 %) as a colorless oil. [αD]
20 (c 1.0, CH2Cl2) = 3.9
o. 1H NMR 
(CDCl3, 500 MHz) δ 8.07 (s, 1H), 7.53 (d, J = 7.5 Hz, 1H), 7.34-7.30 (m, 1 H), 7.28 - 
7.24 (m, 2H), 6.97 (d, J = 7.5 Hz, 2H), 6.84 (d, J = 8 Hz, 2H), 5.42-5.33 (m, 1H), 5.00 - 
4.90 (m, 2H), 3.08 (d, J = 13.5 Hz, 1H), 2.99 (d, J = 13.5 Hz, 1H), 2.64 - 2.56 (m 2H), 
2.58 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 177.7, 155.7, 141.4, 136.4, 133.2, 132.5, 
129.8, 128.8, 128.0, 125.9, 122.7, 121.3, 118.8, 62.0, 40.9, 38.7, 21.2. HRMS (EI+) m/z 
calculated for C19H20N [M+H]
+: 262.1590, found: 262.1591. The ee was determined to 
be 54 % by chiral HPLC (Chiralpak IA, 95:5 hexane:iPrOH, 1.0 mL/min, 6.10 min 
major, 7.70 min minor). 
Chiral Chromatogram for 5-7m. 
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Racemic Chromatogram for 5-7m. 
 
 
 
(S)-3-allyl-3-(4-(tert-butyl)benzyl)-3H-indole (5-7n). 
Following general procedure C with Workup Bxvi for the synthesis of 5-7b, the crude 
product was purified by flash chromatography on silica gel (Hexanes/EtOAc, 90:10) to 
give 5-7n (55 mg, 96 %) as a colorless oil. [αD]
20 (c 1.0, CH2Cl2) = -63.7
o. 1H NMR 
(CDCl3, 500 MHz) δ 8.07 (s, 1H), 7.56 (d, J = 8.5 Hz, 1H), 7.35-7.32 (m, 1 H), 7.28 - 
7.26 (m, 2H), 7.20 (d, J = 8.5 Hz, 2H), 6.92 (d, J = 8.5 Hz, 2H), 5.38-5.29 (m, 1H), 4.95 
(m, 2H), 3.06 (d, J = 13.5 Hz, 2H), 2.97 (d, J = 13.5 Hz, 1H), 2.61 (d, J = 9.5 Hz, 1H), 
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1.27 (s, 9H). 13C NMR (CDCl3, 125 MHz) δ 177.8, 155.7, 149.7, 141.6, 133.3, 132.5, 
129.7, 128.0, 126.0, 125.1, 122.7, 121.3, 118.7, 62.9, 40.8, 38.5, 34.5, 31.5, 31.5. HRMS 
(EI+) m/z calculated for C22H25N [M+H]
+: 304.2065, found: 304.2067. The ee was 
determined to be 59 % by chiral HPLC (Chiralpak ASH, 99:1 hexane:iPrOH, 0.5 
mL/min, 12.44 min major, 14.07 min minor). 
Chiral Chromatogram for 5-7n. 
 
Peak Retention 
Time (min) 
Area (mAU's) Area % 
1 12.438 3898.81177 79.5387 
2 14.075 1002.96954 20.4613 
Total  4901.78131 100.00  
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Racemic Chromatogram for 5-7n. 
 
 
 
(S)-3-allyl-3-(naphthalen-2-ylmethyl)-3H-indole (5-7o). 
Following general procedure C with Workup Bxvi for the synthesis of 5-7b, the crude 
product was purified by flash chromatography on silica gel (Hexanes/EtOAc, 90:10) to 
give 5-7o (49.6 mg, 88 %) as a colorless oil. [αD]
20 (c 1.0, CH2Cl2) = -108.0
o. 1H NMR 
(CDCl3, 500 MHz) δ 8.08 (s, 1H), 7.72-7.65 (m, 2H), 7.60 (d, J= 8.5, 1H), 7.48 (d, J = 
8.0 Hz 1H), 7.41-7.37 (m, 3H), 7.29-7.21 (m, 3H), 7.02 (d, J = 8.0 Hz, 1H), 5.40-5.32 
(m, 1H), 4.97-4.89 (m, 2H), 3.23 (d, J = 13.5 Hz, 1H), 3.14 (d, J = 13.5 Hz, 1H), 2.64-
2.58 (m, 2H). 13C NMR (CDCl3, 125 MHz) δ 177.4, 155.5, 141.2, 133.8, 133.1, 132.3, 
132.2, 128.5, 128.2, 128.0, 127.6, 127.57, 127.51, 126.0, 125.9, 125.6, 122.6, 121.3, 
118.8, 117.4, 61.9, 41.3, 38.7. HRMS (EI+) m/z calculated for C22H20N [M+H]
+: 
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298.1590, found: 298.1604. The ee was determined to be 64 % by chiral HPLC 
(Chiralpak ASH, 99:1 hexane:iPrOH, 0.5 mL/min, 26.33 min major, 29.81 min minor). 
Chiral Chromatogram for 5-7o. 
 
Peak Retention 
Time (min) 
Area (mAU's) Area % 
1 26.334 2.37747e4 82.0034 
2 29.813 5217.63428 17.9966 
Total  2.89924e4 100.00  
 
Racemic Chromatogram for 5-7o. 
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(R,E)-4-(3-(but-2-en-1-yl)-5-methoxy-3H-indol-3-yl)butan-2-one (5-7g). 
Following general procedure C with Workup B for the synthesis of 5-7b, the crude 
product was purified by flash chromatography on silica gel (Hexanes/EtOAc, 73:27) to 
give 5-7g (32 mg, 62 %) as a colorless oil. [αD]
20 (c 1.0, CH2Cl2) = 9.86
o.1H NMR 
(CDCl3, 500 MHz) δ 7.83, (s, 1H), 7.52 (d, J = 8.0 Hz, 1H), 6.87 (dd, J = 2.5, 8.0 Hz, 
1H), 6.7 (d,  J = 2.5 Hz, 1H), 5.47-5.40 (m, 1H), 5.16-5.10 (m, 1H), 3.83 (s, 3H), 2.45-
2.36 (m, 2H), 2.30-2.24 (m, 1H), 2.12-2.05 (m, 1H), 1.93-1.87 (m, 1H), 1.90 (s, 3H), 
1.80-1.73 (m, 1H), 1.55 (d, J = 7.5 Hz, 3H).13C NMR (CDCl3, 125 MHz) δ 207.9, 176.1, 
158.7, 129.6, 124.6, 121.5, 121.4, 116.7, 112.7, 108.6, 55.7, 38.8, 37.9, 30.0, 27.4, 26.6, 
17.8.  HRMS (EI+) m/z calculated for C17H22NO2 [M+H]
+: 242.1651, found: 242.1647. 
The ee was determined to be 74 % by chiral HPLC (Chiralpak IA, 90:10 hexane:iPrOH, 
1.0 mL/min, 11.09 min major, 10.32 min minor). 
Chiral Chromatogram for 5-7g. 
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Racemic Chromatogram for 5-7g. 
 
 
 
(R)-4-(5-methoxy-3-(2-methylallyl)-3H-indol-3-yl)butan-2-one (5-7h). 
Following general procedure C with Workup A for the synthesis of 5-7b with the 
exception of conduction the reaction at 40 oC overnight, the crude product was purified 
by flash chromatography on silica gel (Hexanes/EtOAc, 73:27) to give 5-7h (40 mg, 76 
%) as a light yellow oil. [αD]
20 (c 1.0, CH2Cl2) =    -7.45
o. 1H NMR (CDCl3, 500 MHz) δ 
7.90 (s, 1H), 7.51 (d, J = 8.5 Hz, 1H), 6.86 (dd, J = 2.5, 8.5 Hz, 1 H), 6.78 (d, J  = 2.5 
Hz, 1H), 4.68, (s, 1H), 4.57 (s, 1H), 3.83 (s, 1H), 2.70 (d, J = 14 Hz, 1 H), 2.47 (d, J = 
14 Hz, 1H), 2.33-2.28 (m, 1H), 2.12-2.10 (m, 1H), 1.91-1.84 (m, 1H), 1.89 (s, 3H), 1.78-
1.70 (m, 1H), 1.44 (s, 3H) .13C NMR (CDCl3, 125 MHz) δ 207.9, 176.2, 158.9, 149.4, 
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142.7, 140.7, 121.7, 115.2, 112.9, 108.8, 61.3, 55.9, 44.4, 37.8, 30.2, 28.9, 24.2. HRMS 
(EI+) m/z calculated for C17H22NO2 [M+H]
+: 272.1651, found: 272.1662. The ee was 
determined to be 29 % by chiral HPLC (Chiralpak IA, 90:10 hexane:iPrOH, 1.0 mL/min, 
10.04 min major, 11.26 min minor). 
Chiral Chromatogram for 5-7h. 
 
 
Racemic Chromatogram for 5-7h. 
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(±)-4-(5-methoxy-3-(3-methylbut-2-en-1-yl)-3H-indol-3-yl)butan-2-one (5-7i). 
Following general procedure C using Workup B for the synthesis of 5-7b with the 
exception of conduction the reaction at 45 oC overnight, the crude product was purified 
by flash chromatography on silica gel (Hexanes/EtOAc, 73:27) to give 5-7i (28 mg, 52 
%) as a light yellow oil. 1H NMR (CDCl3, 300 MHz) δ 7.82, (s, 1H), 7.52 (d, J = 8.4 Hz, 
1H), 6.87 (dd, J = 2.7, 8.4 Hz, 1H), 6.7 (d,  J = 2.7 Hz, 1H), 4.86 (t, J = 7.5 Hz, 1H), 
3.83 (s, 3H), 2.47-2.26 (m, 3H), 2.17-2.06 (m, 1H), 1.95-1.73 (m, 2H), 1.89 (s, 3H), 1.60 
(s, 3H), 1.53 (s, 3H).13C NMR (CDCl3, 75 MHz) δ 207.9, 176.2, 158.7, 149.2, 142.9, 
135.2, 121.4, 118.0, 112.7, 108.5, 61.6, 55.7, 37.9, 34.2, 30.0, 27.4, 25.8, 17.9. HRMS 
(EI+) m/z calculated for C18H24NO2 [M+H]
+: 286.1802, found: 286.1808. The ee was 
determined to be 0 % by chiral HPLC (Chiralpak IA, 90:10 hexane:iPrOH, 1.0 mL/min, 
9.97 min, 10.28 min for both enantiomers). 
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Chiral Chromatogram for 5-7i. 
 
Racemic Chromatogram for 5-7i. 
 
 
4-(6-methyl-1H-indol-3-yl)butan-2-one (5-8f). 
Following general procedure C for the synthesis of 5-7b, the crude product was purified 
by flash chromatography on silica gel (Hexanes/EtOAc, 90:10) to give 5-8f (38 mg, 89 
%) as a white solid. 1H NMR (CDCl3, 500 MHz) δ 7.92 (brs, 1H), 7.46 (d, J = 8.0 Hz, 
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1H), 7.06 (t, J = 7.0 Hz, 1H), 7.02-7.00 (m, 2H), 3.06 (t, J = 7.0 Hz, 2 H), 2.85 (t, J = 
7.5 Hz, 2 H), 2.48 (s, 3H), 2.15 (s, 3H). 13C NMR (CDCl3, 125 MHz) δ 208.8, 135.9, 
126.7, 122.6, 121.2, 120.4, 119.5, 116.4, 115.7, 44.1, 30.1, 19.5, 16.6. HRMS (EI+) m/z 
calculated for C13H14NO [M-H]
-: 200.1081, found: 200.1083. 
 
 
4-(7-methyl-1H-indol-3-yl)butan-2-one (5-8a). 
Product was isolated by flash chromatography on silica gel (Hexanes/EtOAc, 73:27) as a 
beige solid. 1H NMR (CDCl3, 300 MHz) δ 7.94 (brs, 1H), 7.46 (d, J = 7.8 Hz, 1H), 7.09-
6.99 (m, 3 H), 3.06 (t, J = 7.8 Hz, 2H), 2.85 (t, J = 7.8 Hz, 2H), 2.48 (s, 3H), 2.15 (s, 
3H). 
 
 
4-(1-allyl-7-methyl-1H-indol-3-yl)butan-2-one. 
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Product was isolated by flash chromatography on silica gel (Hexanes/EtOAc, 73:27) as a 
beige solid. 1H NMR (CDCl3, 300 MHz) δ 7.42 (d, J = 7.8 Hz, 1H), 7.00 (t, J = 7.2 Hz, 
1H), 6.92 (d, J = 7.2 Hz, 1H), 6.80 (s, 1H), 6.08-5.96 (m, 1H), 5.11 (d, J = 10.5 Hz, 1H), 
4.90-4.87 (m, 1H), 4.77 (d, J = 17.1 Hz, 1H), 3.02 (t, J = 7.8 Hz, 2H), 2.83 (t, J = 7.8 Hz, 
2H), 2.66 (s, 3H), 2.14 (s, 3H). 
 
Synthesis of the Racemic HPLC standards. 
A flame-dried flask was charged under N2 with Pd2dba3 (3.8 mg, 0.0047 mmol), tri(2-
furyl)phosphine (2.1 mg, 0.00834 mmol) and 1a-o (0.14 mmol).  Toluene (2.8 mL) was 
then added at RT to the reaction flask and Et3B (0.14 mL, 0.14 mmol, 1M in THF) was 
added.  The reaction was sealed by wrapping with parafilm and stirred overnight (14 
hours) at RT. The reaction was then concentrated and a silica gel column (same polarity 
as chiral 2a-o) was run to give racemic 2a-o in 50-78% yield. The materials were 
identical in appearance and spectral analysis to the chiral 2a-o. 
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CHAPTER VI 
General Proceedure A. The Racemic Palladium-Catalyzed Allylic Alkylation of 
Aldehydes. The Synthesis of 2-methyl-2-phenylpent-4-enal (6-3) is Representative. 
 
 
 A flame-dried flask was charged with Pd(OAc)2 (4.7 mg, 0.021 mmol), PPh3 
(10.9 mg, 0.041 mmol), and dried LiCl (8.9 mg, 0.21 mmol). The flask was placed under 
N2 and THF (1 mL) was added. To this solution was added 6-2 (30.9 μL, 0.23 mmol), 
allyl acetate (26 μL, 0.24 mmol), Et3N (35 μL, 0.25 mmol), and Et3B (0.51 mL, 0.51 
mmol, 1M in hexanes) at room temperature. The reaction was stirred and monitored by 
TLC. The reaction was complete after 40 minutes and was concentrated en vacuo. The 
material was then loaded onto a pasture pipette silica column that had been neutralized 
by suspending the silica gel in a 1% Et3N in hexanes solution. The column was run with 
~7 mL of 90:10 hexanes:EtOAc to give  6-3 (30.5 mg, 81% yield) as a colorless oil. 1H 
NMR (CDCl3, 500 MHz) δ 9.52 (s, 1H), 7.41-7.37 (m, 2H), 7.31-7.28 (m, 1H), 7.27-
7.24 (m 2H), 5.59-5.51 (m, 1H), 5.08-5.02 (m, 2H), 2.72-2.61 (m, 2H), 1.45 (s, 3H). The 
spectra were consistent with the literature.xvii  
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2-(4-methoxyphenyl)-2-methylpent-4-enal (6-5) 
 The starting material 6-4 was prepared according to the literature.xviii 6-5 was 
prepared according to general proceedure A and the reaction was run for 18 hours (38.7 
mg, 82% yield). 1H NMR (CDCl3, 300 MHz) δ 9.46 (s, 1H), 7.18 (d, J = 8.7 Hz, 2H), 
6.92 (d, J = 9.0 Hz, 2H), 5.62-5.48 (m, 1H), 5.08-5.01 (m, 2H), 3.81 (s, 3H), 2.71-2.56 
(m, 2H), 1.42 (s, 3H). The spectra were consistent with the literature.xix 
 
 
1-allyl-1,2,3,4-tetrahydronaphthalene-1-carbaldehyde (6-7) 
 The starting material 6-6 was prepared according to the literature.xviii 6-7 was 
prepared according to general proceedure A and the reaction was run for 18 hours (41.5 
mg, 90% yield). 1H NMR (CDCl3, 500 MHz) δ 9.56 (s, 1H), 7.21-7.14 (m, 4H), 5.64-
5.56 (m, 1H), 5.09-5.03 (m, 2H), 2.80-2.77 (m, 2H), 2.64-2.62 (m, 2H), 2.12-2.07 (m, 
1H), 1.90-1.74 (m, 3H). 13C NMR (CDCl3, 125 MHz) δ 202.4, 139.0, 134.3, 134.0, 
130.2, 128.6, 127.3, 126.7, 118.8, 53.4, 41.4, 30.2, 28.2, 19.5. HRMS (EI+) m/z 
calculated for C14H17O [M+H]
+: 201.1274, found: Not Found. 
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General Proceedure B. The Racemic Palladium-Catalyzed Allylic Alkylation of 
Aldehydes. The Synthesis of Enantioenriched 2-methyl-2-phenylpent-4-enal (6-3) is 
Representative. 
 
 
 A flame-dried flask was charged with Pd2(dba)3 (6.3 mg, 0.0069 mmol), 6-L3 
(7.4 mg, 0.0138 mmol), and dried LiCl (8.9 mg, 0.21 mmol). The flask was placed under 
N2 and THF (1 mL) was added. The reaction was stirred for 10 minutes at r.t. To this 
solution was added 6-2 (30.9 μL, 0.23 mmol), allyl acetate (26 μL, 0.24 mmol), Et3N (35 
μL, 0.25 mmol), and Et3B (0.51 mL, 0.51 mmol, 1M in hexanes) at room temperature. 
The reaction was stirred and monitored by TLC. The reaction was complete after 1 hour 
and was concentrated en vacuo. The material was then loaded onto a pasture pipette 
silica column that had been neutralized by suspending the silica gel in a 1% Et3N in 
hexanes solution. The column was run with ~7 mL of 90:10 hexanes:EtOAc to give  6-3 
(36.6 mg, 91% yield) as a colorless oil. 1H NMR (CDCl3, 500 MHz) δ 9.52 (s, 1H), 
7.41-7.37 (m, 2H), 7.31-7.28 (m, 1H), 7.27-7.24 (m 2H), 5.59-5.51 (m, 1H), 5.08-5.02 
(m, 2H), 2.72-2.61 (m, 2H), 1.45 (s, 3H). The spectra were consistent with the 
literature.xvii The ee was determined to be 26% by chiral HPLC (Chiralpak AS-H, 99:1 
hexane:iPrOH, 0.5 mL/min, 14.53 min major, 15.10 min minor). 
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Chiral Chromatogram for 6-3 
 
 
Racemic Chromatogram for 6-3 
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Enantioenriched 2-(4-methoxyphenyl)-2-methylpent-4-enal (6-5) 
 The starting material 6-4 was prepared according to the literature.xviii 6-5 was 
prepared according to general proceedure B and the reaction was run for 19 hours (50.3 
mg, >95% yield). 1H NMR (CDCl3, 300 MHz) δ 9.46 (s, 1H), 7.18 (d, J = 8.7 Hz, 2H), 
6.92 (d, J = 9.0 Hz, 2H), 5.62-5.48 (m, 1H), 5.08-5.01 (m, 2H), 3.81 (s, 3H), 2.71-2.56 
(m, 2H), 1.42 (s, 3H). The spectra were consistent with the literature.xix The ee was 
determined to be 34% by chiral HPLC (Chiralpak AS-H, 99:1 hexane:iPrOH, 0.5 
mL/min, 19.98 min major, 22.82 min minor). 
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Chiral Chromatogram for 6-5. 
 
 
Racemic Chromatogram for 6-5. 
 
 
198 
 
 
 
Enantioenriched 1-allyl-1,2,3,4-tetrahydronaphthalene-1-carbaldehyde (6-7) 
 The starting material 6-6 was prepared according to the literature.xviii 6-7 was 
prepared according to general proceedure B and the reaction was run for 20 hours (48.0 
mg, >95% yield). Proton and carbon NMR were consistent with the racemic sample. The 
ee was determined to be 25% by chiral HPLC (Chiralpak IB, 97:3 hexane:iPrOH, 0.5 
mL/min, 9.21 min major, 9.61 min minor). 
Chiral Chromatogram for 6-7. 
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Racemic Chromatogram for 6-7. 
 
 
 
                                                 
i. This material was prepared according to the method of Myers et al. J. Am. Chem. 
 Soc. 1997, 119, 6496-6511. 
 
ii. This material was prepared according to the method of Pattenden et al. Synlett
 2001, 365-368. 
 
iii. Negishi, E.; Pour, M.; Cederbaum, F.E.; Kotora, M. Tetrahedron 1998, 54, 7057-
 7074. 
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vii. Guo, H.; Mortensen, M. S.; O'Doherty, G. A. Org. Lett. 2008, 10, 3149-3152. 
viii. The potassium serinate solution was prepared by mixing 6.59 g of serine, 4.71 g 
 of KHCO3 and 3.25 g of K2CO3 in 55 mL of H2O. 
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APENDIX B 
NMR SPECTRA 
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